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ABSTRACT 
APPLICATIONS OF BIG KNOWLEDGE SUMMARIZATION 
by 
Ling Zheng 
Advanced technologies have resulted in the generation of large amounts of data (“Big 
Data”). The Big Knowledge derived from Big Data could be beyond humans’ ability of 
comprehension, which will limit the effective and innovative use of Big Knowledge 
repository. Biomedical ontologies, which play important roles in biomedical information 
systems, constitute one kind of Big Knowledge repository. Biomedical ontologies 
typically consist of domain knowledge assertions expressed by the semantic connections 
between tens of thousands of concepts. Without some high-level visual representation of 
Big Knowledge in biomedical ontologies, humans cannot grasp the “big picture” of those 
ontologies. Such Big Knowledge orientation is required for the proper maintenance of 
ontologies and their effective use. This dissertation is addressing the Big Knowledge 
challenge – How to enable humans to use Big Knowledge correctly and effectively 
(referred to as the “Big Knowledge to Use” (BK2U) problem) – with a focus on 
biomedical ontologies. 
In previous work, Abstraction Networks (AbNs) have been demonstrated 
successful for the summarization, visualization and quality assurance (QA) of biomedical 
ontologies. Based on the previous research, this dissertation introduces new AbNs of 
various granularities for Big Knowledge summarization and extends the applications of 
AbNs. This dissertation consists of three main parts. The first part introduces two 
advanced AbNs. One is the weighted aggregate partial-area taxonomy with a parameter 
 
 
to flexibly control the summarization granularity. The second is the Ingredient 
Abstraction Network (IAbN) for the National Drug File – Reference Terminology (NDF-
RT) Chemical Ingredients hierarchy, for which the previously developed AbNs for 
hierarchies with outgoing relationships, are not applicable. Since NDF-RT’s Chemical 
Ingredients hierarchy has no outgoing relationships. 
The second part describes applications of the two advanced AbNs. A study 
utilizing the weighted aggregate partial-area taxonomy for the identification of major 
topics in SNOMED CT’s Specimen hierarchy is reported. A multi-layer interactive 
visualization system of required granularity for ontology comprehension, based on the 
weighted aggregate partial-area taxonomy, is demonstrated to comprehend the Neoplasm 
subhierarchy of National Cancer Institute thesaurus (NCIt). The IAbN is applied for 
drug-drug interaction (DDI) discovery.  
The third part reports eight family-based QA studies on NCIt’s Neoplasm, Gene, 
and Biological Process hierarchies, SNOMED CT’s Infectious disease hierarchy, the 
Chemical Entities of Biological Interest ontology, and the Chemical Ingredients 
hierarchy in NDF-RT. There is no one-size-fits-all QA method and it is impossible to 
find a QA method for each individual ontology. Hence, family-based QA is an effective 
way, i.e., one QA technique could be applicable to a whole family of structurally similar 
ontologies. The results of these studies demonstrate that “complex concepts” and 
“uncommonly modeled concepts” are more likely to have errors. Furthermore, the three 
studies on overlapping concepts in partial-area taxonomies reported in this dissertation 
combined with previous three studies prove the success of “overlapping concepts” as a 
QA methodology for a whole family of 76 similar ontologies in BioPortal. 



































A Dissertation  
Submitted to the Faculty of 
New Jersey Institute of Technology  
in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy in Computer Science 
 







































Dr. Yehoshua Perl, Dissertation Co-Advisor      Date 





Dr. James Geller, Dissertation Co-Advisor      Date 





Dr. James A. McHugh, Committee Member      Date 





Dr. Michael Halper, Committee Member      Date 





Dr. Huanying (Helen) Gu, Committee Member     Date 





Dr. Mei Liu, Committee Member       Date 










Author:  Ling Zheng 
Degree:  Doctor of Philosophy 
Date:   August 2018 
  
  
Undergraduate and Graduate Education: 
 Doctor of Philosophy in Computer Science, 
 New Jersey Institute of Technology, Newark, NJ, 2018 
 
 Master of Science in Biomedical Engineering, 
 Zhejiang University, Hangzhou, P. R. China, 2012 
 
 Bachelor of Science in Biomedical Engineering, 
Southern Medical University, Guangzhou, P. R. China, 2009 
 




Published Journal Papers 
 
Zheng L, Chen Y, Elhanan G, Perl Y, Geller J, Ochs C. Complex overlapping concepts: 
an effective auditing methodology for families of similarly structured BioPortal 
ontologies. Journal of biomedical informatics. 2018;83:135-149.  
  
Halper M, Perl Y, Ochs C, Zheng L. Taxonomy-based approaches to quality assurance of 
ontologies. Journal of healthcare engineering. 2017;10.1155/2017/3495723. 
 
Zheng L, Yumak H, Chen L, Ochs C, Geller J, Kapusnik-Uner J, et al. Quality assurance 
of chemical ingredient classification for the National Drug File - Reference 
Terminology. Journal of biomedical informatics. 2017;73:30-42. 
 
Zheng L, Min H, Chen Y, Xu J, Geller J, Perl Y. Auditing National Cancer Institute 





Min H, Zheng L, Perl Y, Halper M, De Coronado S, Ochs C. Relating complexity and 
error rates of ontology concepts. More complex NCIt concepts have more errors. 
Methods of Information in Medicine. 2017;56(3):200-208. 
 
Perl Y, Geller J, Halper M, Ochs C, Zheng L, Kapusnik-Uner J. Introducing the Big 
Knowledge to Use (BK2U) challenge. Annals of the New York Academy of 
Sciences. 2017;1387(1):12-24. 
 
Ochs C, He Z, Zheng L, Geller J, Perl Y, Hripcsak G, et al. Utilizing a structural meta-
ontology for family-based quality assurance of the BioPortal ontologies. Journal 
of biomedical informatics. 2016;61:63-76. 
 
Journal Papers in Process 
 
Chen Y, Zheng L, Perl Y, Halper M, De Coronado S. Quality assurance of concept roles 
in the National Cancer Institute thesaurus. Artificial intelligence in medicine. 
Submitted for review. 
 
Yumak H, Chen L, Zheng L, Halper M, Perl Y. Quality assurance analysis of ChEBI 
concepts based on relationship types. Journal of biomedical informatics. 
Submitted for review. 
 
Published Conference Papers 
 
Zheng L, Min H, Perl Y, Geller J. Discovering additional complex NCIt gene concepts 
with high error rate. 2017 IEEE International Conference on Bioinformatics and 
Biomedicine (BIBM). 2017:653-657. 
 
Zheng L, Perl Y, Elhanan G, Ochs C, Geller J, Halper M. Summarizing an ontology: a 
“Big Knowledge” coverage approach. Studies in health technology and 
informatics. 2017;245:978-982. 
 
Zheng L, Ochs C, Geller J, Liu H, Perl Y, De Coronado S. Multi-layer Big Knowledge 
visualization scheme for comprehending neoplasm ontology content. 2017 IEEE 
International Conference on Big Knowledge (ICBK). 2017:127-134. 
 
Yumak H, Chen L, Halper M, Zheng L, Perl Y, Elhanan G. A quality-assurance study of 
ChEBI. 2016 International Conference on Biological Ontology & BioCreative. 
 
Ochs C, Zheng L, Gu H, Perl Y, Geller J, Kapusnik-Uner J, et al. Drug-drug interaction 
discovery using abstraction networks for “National Drug File - Reference 








Accepted Conference Papers 
 
Zheng L, Liu H, Perl Y, Geller J, Ochs C, Case JT. Overlapping complex concepts have 
more commission errors, especially in intensive terminology auditing. 2018 
AMIA Annual Symposium Proceedings. 
 
Liu H, Chen L, Zheng L, Perl Y, Geller J. A quality assurance methodology for ChEBI 
Ontology focusing on uncommonly modeled concepts. 2018 International 
Conference on Biological Ontology. August 7-10, 2018, Corvallis, Oregon, USA. 
 
Liu H, Zheng L, Perl Y, Geller J, Elhanan G. Can a Convolutional Neural Network 
support auditing of NCI thesaurus neoplasm concepts? 2018 International 




Liu H, Zheng L, Perl Y, Chen Y, Elhanan G. Correcting ontology errors simplifies visual 
complexity. Studies in health technology and informatics. 2017;245:1330. 
 
Zheng L, Perl Y, Geller J, Elhanan G. How to summarize Big Knowledge subjects. 2016 




Discovering Additional Complex NCIt Gene Concepts with High Error Rate. 2017 IEEE 
International Conference on Bioinformatics and Biomedicine (BIBM). Kansas 
City, MO, USA, November 14, 2017. 
 
Summarizing an Ontology: A “Big Knowledge” Coverage Approach. MedInfo 2017, 
Hangzhou, China, August 25, 2017. 
 
Multi-layer Big Knowledge Visualization Scheme for Comprehending Neoplasm 
Ontology Content. 2017 IEEE International Conference on Big Knowledge 
(ICBK), Anhui, China, August 9, 2017. 
 
A Quality-Assurance Study of ChEBI. 2016 International Conference on Biological 

































I would like to express my deepest appreciation to my dissertation co-advisors Dr. 
Yehoshua Perl and Dr. James Geller for their continuous guidance and encouragement. 
Their expertise and professional dedication to scientific research has been having a 
profound effect upon me. The journey of being their Ph.D. student is amazing and 
precious during my whole life. I also would like to thank Dr. Michael Halper for his help 
on some of the research projects described in the dissertation. I am thankful to Dr. James 
McHugh, Dr. Huanying Gu and Dr. Mei Liu for serving on my dissertation committee. 
The research projects in this dissertation were partially supported by the National 
Cancer Institute of the National Institutes of Health under Award Number R01CA190779.  
Special thanks are given to Dr. Christopher Ochs, Dr. Gai Elhanan, Dr. Yan Chen, 
Dr. Hua Min, Dr. Ling Chen, Dr. Hasan Yumak, Dr. Julia Xu, and many other 
collaborators for all of their contributions to the work in the dissertation. I also would like 
to thank Prof. Janet Bodner for her continuous help with my English.  
Lastly, I want to thank my parents, Yongman Zheng and Xiuyu Zhang; my 
brother, Long Zheng; my friends, Xiang Ji, Yanfei Liu, Hao Liu, Xiaowei Shang, 
Hongxiang Niu, Xiaohan Yang, and Vipina Kuttichi Keloth; Dr. Ning Deng and Dr. Li 
Wang, who are very important for my success in Zhejiang University; and my favorite 






TABLE OF CONTENTS 
 
Chapter Page 
1 INTRODUCTION …………………………………………………………….. 1 
 1.1 Motivation ………………………………………………………………. 1 
 1.2 Dissertation Overview …………………………………………………... 4 
2 BACKGROUND ……………………………………………………………… 7 
 2.1 Biomedical Ontologies ………………………………………………….. 7 
  2.1.1 SNOMED CT …………………………………………………… 7 
  2.1.2 National Drug File – Reference Terminology (NDF-RT) ……… 8 
  2.1.3 National Cancer Institute Thesaurus (NCIt) ……………………. 12 
  2.1.4 Chemical Entities of Biological Interest (ChEBI) ……………… 16 
 2.2 Abstraction Networks for Biomedical Ontologies ……………………… 18 
  2.2.1 Area Taxonomy and Partial-area Taxonomy …………………… 19 
  2.2.2 Disjoint Partial-area Taxonomy ………………………………… 22 
 2.3 Quality Assurance of Biomedical Ontologies …………………………... 25 
3 ADVANCED ABSTRACTION NETWORKS ……………………………….. 
 
29 
 3.1 Weighted Aggregate Partial-area Taxonomy …………………………… 30 
 3.2 Ingredient Abstraction Network (IAbN) ………………………………... 35 
4 BIG KNOWLEDGE COMPREHENSION …………………………………… 44 
 4.1 Major Topic Identification ………………………………………............ 44 
  4.1.1 Partial-area Taxonomies for Major Topic Identification ……….. 45 











 4.2 Multi-layer Big Knowledge Visualization Scheme for Comprehending 
Neoplasm Ontology Content ……………………………………………. 
 
54 
  4.2.1 Hypothesis for Limited Human Comprehension Capacity ……... 57 
  4.2.2 Multi-layer Visualization Scheme for Big Knowledge …………. 58 
 4.3 Application of the IAbN to Drug-Drug Interaction Discovery …………. 64 




 5.1 Quality Assurance of Complex Concepts ………………………………. 
 
72 
  5.1.1 Quality Assurance of Complex Neoplasm Concepts in NCIt …... 73 
  5.1.2 Quality Assurance of NCIt Gene Hierarchy by Role-subset 
Partial-area Sub-taxonomy ……………………………………… 
 
83 
  5.1.3 Quality Assurance of Complex Infectious Disease Concepts in 
SNOMED CT …………………………………………………… 
 
95 
  5.1.4 Quality Assurance of Complex Concepts in NCIt Biological 
Process Hierarchy ……………………………………………….. 
 
99 
  5.1.5 Quality Assurance of Complex Concepts in ChEBI ……………. 110 
  5.1.6 Auditing the Chemical Ingredient Hierarchy Based on the IAbN 122 
 5.2 Quality Assurance of Concepts with Uncommon Modeling…................. 128 








6 CONCLUSIONS …………………………………………................................ 157 




LIST OF TABLES 
 
Table Page 
2.1 Distribution of Concepts in the Gene Hierarchy of NCIt .............................. 15 
2.2 Roles in the Biological Process Hierarchy and their Abbreviations ............. 16 
4.1 Identification Results for 21 Chosen Topics in Weighted Aggregate 
Taxonomies with Different Thresholds b ...................................................... 
 
52 
4.2 Performance of Weighted Aggregate Taxonomies for Various Thresholds .. 53 
4.3 The Index Numbers for the Roles in NCIt Appearing in this Section ……... 60 
4.4 Potential DDI Findings for Seven Pairs of Drug Families ............................ 70 




5.2 The 2x2 Contingency Table for Erroneous Overlapping Neoplasm 
Concepts and Non-overlapping Neoplasm Concepts in NCIt ....................... 
 
78 




5.4 Three Other Error Types Identified in Non-overlapping Concepts of the 
QA Study ....................................................................................................... 
 
81 
5.5 Four Examples of Confirmed Errors by the NCIt Team ............................... 92 
5.6 The Distribution of Confirmed Erroneous Concepts with Missing Role 
Errors by Role Type ....................................................................................... 
 
92 
5.7 The 2x2 Contingency Table for Erroneous Overlapping versus Non-
overlapping Infectious Disease Concepts in SNOMED CT ……………….. 
 
97 
5.8 Different Kinds of Commission Errors for Overlapping versus Non-
overlapping Concepts ……………………………………………………… 
 
98 
5.9 Distribution of Erroneous Concepts in the Biological Process Hierarchy .... 105 













5.11 The Number of Concepts Reported with Errors for Each Role Kind ……… 106 
5.12 Erroneous Concepts in the Lower-half and Upper-half Levels Confirmed 
by the NCIt Curator ....................................................................................... 
  
107 








5.15 Erroneous Concept Distribution by Error Types for Concepts in Each 
Level and for the Lower-half Levels (Levels 1-2) and the Upper-half 
Levels (Levels 3-5) of the Area Taxonomy ................................................... 
 
108 




5.17 The 2x2 Contingency Table for the Lower Numbered Levels (Levels 1–4) 
and the Higher Numbered Levels (Levels 5–8) with m= 4 ............................ 
 
117 
5.18 The 2x2 Contingency Table for the Lower Numbered Levels (Levels 1–2) 
and the Higher Numbered Levels (Levels 3–8) with m= 2 ............................ 
  
117 
5.19 Error Distribution from the Ontological Perspective ..................................... 118 
5.20 Typical Chemistry-based Errors .................................................................... 119 
5.21 Example Concepts with Confirmed Errors by ChEBI Curators …………… 121 
5.22 Example Concepts with Rejected Errors by ChEBI Curators ……………... 121 
5.23 The Distribution of the Drug Ingredients in Exactly One Ingredient Group 
Based on their Number of Parent Ingredient Groups .................................... 
 
124 











5.25 The 2x2 Contingency Table for the Control and Study Concepts ................. 126 
5.26 The 2x2 Contingency Table for the Concepts with Two and More Than 
Two Parent Ingredient Groups ....................................................................... 
 
126 
5.27 Examples of Error Types with Counts ........................................................... 
 
128 
5.28 Distribution of Erroneous Concepts According to Partial-area Node Size in 
the Partial-area Taxonomy ............................................................................. 
 
137 
5.29 The 2x2 Contingency Table for Small Partial-areas and Large Partial-areas  138 
5.30 Comparison of Error Distribution by Types between Concepts from Small 
and Large Partial-area Nodes ………………………………………………. 
 
139 
5.31 Examples of Erroneous Hierarchical Relationships ...................................... 139 
5.32 The Number of Concepts from Small Partial-area Nodes Missing Roles for 
Each Role Type .............................................................................................. 
 
140 
5.33 Example Concepts with Errors Confirmed by NCIt Curators ....................... 142 
5.34 Example Concepts with Errors Not Corrected by NCIt Curators .................. 143 
5.35 The Neoplasm Concept Distribution According to Partial-area Size ............ 144 
5.36 Missing-role Error Distribution by Level in the Top Area ............................ 150 
5.37 Number of Concepts in the Top Area Reported Missing Roles for Each 
Role Kind …………………………………………………………………... 
 
151 
5.38 Examples of Concepts Confirmed to Have Missing Roles in the Top Area 
for Different Roles ......................................................................................... 
  
152 
5.39 Rejected Examples of Concepts Missing Roles in the Top Area for 
Different Roles ……………………………………………………………... 
 
152 
5.40 The 2x2 Contingency Table for the Concepts with Errors in the Top Area 











5.41 The 2x2 Contingency Table for Erroneous Concepts in the Top Area and 
Non-top Areas Confirmed by the NCIt Curator …………………………… 
 
153 
5.42 The 2x2 Contingency Table for Concept Errors between the Lower-half 
Levels and Upper-half Levels ……………………………………………… 
 
154 
5.43 Affected Descendants of the 68 Non-leaf Concepts Missing Roles in the 








LIST OF FIGURES 
 
Figure Page 
1.1 The 8,445 neoplasm concepts from NCIt. Concepts are drawn as white 
boxes organized into levels according to their longest-path distance from 
the root class (i.e., Neoplasm). Only 14,420 hierarchical relationships are 
shown (as color-coded lines, based on the level of the child class). At this 
scale, “white boxes” appear as white dots ...................................................... 
 
2 
2.1 Excerpt of 15 concepts from the Specimen hierarchy of SNOMED CT. 
Concepts represented by boxes with rounded corners are connected by IS-A 
relationships shown as upward arrows. Each of the three concepts Specimen 
from digestive system, Soft tissue sample, and Specimen from liver enclosed 
in the dashed green box has a lateral relationship Specimen source 
topography with the corresponding values Structure of digestive system, 






2.2 Content Model of NDF-RT [24] (The “CI” in role names means 
contraindicated, not Chemical Ingredient) ..................................................... 
 
10 
2.3 An excerpt from NDF-RT’s Pharmaceutical Preparations and Chemical 
Ingredients hierarchies. Concepts are shown as blue boxes and hierarchical 
relationships are shown as upward directed blue arrows. The 
has_Ingredient roles linking the concepts in the two hierarchies are shown 
as labeled blue arrows .................................................................................... 
 
11 
2.4 An excerpt of 13 neoplasm concepts in the Disease, Disorder or Finding 
hierarchy of NCIt. Concepts represented by boxes with rounded corners are 
connected by IS-A relationships shown as upward thin arrows ..................... 
 
14 
2.5 (a) An excerpt of 13 neoplasm concepts in the Disease, Disorder or 
Finding hierarchy of NCIt. Concepts represented by boxes with rounded 
corners are connected by IS-A relationships shown as upward thin arrows. 
(b) The area taxonomy for the excerpt in (a). (c) The partial-area taxonomy 

















2.6 (a) An excerpt of 15 neoplasm concepts from the area {Disease Excludes 
Abnormal Cell, Disease Excludes Finding, Disease Has Abnormal Cell, 
Disease Has Finding, Disease Has Normal Cell Origin, Disease Has 
Normal Tissue Origin} distributed in four partial-areas enclosed by four 
different colored dashed boxes. (b) The roots of disjoint partial-areas are 
colored. Area roots have a single color and overlapping roots have multiple 
colors according to the colors of their multiple ancestor area roots. (c) The 
disjoint partial-area taxonomy for the excerpt in (a). Disjoint partial-areas 
are color coded according to the colors of their roots. Disjoint partial-areas 
with the same number of colors are placed at the same level, e.g., the five 
disjoint partial-areas with two colors are at the second level. There may be 
child-of relationships between disjoint partial-areas at the same level ..........  
 
23 
3.1 (a) An excerpt of eight partial-areas in the NCIt Neoplasm partial-area 
taxonomy. (b) Weighted aggregate partial-area taxonomy for (a) with 
b=20. A “rounded” white rectangle represents an aggregate partial-area 
with its number of concepts in the original partial-area taxonomy in {}, its 
number of concepts in the aggregated taxonomy in () including all concepts 
from aggregated partial-areas, and the number of its aggregated partial-
areas in []. A white rectangle with “corners” represents an aggregate 
partial-area that does not summarize any descendant partial-areas ……….... 
 
32 
3.2 The partial-area taxonomy for the NCIt Neoplasm subhierarchy with 8,445 
concepts shown in Figure 1.1 ………………………………………………. 
 
33 
3.3 The weighted aggregate partial-area taxonomy with 25 aggregate partial-



















3.4 (a) An excerpt of concepts from NDF-RT’s Pharmaceutical Preparations 
(PP) and Chemical Ingredients (CI) hierarchies. On the left, drug concepts 
in the PP hierarchy with no dosage information have a shaded background. 
On the right, nine drug ingredient concepts have red borders and five 
classification ingredient concepts have a pink background. Two concepts, 
Aminosalicylic Acid and Warfarin, are both drug ingredient concepts and 
classification ingredient concepts, i.e., they are dual ingredient concepts. 
Ethyl Biscoumacetate is neither a drug ingredient concept nor a 
classification ingredient concept, i.e., it is an uncategorized ingredient 
concept. (b) CI grouped. Drug ingredient concepts are not shaded and their 
lowest common ancestor classification ingredient concepts are shaded. 
Each drug ingredient concept is color-framed according to its lowest 
common ancestor classification ingredient concept. (c) The IAbN for 
Figure 3.4(a). Ingredient groups are shown as boxes that are labeled with 
the name of the lowest common ancestor from Figure 3.4(b). In each box 
are the total number of ingredient concepts summarized by the group, and 
the total number of drug concepts (without dosage information!) with 
has_Ingredient roles pointing to the summarized concepts in the CI 
hierarchy. Child-of links between ingredient groups are shown as upward 
directed bold arrows ………………………………………………………... 
 
41 
3.5 An excerpt of 128 (15%) ingredient groups from the IAbN for the June 
2015 version of the CI hierarchy. The smaller ingredient groups have been 
hidden as follows. Each level shows as many groups as possible, in 
decreasing order by the number of ingredients in each group, while keeping 
the group names readable. Child-of links are hidden for readability. The 
numbers of ingredients and drugs summarized by each ingredient group are 
shown in parentheses and prepended with I: and D:, respectively. 




4.1 An excerpt of the partial-area taxonomy for the Specimen hierarchy. 
Partial-areas are sorted (left to right and top to bottom) according to their 
numbers of concepts. The yellow partial-areas are the descendant partial-
areas of the pink partial-area Specimen from trunk. That is, there is a path 














4.2 (a) An excerpt of 10 partial-areas (b) Weighted aggregate partial-area with 
b=11 for (a), shown as a rounded white rectangle with its number of 
concepts in () including all concepts from aggregated partial-areas and the 
number of aggregated partial-areas in [] ……………………………………. 
 
49 
4.3 Weighted aggregate taxonomy for the Specimen hierarchy with b=25. The 
12 partial-areas corresponding to the original given topics are highlighted 
in yellow. The 13 topics added during the enhancement step are highlighted 
in pink ............................................................................................................. 
 
53 
4.4 Neoplasm Aggregate Taxonomy with 25 aggregate partial-areas (b=200) … 61 
4.5 Malignant Digestive System Neoplasm (from Figure 4.4) Aggregate 
Taxonomy with 24 aggregate partial-areas (b=8) ………………………….. 
 
62 
4.6 Small Intestinal Carcinoma (from Figure 4.5) Partial-area Taxonomy with 
19 partial-areas ……………………………………………………………... 
 
63 
4.7 (a) Illustration of 70 DDIs. There are 10x7=70 DDIs between the ten 
salicylates on the left and the seven anticoagulants on the right in FDB’s 
DDI knowledge base. AVD = “Avoid concurrent use when possible” and 
INL = “Increases the effect of latter drug.”  (b) Three new candidate DDIs 
not appearing in FDB’s DDI knowledge base, between the Salicylate 
Salsalate on the left and the three anticoagulants on the right ……………... 
 
65 
5.1 The disjoint partial-area taxonomy of the area with the six role types 
Disease Excludes Abnormal Cell, Disease Excludes Finding, Disease Has 
Abnormal Cell, Disease Has Finding, Disease Has Normal Cell Origin, 
and Disease Has Normal Tissue Origin. To reduce the density of the figure, 
the child-of links for the disjoint partial-areas at the second row of Level 2 
are not shown .................................................................................................. 
 
77 
   














5.2 Simplification of the complexity of the disjoint partial-area taxonomy due 
to correction of overlapping concepts: (a) Excerpt from disjoint partial-
area taxonomy before correction of three erroneous overlapping concepts 
in the partial-area Pituitary Gland Neoplasm (3) with the error “missing 
the role Disease Has Primary Anatomic Site”; (b) after correction by 
adding the missing role (italic and underline) to the three erroneous 
overlapping concepts. The two partial-areas in Figure 5.2(a) Pituitary 
Gland Neoplasm (3) and Recurrent Anterior Pituitary Gland Neoplasm (1) 
are merged together to become a new partial-area Pituitary Gland 
Neoplasm (4), because Recurrent Anterior Pituitary Gland Neoplasm (1) is 
child-of Pituitary Gland Neoplasm (3). All three partial-areas are not 
colored, since they do not contain overlapping concepts .............................. 
 
81 
5.3 Flowchart for finding overlapping concepts (a) for the original Gene 
hierarchy (b) for the role-reduced Gene hierarchy ........................................ 
 
86 
5.4 (a) Two overlapping partial-areas in T1. (b) An excerpt of T2 shows the 
effect of the addition of one role .................................................................... 
  
88 
5.5 An excerpt of the disjoint partial-area taxonomy for the {Gene Plays Role 
In Process} area, which only shows the nine largest partial-areas and all 
disjoint partial-areas derived from these nine partial-areas. Child-of links 
are omitted for readability, since they are implied by the color coding ….... 
 
91 
5.6 Complete area taxonomy of the Biological Process hierarchy. Most child-
ofs have been omitted to avoid overload. Note how the importance of the 
role Location is reflected in the area taxonomy. The area {Location} has 
207 concepts, and Location appears in 20 of 37 area names ......................... 
 
101 




5.8 Example of the structure of the Neoplasm partial-area taxonomy (a) before 
and (b) after auditing ………………………………………………………. 
 
133 
5.9 Example of error correction propagation and the resultant partial-area 
taxonomy simplification; (a) shows the partial-area taxonomy before and 
(b) after the auditing/correction steps ............................................................ 
 
135 








5.11 Revised area taxonomy for the Biological Process hierarchy incorporating 
the confirmed corrections. Pink highlights the areas that are different from 










he purpose of the “Big Data to Knowledge” (BD2K) initiative launched by the US 
National Institutes of Health in 2014 is to develop methodologies and techniques for 
extracting new knowledge hidden in large amounts of biomedical data [1]. However, if 
the resulting knowledge stored in a knowledge repository is too much for humans’ 
comprehension, it is impossible for humans to make effective or innovative use of the 
knowledge. According to Perl et al. [2], knowledge that is so big that humans cannot 
easily comprehend it is defined as “Big Knowledge.”  
There are various kinds of knowledge. This dissertation concentrates on large 
biomedical ontologies, a special kind of knowledge repository typically consisting of 
many thousands of domain knowledge assertions. Concepts and relationships are two 
essential elements to represent knowledge in ontologies. A concept represents a unique 
entity in a domain. Concepts are linked by hierarchical IS-A relationships and lateral 
relationships (“relationships” for short). The hierarchical IS-A relationship between two 
concepts represents a concept that is a specification of the other concept. For example, 
Neoplasm IS-A Disease or Disorder, because the concept Neoplasm is more specific than 
the concept Disease or Disorder. The lateral relationships are used to define the 
semantics in the domain. For example, the concept Breast Neoplasm is connected to the 
concept Breast through the lateral relationship Disease Has Associated Anatomic Site to 
define the anatomic location of breast neoplasm.  As an example of large biomedical 
T 
2 
ontologies, National Cancer Institute Thesaurus (NCIt) [3], the most famous cancer-
focused biomedical terminology, has more than 100,000 active concepts connected by 
more than 400,000 relationships. Hence, large biomedical ontologies are complex 
networks due to the large number of concepts and relationships respectively represented 
by nodes and links in the networks. Figure 1.1 demonstrates the complexity of a large 
biomedical ontology and the difficulty for humans to comprehend such Big Knowledge. 
Figure 1.1 only shows a small part of NCIt, i.e., 8,445 neoplasm-related concepts (7.8% 
of the complete NCIt). 
 
Figure 1.1 The 8,445 neoplasm concepts from NCIt. Concepts are drawn as white boxes 
organized into levels according to their longest-path distance from the root concept (i.e., 
Neoplasm). Only 14,420 hierarchical relationships are shown (as color-coded lines, based 




 In general, humans typically comprehend complex knowledge by summaries and 
visual representations. Without some smart techniques, e.g., summarization and 
visualization tools to assist humans’ high-level mental comprehension, even the curators 
of large biomedical ontologies cannot see the “big picture” of their ontologies. It would 
be even more difficult for external users who utilize large biomedical ontologies, to 
develop applications using such an ontology. Hence, this dissertation is trying to address 
the new challenge after BD2K: How to enable humans to use Big Knowledge correctly 
and effectively (referred to as the “Big Knowledge to Use” (BK2U) problem [2]).  
 The Structural Analysis of Biomedical Ontologies Center (SABOC) has 
developed various kinds of Abstraction Networks (AbNs) to support the summarization, 
visualization and quality assurance (QA) of biomedical ontologies [4]. An Abstraction 
Network derived from an ontology is itself a compact summary network consisting of 
“nodes,” each representing a set of concepts that are similar in their structure and 
semantics. Thus, the Abstraction Network summarizes the structure and content of the 
ontology. Two basic kinds of AbNs are area taxonomy and partial-area taxonomy, which 
have been developed for various biomedical ontologies [5, 6] (e.g., NCIt [3] and 
SNOMED CT [7]).  
Based on the previous work on AbNs conducted at SABOC, this dissertation 
presents advanced AbNs to summarize and visualize the content of Big Knowledge in 
large biomedical ontologies to support BK2U. The Big Knowledge summarization and 
visualization technique was demonstrated to be useful for the identification of major 
topics in a large ontology, as a multi-layer Big Knowledge visualization scheme for 
ontology comprehension, for the discovery of drug-drug interactions and also for the 
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quality assurance of large biomedical ontologies.  
In a multi-year research program on quality assurance of biomedical ontologies, 
the SABOC team has observed that no one-size-fits-all QA method exists. However, 
Ochs et al. [8] have developed a family-based approach to ontology QA, where the same 
QA method can be applicable to most members of one family, while different families 
need different approaches. In order to demonstrate such scaling of a method to most 
ontologies of a family, the effectiveness of a method has to be demonstrated for “six out 
of six” members of the family to allow drawing a conclusion about the whole family. 
Thus, this dissertation also contains several quality assurance studies on different large 
biomedical ontologies utilizing different QA techniques to achieve the goal of showing 
the effectiveness of family-based QA for biomedical ontologies.  
 
 
1.2 Dissertation Overview 
 
Chapter 2 provides background information on biomedical ontologies used in this 
dissertation, i.e., SNOMED CT, National Drug File-Reference Terminology (NDF-RT), 
NCIt and Chemical Entities of Biological Interest (ChEBI). Chapter 2 also introduces the 
Abstraction Networks for biomedical ontologies developed by the SABOC team, the 
previous quality assurance studies of biomedical ontologies based on the Abstraction 
Networks, and a brief review of other QA studies for biomedical ontologies. 
Chapter 3 describes two advanced Abstraction Networks, weighted aggregate 
partial-area taxonomy that provides a more compact summary of biomedical ontologies 
compared with a partial-area taxonomy, and Ingredient Abstraction Network (IAbN) to 
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summarize NDF-RT’s Chemical Ingredient hierarchy, due to that terminology’s unique 
modeling structure.  
Chapter 4 presents two applications of the weighted aggregate partial-area 
taxonomy. One is the identification of major topics in an ontology, which was 
successfully demonstrated on SNOMED CT’s Specimen hierarchy. The other is a multi-
layer multi-granularity visualization scheme based on the weighted aggregate partial-area 
taxonomy, which was applied to comprehend the NCIt’s Neoplasm subhierarchy. This 
chapter also includes one application of the Ingredient Abstraction Network, namely for 
Drug-Drug Interaction discovery. 
Chapter 5 reports several family-based quality assurance studies in the framework 
of Abstraction Networks for NCIt’s Neoplasm hierarchy, Gene hierarchy, and Biological 
Process hierarchy, for SNOMED CT’s Infectious Disease hierarchy, for the ChEBI 
ontology, and for NDF-RT’s Chemical Ingredients hierarchy. The results confirmed that 
two characterizations of concepts ‒ complex concepts and uncommonly modeled 
concepts ‒ which can be automatically identified by Abstraction Networks ‒ are more 
likely to have errors than other concepts. The QA results of these studies in Chapter 5 
pave the way to the family-based QA approach for biomedical ontologies. Chapter 6 
concludes this dissertation.  
The studies in this dissertation have been published in journals and proceedings of 
conferences on biomedical informatics. The weighted aggregate partial-area taxonomy in 
Section 3.1 and its application to major topic identification in Section 4.1 were published 
in the Proceedings of the 16th World Congress on Medical and Health Informatics 
(MedInfo 2017) [9]. The multi-layer visualization scheme in Section 4.2 was published in 
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the Proceedings of the 2017 IEEE International Conference on Big Knowledge (ICBK) 
[10]. The application of the Ingredient Abstraction Network to drug-drug interaction 
discovery was published in the 2015 AMIA Annual Symposium Proceedings [11] and in 
an extended form in the Annals of the New York Academy of Sciences [2]. Most of the 
QA studies in Chapter 5 have been published in the Journal of Biomedical Informatics 
[12, 13], the Methods of Information in Medicine [14], the Applied Ontology [15], and 
the Proceedings of the 2017 IEEE International Conference on Bioinformatics and 
Biomedicine (BIBM) [16]. 
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CHAPTER 2  
BACKGROUND 
 
2.1 Biomedical Ontologies 
 
In recent years, ontologies have played an important role in the biomedical field to 
support the rapid increase of data processing in healthcare and basic research [17]. 
Biomedical ontologies have been used for data annotation, information integration, 
knowledge discovery and other applications [18-22]. This section will introduce several 
relevant and important biomedical ontologies. 
2.1.1 SNOMED CT  
 
SNOMED CT (SNOMED Clinical Terms) [7] is the most comprehensive clinical 
terminology, used in more than fifty countries in the world, providing multiple language 
versions. It is maintained and distributed by an international non-profit organization 
named SNOMED International which is the trading name of the International Health 
Terminology Standards Development Organisation (IHTSDO) [23]. SNOMED CT 
covers a wide range of clinical specialties, disciplines and requirements so that it enables 
consistent and processable representation of clinical content in electronic health records 
[24] and facilitates the semantic interoperability of health records.  
Concepts are SNOMED CT’s basic components to represent healthcare data [25]. 
SNOMED CT’s concepts are organized into 19 top-level hierarchies (e.g., Clinical 
finding and Specimen) through IS-A relationships. A concept may have multiple parents 
in a hierarchy, i.e., a concept may have multiple IS-A relationships pointing to other 
concepts in the same hierarchy. The lateral relationships provide formal definitions for 
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concepts. There were about 316,840 active concepts connected by more than 574,000 IS-
A hierarchical relationships and about 960,000 lateral relationships in SNOMED CT’s 
July 2015 version. Figure 2.1 shows an excerpt of 15 concepts from the Specimen 
hierarchy with 1,620 concepts. The concept Bile specimen has three parents Specimen 
from digestive system, Body substance sample and Fluid sample. The lateral relationship 
Specimen source topography in the dashed green box defines the body structure where a 
specimen comes from. For example, the concept Specimen from liver has a lateral 
relationship Specimen source topography linking it to Liver structure. 
 
Figure 2.1 Excerpt of 15 concepts from the Specimen hierarchy of SNOMED CT. 
Concepts represented by boxes with rounded corners are connected by IS-A relationships 
shown as upward arrows. Each of the three concepts Specimen from digestive system, Soft 
tissue sample, and Specimen from liver enclosed in the dashed green box has a lateral 
relationship Specimen source topography with the corresponding values Structure of 




2.1.2 National Drug File – Reference Terminology (NDF-RT) 
 
National Drug File – Reference Terminology (NDF-RT) is a drug terminology developed 
and maintained by the U.S. Department of Veterans Affairs (VA), Veterans Health 
Administration (VHA). NDF-RT is a formal representation of the VHA National Drug 
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File (NDF) [26], which is a drug classification hierarchy used to group orderable drug 
products into one of 579 drug classes. NDF-RT is used to support clinical applications at 
the VHA’s clinical centers. 
NDF-RT uses a description logic-based reference model to define drugs in the 
Pharmaceutical Preparations (PP) hierarchy according to multiple aspects (other 
hierarchies) [27]. These aspects include the Chemical Ingredients (CI) hierarchy, 
describing the chemical ingredients of drugs, the Cellular or Molecular Interactions 
(MoA) hierarchy, describing the drug effects at molecular, subcellular, or cellular levels, 
the Physiological Effects (PE) hierarchy, describing drug effects at tissue, organ, or 
system levels, the Clinical Kinetics (PK – from Pharmacokinetics) hierarchy, describing 
the absorption, distribution, and elimination of drugs, and the Therapeutic Categories 
(TC) hierarchy, which is an experimental hierarchy exclusively used to model FDA 
established pharmacologic class concepts to describe general therapeutic intents of drugs. 
Two more hierarchies are the Diseases, Manifestations or Physiologic States (Disease) 
hierarchy, describing the therapeutic, preventative, or diagnostic indications of drugs, and 
the Dose Forms hierarchy, describing the dose forms of drugs.   
The MoA, PE and CI hierarchies were initially created by matching VHA drug 
ingredient names to terms from the National Library of Medicine’s Medical Subject 
Headings (MeSH) [28]. Specifically, the CI hierarchy was derived from MeSH's 
Chemicals and Drugs Category and the MoA and PE hierarchies were created by 
extending and restructuring selected Pharmacologic Actions associated with ingredients 
in MeSH. Concepts in the Disease hierarchy were included from MeSH’s Diseases 
Category [27, 29]. The purpose of developing the MeSH was to support the classification  
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of biomedical publications in the PubMed system [30] of the National Library of 
Medicine. 
NDF-RT is available for download in Apelon DTS format at the National Cancer 
Institute’s Enterprise Vocabulary Services (EVS) website [31]. NDF-RT is also released 
as part of the Unified Medical Language System (UMLS) [32] and it is available for 
download at the National Center for Biomedical Ontology (NCBO) BioPortal [33]. NDF-
RT organizes concepts around the PP hierarchy (the triangle in Figure 2.2), which is the 
largest hierarchy in NDF-RT with 25,759 concepts (59.4% of the 43,397 NDF-RT 
concepts in the June 2015 version). The root concept of the PP hierarchy is 
Pharmaceutical Preparations. Besides IS-A relationships, concepts in the PP hierarchy 
can have role relationships (represented by the arrows in Figure 2.2) pointing to concepts 
in the other hierarchies (the seven rectangles in Figure 2.2). Role relationships 
(corresponding to lateral relationships) are used to define drugs according to their various 
aspects. Drug-disease relationships were mined from co-occurrence data in the UMLS 
[34] (see Figure 2.2). The TC hierarchy is exclusively used for concepts established by 
the FDA, so there are no NDF-RT asserted roles between the PP hierarchy and the TC 
hierarchy and the arrow in Figure 2.2 is not labeled with any NDF-RT asserted role. 
 
Figure 2.2 Content Model of NDF-RT [27] (The “CI” in role names means 
contraindicated, not Chemical Ingredient). 
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For example, in Figure 2.3, the drug preparation ASPIRIN in the PP hierarchy has 
the role relationship has_Ingredient pointing to the chemical ingredient Aspirin in the CI 
hierarchy, the second largest hierarchy in NDF-RT with 10,145 concepts. The role 
relationships of drug classes and drug preparations are inherited by orderable drug 
products, e.g., ASPIRIN 300MG TAB (a VA Product) inherits the role relationship 
has_Ingredient and its target concept Aspirin from its parent drug preparation ASPIRIN.  
Concepts in each of the above hierarchies are organized as a generalization 
hierarchy; higher level concepts are more general than lower level concepts. Concepts 
may have multiple parents. For example, ASPIRIN in the PP hierarchy and Salicylates in 
the CI hierarchy each have two parents in Figure 2.3.  
Concepts in the PP hierarchy may have different types of role relationships to 
concepts in the CI hierarchy. These role relationships are introduced at a drug class level 
or a drug preparation level. For example, the role relationship has_Chemical_Structure 
 
Figure 2.3 An excerpt from NDF-RT’s Pharmaceutical Preparations and Chemical 
Ingredients hierarchies. Concepts are shown as blue boxes and hierarchical relationships 
are shown as upward directed blue arrows. The has_Ingredient roles linking the concepts 
in the two hierarchies are shown as labeled blue arrows.  
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that describes the chemical structure of an FDA-established pharmacologic class is 
introduced at a drug class level, while the roles has_Ingredient, CI_ChemClass, and 
has_active_metabolites are introduced at a drug preparation level. 
Extensive research has been conducted on NDF-RT, e.g., on its content coverage, 
the adequacy of representation, drug normalization and classification, etc. Rosenbloom et 
al. [35] investigated the adequacy of representation in the Physiologic Effect hierarchy. 
Carter et al. [36] studied drug class names from three sources to understand how drugs 
were classified. They further evaluated NDF-RT’s semantic coverage. Zhu et al. [37] 
normalized drug data in PharmGKB [38] by mapping extracted drugs and drug classes to 
NDF-RT. Pathak et al. [39] investigated drug-disease relationships in NDF-RT and 
PharmGKB to make both more robust and integratable. Pathak et al. [40] also evaluated 
the applicability of RxNorm [41] and NDF-RT to classification of medication data 
extracted from electronic health records.  
2.1.3 National Cancer Institute Thesaurus (NCIt) 
 
The National Cancer Institute Thesaurus (NCIt) [3] is a cancer-focused reference 
terminology developed and published by the National Cancer Institute (NCI) with the 
initial goal to facilitate interoperability and data sharing among various information 
systems at the NCI.  It is released at the beginning of each month for free public access in 
OWL and flat file formats and has been used by an increasing number of information 
systems outside the NCI, both nationally and internationally [42].  
 The NCIt covers vocabulary in different domains important for cancer research,  
including clinical care, basic research, public information dissemination and 
administrative activities. The content of the NCIt is modeled based on description logic 
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[43, 44]. A “concept” is the basic unit in the NCIt, just as in many other 
ontologies/terminologies. The NCIt exists in two versions, the asserted and the inferred 
version. The asserted version contains assertions explicitly defined by the NCIt team, 
while the inferred version is obtained by running a reasoner on the asserted version. The 
studies reported in this dissertation were conducted on the inferred version of the NCIt. 
The 15.02d release of the NCIt had 108,376 active concepts organized into 19 disjoint IS-
A hierarchies, e.g., Disease Disorder or Finding, Gene, Biological Process, Molecular 
Abnormality, and Abnormal Cell. Concepts in each hierarchy are connected by IS-A 
relationships to their parents, forming a directed acyclic graph (DAG), i.e., a concept may 
have multiple parents.  
Roles are binary semantic relationships between pairs of concepts. Each role has a 
domain and a range, e.g., for the role Disease Has Abnormal Cell, relating a disease to 
the type of neoplastic cell present in the disease, the domain is the Disease Disorder or 
Finding hierarchy and the range is the Abnormal Cell hierarchy. Roles are inherited along 
the IS-A hierarchy. For example, as shown in Figure 2.4, the concept Neoplasm has the 
role Disease Has Abnormal Cell pointing to the concept Neoplastic Cell. Since Neoplasm 
by Morphology IS-A Neoplasm, it inherits the role Disease Has Abnormal Cell with the 
target Neoplastic Cell from its parent Neoplasm. In fact, all the concepts under Neoplasm 
in Figure 2.4 inherit the above role from Neoplasm, because those concepts are 
Neoplasm’s descendants.  
Use cases determine, to a large extent, the modeling priorities of the NCIt. Hence, 
not every hierarchy is modeled with roles. Concepts in eight hierarchies, such as the 
Organism hierarchy and the Biochemical Pathway hierarchy, only serve as the ranges of  
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Figure 2.4 An excerpt of 13 neoplasm concepts in the Disease, Disorder or Finding 
hierarchy of NCIt. Concepts represented by boxes with rounded corners are connected by 
IS-A relationships shown as upward thin arrows. 
 
 
roles and do not serve as the domains of roles. Each of the other 11 hierarchies has a list 
of associated defined role types. For example, the Disease, Disorder or Finding hierarchy 
has 29 role types, including Disease Excludes Abnormal Cell with the range Abnormal 
Cell hierarchy, Disease Has Finding with the range Disease, Disorder or Finding 
hierarchy, Disease Mapped To Gene with the range Gene hierarchy, and Disease Has 
Normal Cell Origin with the range Anatomic Structure, System, or Substance hierarchy. 
Due to the mission of NCIt, cancer-related concepts are modeled with a higher 
priority and more detail than other concepts. In the February 2015 release, the Disease, 
Disorder or Finding hierarchy, which is the largest hierarchy in NCIt in all releases, 
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contained 25,360 concepts (23.4% = 25360/108376) with 7.79 roles on average. The 
Neoplasm subhierarchy in the Disease, Disorder or Finding hierarchy had 8,166 concepts 
(32.2% = 8166/25360) with an average of 23.02 roles.  However, the corresponding 
average was 0.55 for non-neoplasm concepts, because only 2,858 non-neoplasm concepts 
(16.6% = 2858/17194) had roles. These 2,858 non-neoplasm concepts had an average 
number of 3.33 roles. The average number of parents for concepts in the Neoplasm 
subhierarchy was 1.73, while it was 1.10 for the remaining concepts in the Disease, 
Disorder or Finding hierarchy. 
The Gene hierarchy which had 9,540 concepts in the September 2016 release is 
another important component of NCIt, because it contains cancer-related knowledge 
about genes, which are organized according to biological functions [45]. It has a list of 16 
defined role types. Some of these role types are Gene Plays Role In Process, specifying a 
biological process in which the gene participates, Gene Associated With Disease, 
indicating a disease associated with molecular abnormalities in a gene, and Gene In 
Chromosomal Location, describing the general location of a gene by chromosomal band 
position. Table 2.1 shows the number of concepts in the Gene hierarchy with each of the 
five most frequent role types. The other roles are less frequent. 
Table 2.1 Distribution of Concepts in the Gene Hierarchy of NCIt 
 
Five Most Frequent Role Types # of Concepts Percentage (%) 
Gene Plays Role In Process 8775 91.98 
Gene In Chromosomal Location  3548 37.19 
Gene Found In Organism 3258 34.15 
Gene Is Element In Pathway 2234 23.42 




The Biological Process (BP) hierarchy is also a core hierarchy in NCIt, because 
of its relevance for cancer research and treatment, containing 1,145 concepts in the 
February 2015 release, with seven defined role types (whose full names and abbreviated 
names are given in Table 2.2). The Gene hierarchy and the Biological Process hierarchy 
are closely related to one another. This relation is manifested, for example, by the role 
Gene Plays Role In Process that exists for 92% of the concepts of the Gene hierarchy 
shown in Table 2.1. Among the BP hierarchy’s 1,145 concepts, 513 (44.8%) have no 
roles at all. The levels of these concepts without roles (i.e., the maximum distance from 
the BP hierarchy root to each concept) varied from 0 to 9. 
Table 2.2 Roles in the Biological Process Hierarchy and their Abbreviations 
 
Role Abbreviated Name 
Biological Process Has Associated Location Location 
Biological Process Has Initiator Chemical Or Drug Initiator Chemical or Drug 
Biological Process Has Initiator Process Initiator BP 
Biological Process Has Result Anatomy Resulting Anatomy 
Biological Process Has Result Biological Process Resulting BP 
Biological Process Has Result Chemical Or Drug Resulting Chemical or Drug 
Biological Process Is Part Of Process Part of Process 
 
 
2.1.4 Chemical Entities of Biological Interest (ChEBI) 
 
The Chemical Entities of Biological Interest (ChEBI) ontology [46] is a structure that 
houses terminological knowledge concerning chemicals in biological contexts. It serves 
as an important electronic reference for software systems needing such knowledge. For 
example, ChEBI has been used in many annotation, text-mining, and chemical-analysis 
applications. Also, ChEBI’s hierarchy has been integrated into the Gene Ontology (GO) 
[47-50] to support the integration of data across the biology and chemistry domains. 
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ChEBI’s August 2016 release comprised 103,478 concepts, 161,256 IS-A relationships, 
and 68,395 lateral relationships. 
The ChEBI ontology is maintained by the European Molecular Biology 
Laboratory-European Bioinformatics Institute (EMBL-EBI) and is updated monthly in 
OBO and OWL format. The version used in this dissertation is the February 2016 
inferred version in OWL format. It contained 61,896 concepts, including 47,752 fully 
annotated chemical entities. Each concept in ChEBI has a unique id, written in the 
general form “CHEBI: num.” For example, the concept Neticonazole hydrochloride has 
the id “CHEBI: 31900.” 
 ChEBI divides its classification of molecular entities into three hierarchies. The 
chemical entity hierarchy categorizes molecular entities based on their chemical structure. 
The subatomic particle hierarchy classifies particles that are smaller than atoms. The role 
hierarchy, with its three subhierarchies, defines the roles of compounds in three different 
settings: (1) their intended use by humans (e.g., fuel, anti-inflammatory agent), (2) their 
biological context (e.g., growth regulator, inhibitor), and (3) their chemical role (e.g., acid, 
base). 
 ChEBI employs three primary relationships in the modeling of its concepts. The 
hierarchical IS-A relationship denotes the standard subsumption relationship between 
concepts in the hierarchies. The relationship has part indicates the whole/part association 
between compounds. The relationship has role serves to link concepts in the chemical 
entity hierarchy with those in the role hierarchy. Seven other chemistry-specific, non-
hierarchical (“lateral”) relationships are also used in modeling concepts. These are is 
conjugate base of, is conjugate acid of, is tautomer of, is enantiomer of, has functional 
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parent, has parent hydride, and is substituent group from. Certain pairs of these 
relationships form converses. For example, the two relationships is conjugate base of and 
conjugate acid of are converses of each other, as are is tautomer of and is enantiomer of 
[51]. 
 ChEBI is highly user-driven. Users can make requests (e.g., to add a new concept) 
to the ChEBI curatorial team using the ChEBI submission tool [52]. In the case of a new 
concept, users must provide minimal unique information, including classifications. Issues 
and bugs of ChEBI’s concepts can be reported using ChEBI’s GitHub issue tracking 
system [53]. As of August 2016, there were 2,951 closed and 243 open issues in the 
ChEBI GitHub. After ChEBI’s curators have validated requests, changes are made 
available in subsequent releases. For example, a user reported on July 31, 2016 that the 
has role relationship between protein polypeptide chain (CHEBI: 16541) and mouse 
metabolite (CHEBI: 75771) is questionable. Two days later, a ChEBI curator responded 
that the problem was fixed.  
 
 
2.2  Abstraction Networks for Biomedical Ontologies 
 
As demonstrated by Figure 1.1 in Chapter 1 and the introduction to biomedical ontologies 
in the previous section, Big Knowledge in large biomedical ontologies is beyond humans’ 
comprehension ability. In order to facilitate the comprehension of the complex content in 
biomedical ontologies, in a long range research program, the SABOC team [54] has 
developed an Abstraction Network-based framework to support the summarization and 
visualization of biomedical ontologies. An Abstraction Network (AbN) of an ontology is 
a compact summary network consisting of “nodes,” each representing a set of concepts 
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that are similar in their structure and semantics. Nodes are connected by hierarchical 
child-of links that are derived from the IS-A relationships in the ontology.  
The definition of “similar” depends on an ontology’s structural characteristics and 
is not the same for all ontologies, hence there are various types of Abstraction Networks. 
For example, the SABOC team has developed the area taxonomies and partial-area 
taxonomies [5, 6, 55] for the National Cancer Institute thesaurus (NCIt) [3], SNOMED 
CT [7], and the Gene Ontology [56]. Furthermore, the disjoint partial-area taxonomies 
[57] and the tribal abstraction networks [58] have been designed for SNOMED CT. 
Besides, they have introduced the domain-defined partial-area taxonomy [59, 60] for the 
Ontology of Clinical Research (OCRe) [61] and the Cancer Chemoprevention Ontology 
(CanCo) [62], the restriction-defined partial-area taxonomy [63] for the Sleep Domain 
Ontology (SDO) [64], and the domain-defined and restriction-defined partial-area 
taxonomies [65] for the Drug Discovery Investigations Ontology [66]. An extensive 
review of Abstraction Networks has been presented by Halper et al. [4]. The Ontology 
Abstraction Framework (OAF) created by Ochs et al. [67] is an open source software 
system and tool for deriving Abstraction Networks, which is available at 
http://saboc.njit.edu/. The following sections will describe the Abstraction Networks 
associated with this dissertation using example neoplasm concepts from NCIt. 
2.2.1 Area Taxonomy and Partial-area Taxonomy 
 
The first discussed Abstraction Network is the area taxonomy. It is a network composed 
of area nodes and links denoted child-of. Another basic Abstraction Network is called 
partial-area taxonomy [6], which is derived from an area taxonomy.  
Figure 2.5 shows the derivation of the area taxonomy and partial-area taxonomy 
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for an excerpt of 13 neoplasm concepts. Concepts with the exact same set of roles are 
enclosed in dashed, colored boxes in Figure 2.5(a).  An area represents such a group of 
concepts with the exact same set of roles and is named by the set of roles. For example, in 
Figure 2.5(a) the five concepts in the dashed gray box Neoplasm, Neoplasm by Special 
Category, Neoplasm by Morphology, Papillary Neoplasm, and Epithelial Neoplasm have 
only one role Disease Has Abnormal Cell. Therefore, there is a corresponding area node 
named {Disease Has Abnormal Cell} summarizing these five concepts in Figure 2.5(b). 
An area taxonomy is an Abstraction Network composed of area nodes connected by 
child-of links, which are derived from the underlying IS-A relationships in the 
terminology. 
A root of an area is a concept such that its parent concept(s) are not in this same 
area. An area may have multiple root concepts. For example, the dashed blue box has the 
two roots Papillary Epithelial Neoplasm and Glandular Cell Neoplasm. An area A is 
child-of another area B if a root in A has a parent in B. Figure 2.5(b) is the area taxonomy 
for the 13 concepts in Figure 2.5(a). Area nodes in Figure 2.5(b) are color coded by the 
number of roles, i.e., areas with the same number of roles have the same color. Child-of 
links are displayed as bold upward arrows. For example, the single red area node at the 
bottom of Figure 2.5(b) is child-of both the green area node and the blue area node. 
The area taxonomy summarizes groups of concepts with similar structure. A root 
concept and all its descendant concepts in an area share a similar semantics, as they are 
all specializations of the same root concept. Since an area may have multiple roots 
representing various semantics, an area is further divided into partial-area(s) to get groups 
of concepts sharing similar structure and similar semantics. A partial-area is composed  
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Figure 2.5 (a) An excerpt of 13 neoplasm concepts in the Disease, Disorder or Finding 
hierarchy of NCIt. Concepts represented by boxes with rounded corners are connected by 
IS-A relationships shown as upward thin arrows. (b) The area taxonomy for the excerpt 
in (a). (c) The partial-area taxonomy for the excerpt in (a). 
 
 
of a root concept in an area and all its descendant concepts (i.e., children, grand-children, 
etc.) in the same area.  Partial-area nodes represent partial-areas of the terminology in the 
derived partial-area taxonomy. Partial-area nodes are connected by child-of links to form 
the partial-area taxonomy. Figure 2.5(c) is the partial-area taxonomy for Figure 2.5(a), in 
which partial-area nodes are represented as white boxes within area nodes. A partial-area 
node is labeled by its root concept, with the number of concepts that the node summarizes 
in () parentheses. Child-of links connecting partial-area nodes are also represented as bold 
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arrows. For example, Papillary Cystic Neoplasm (2) is child-of both Cystic Neoplasm (1) 
and Papillary Epithelial Neoplasm (1). 
2.2.2 Disjoint Partial-area Taxonomy 
 
Note that the red (bottom) area in Figure 2.5(b) has five concepts, while the sum of the 
numbers of concepts in the three partial-areas in Figure 2.5(c) is 7 (= 2+3+2). That is the 
case, because both Papillary Cystadenoma and Serous Cystadenoma have two parents 
which are roots of the red area. Therefore, both concepts are simultaneously summarized 
by two partial-areas. Concepts that are summarized by more than one partial-area are 
called “overlapping concepts.” Note that overlapping concepts cause some ambiguity in 
the summarization due to their multiple summarizations. 
In order to eliminate the phenomenon of summarization ambiguity of overlaps 
among partial-areas, the disjoint partial-area taxonomy [57] was developed. The basic 
idea is to extract overlapping concepts from their original partial-areas and place them 
into their own partial-areas. As a result all resulting partial-areas become disjoint. Figure 
2.6 illustrates the derivation of the disjoint partial-area taxonomy for an excerpt of 15 
neoplasm concepts in the area {Disease Excludes Abnormal Cell, Disease Excludes 
Finding, Disease Has Abnormal Cell, Disease Has Finding, Disease Has Normal Cell 
Origin, Disease Has Normal Tissue Origin}. Figure 2.6(a) shows that the 15 concepts of 
the excerpt are organized into four partial-areas Serous Neoplasm (5) enclosed by dashed 
orange lines, Cystadenoma (12) enclosed by dashed green lines, Papillary Cystic 
Neoplasm (8) enclosed by dashed red lines and Mucinous Neoplasm (4) enclosed by 
dashed blue lines. The upward thin arrows represent IS-A relationships between concepts.  
These four partial-areas have 10 overlapping concepts. For example, the concept 
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Papillary Serous Cystadenoma appears in three partial-areas (red, yellow, and green). 
In Figure 2.6(b), the four concepts in the first row (=Level 1) in different solid 
colors are the roots of the area (“area roots”). The concept Borderline Cystadenoma 
(without color at Level 2) and the four root concepts are non-overlapping concepts. The 
concept Serous Cystadenoma (Level 2) is a child of two root concepts. Previously, in the 
partial-area taxonomy, this concept would appear twice, namely once in the partial-area 
defined by each of the two roots. In the disjoint partial-area taxonomy, however, this 
concept is promoted to becoming a root of its own partial area. Such a concept is called 
an overlapping root. The same process is repeated for other concepts that have two or  
 
Figure 2.6 (a) An excerpt of 15 neoplasm concepts from the area {Disease Excludes 
Abnormal Cell, Disease Excludes Finding, Disease Has Abnormal Cell, Disease Has 
Finding, Disease Has Normal Cell Origin, Disease Has Normal Tissue Origin} 
distributed in four partial-areas enclosed by four different colored dashed boxes. (b) The 
roots of disjoint partial-areas are colored. Area roots have a single color and overlapping 
roots have multiple colors according to the colors of their multiple ancestor area roots. (c) 
The disjoint partial-area taxonomy for the excerpt in (a). Disjoint partial-areas are color 
coded according to the colors of their roots. Disjoint partial-areas with the same number 
of colors are placed at the same level, e.g., the five disjoint partial-areas with two colors 
are at the second level. There may be child-of relationships between disjoint partial-areas 
at the same level.  
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more parents that are area roots. As a side remark, the concept Clear Cell Papillary 
Cystadenoma (Level 3) is without color, because it is not a root; however, it is an 
overlapping concept, as it inherits from Cystadenoma and from Papillary Cystic 
Neoplasm.  
There is a complication that requires performing the above operation recursively 
at every level of the taxonomy. Papillary Serous Cystadenoma (at Level 3) is a child of 
two concepts that have now become overlapping roots. Thus, it would have to appear in 
the partial-areas defined by both these two overlapping roots in the partial-area taxonomy 
(Figure 2.6(a)). To avoid this, the same method is applied again one level down, and 
Papillary Serous Cystadenoma is itself promoted to overlapping root.  
 Overlapping roots are multicolored according to the colors of their multiple 
ancestor area roots. For example, the overlapping root Serous Cystadenoma has two 
colors, orange and green, because its two parents Serous Neoplasm (orange) and 
Cystadenoma (green) are area roots. Another example is the overlapping root Papillary 
Serous Cystadenoma with three colors, orange, green and red, because it has the 
combined semantics inherited (over two levels) from the three area roots Serous 
Neoplasm, Cystadenoma and Papillary Cystic Neoplasm.  
Figure 2.6(b) still displays “concept space,” like the original terminology. To 
arrive at the final disjoint partial-area taxonomy, three more steps have to be taken. All 
non-root concepts have to be deleted, because they are represented by their disjoint 
partial-area root nodes. Any IS-A link pointing to a deleted concept is redirected to the 
disjoint partial-area root node that will represent the deleted concept. Thus, the two 
uncolored concepts of Figure 2.6(b) are eliminated. Secondly, it is more intuitive to 
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organize overlapping roots (and thus disjoint partial-area nodes) by the number of colors 
in one node. Thus, all nodes with two colors are shown next to each other at Level 2 in 
Figure 2.6(c). Finally, for every root concept, whether overlapping root or area root, the 
number of concepts that this disjoint partial-area node represents is shown in () 
parentheses. (By this step, a root concept is effectively converted into a disjoint partial-
area node.) Thus, Cystadenoma appears in Figure 2.6(c) as Cystadenoma (2), because this 
disjoint partial-area node represents the deleted concept Borderline Cystadenoma. The 
arrows represent child-of links between disjoint partial-area nodes, with a similar 
interpretation as the previously described child-of links in a partial-area taxonomy and an 
area taxonomy.  
 
 
2.3 Quality Assurance of Biomedical Ontologies 
 
Building an ontology is a burdensome task, requiring a thorough understanding of the 
application domain as well as authoring skills following ontological rules. Many 
important biomedical ontologies (e.g., NCIt) have a large, complex network structure that 
poses significant maintenance challenges. It is not reasonable to expect that ontologies 
are completely free of modeling errors and inconsistencies. Errors and inconsistencies in 
biomedical ontologies impede their applications. Hence, Quality Assurance (QA) is a 
fundamental part of the life cycle of an ontology [5]. However, QA is a challenging and 
resource-intensive task. Without the help of automatic or semi-automatic techniques and 
tools, it is impossible to maintain ontologies with a high quality. 
Automated support for terminology and ontology QA has been a focus of much 
research, especially for large complex structures playing important roles in the 
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biomedicine field like the UMLS Metathesaurus [68-72], SNOMED CT [73-77], and 
Gene Ontology (GO) [78-81]. For NCIt, both internal and external QA reviews of NCIt 
have been conducted. Different internal QA techniques, including various automated and 
manual methods, have been employed during the whole life-cycle of NCIt [42]. For 
example, during the editing phase, concept definitions are reviewed by editors following 
the NCIt Editor Guide. Externally, a qualitative analysis of NCIt determining its 
adherence to relevant ISO terminology standards and ontological principles was 
performed [82]. In that study, it was concluded that the particular version of the NCIt 
suffered from the same broad range of problems (e.g., missing or inappropriately 
assigned verbal and formal definitions) as other biomedical ontologies.  
Structural characterizations based on Abstraction Networks have been applied to 
the Biological Process hierarchy of NCIt to identify sets of concepts with different kinds 
of errors in the hierarchy [5]. The main observation was that small partial-areas, which 
are units comprising few concepts that are all similar to each other in their structure and 
semantics, tend to exhibit higher error rates than large partial-areas. A comparative QA 
methodology focusing on the biological processes of different genes was carried out on 
NCIt’s Gene hierarchy with the use of the National Center for Biotechnology 
Information’s (NCBI’s) Entrez Gene database [83]. A multiphase QA methodology based 
on Abstraction Networks was also used on the Gene hierarchy to detect different kinds of 
role errors [84]. Another QA methodology based on semantic web technologies and using 
relationships defined in the UMLS Semantic Network identified inconsistencies in the 
hierarchical relationships and roles in the NCIt [85].  
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More and more biomedical ontologies, including large ones such as SNOMED 
CT [7], National Drug File – Reference Terminology (NDF-RT) [27] and NCIt [42] are 
modeled using description logic (DL) to ensure logical consistency of these ontologies. 
DL reasoners can automatically identify logical inconsistencies but cannot detect 
semantic errors (e.g., missing or incorrect relationships) that do not cause logical 
conflicts. Wei et al. [86] demonstrated that other methods (e.g., Abstraction Network-
based methodologies) are needed to complement DL classifiers to identify semantic 
errors.  
Below is a discussion of two general overviews of quality assurance of 
biomedical ontologies. Rogers [87] reviewed literature on the quality assurance of logic-
based medical ontologies from scholar.google.com in 2006 and proposed a framework to 
evaluate ontologies according to four aspects, namely philosophical rigor, ontological 
commitment, content correctness and fitness for purpose. Zhu et al. [88] performed an 
extensive review of auditing methods applied to various biomedical terminologies in 130 
studies, which appeared in the first journal special issue on auditing of terminologies [89]. 
They extended the review target from ontologies to all forms of controlled biomedical 
terminologies and presented a framework to characterize various auditing methods, 
applied to different terminologies, with appropriate examples. 
The SABOC research team has shown that Abstraction Networks are useful in 
support of ontology QA [4]. In particular, the alternative view of an ontology offered by 
an Abstraction Network supports the identification of sets of concepts with high 
likelihood of errors.  
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Two main characterizations of concepts with high likelihood of errors identified 
by the SABOC team are “uncommonly modeled” concepts and “complex” concepts. For 
different ontologies, the definitions of “uncommon” and “complex” may be different. For 
example, Halper et al. [90] identified partial-areas of up to seven concepts in the 
Specimen hierarchy of SNOMED CT as sets of “uncommon” concepts. Min et al. [5] also 
obtained a similar result for the Biological Process hierarchy of NCIt, but only for 
partial-areas of up to three concepts. Several studies have demonstrated that overlapping 
concepts in partial-area taxonomies are “complex” concepts [4, 91-93] such as for the 
Specimen hierarchy and the Clinical finding hierarchy of SNOMED CT, and for the Uber 
Anatomy Ontology (UBERON) [94]. 
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CHAPTER 3  
ADVANCED ABSTRACTION NETWORKS  
 
The Big Data to Knowledge (BD2K) initiative is expected to produce many knowledge 
items that can be expressed as assertions or as rules. However, orientation into large 
knowledge bases is a challenge by itself, the “Big Knowledge” challenge. Without some 
high-level mental representation of the kinds of content in a large knowledge base, 
effective use of the knowledge may be limited [95]. When an ontology surpasses many 
thousands of assertions, even its curators are confronted with the problem of seeing the 
“big picture” of its content, which would impede the ontology’s maintenance and 
applications. Hence, in order to facilitate the users’ “big picture” comprehension, it is 
important to provide automated tools for summarization of the content in a large ontology. 
This is one manifestation of the “Big Knowledge” challenge [4].  
In order to address the “Big Knowledge” challenge, this chapter introduces two 
advanced Abstraction Networks, the weighted aggregate partial-area taxonomy [9, 10] 
that provides a more compact and flexible summary of biomedical ontologies compared 
with the original partial-area taxonomy, and the Ingredient Abstraction Network (IAbN) 
[11, 12], summarizing and visualizing NDF-RT’s Chemical Ingredient hierarchy. The 
latter had to be derived due to the terminology’s unique modeling structure, for which the 







3.1 Weighted Aggregate Partial-area Taxonomy 
 
In previous studies by the SABOC team, various types of Abstraction Networks have 
been developed to summarize, visualize, and support the quality assurance of biomedical 
ontologies. However, biomedical ontologies are complex knowledge systems in terms of 
their large numbers of concepts and tens or even hundreds of thousands of relationships. 
Although the previously derived Abstraction Networks, e.g., the partial-area taxonomy, 
are compact compared to the ontologies themselves, they are usually still too 
overwhelming to comprehend, since there are many nodes, some of which are 
summarizing only a few concepts. In order to address the “Big Knowledge” challenge, 
this section introduces a more compact Abstraction Network for ontologies, named 
weighted aggregate partial-area taxonomy. 
A weighted aggregate partial-area taxonomy [9, 10] (“aggregate taxonomy” for 
short) is a variation of a partial-area taxonomy with an adjustable parameter b that is used 
to control the granularity of summarization. First, a complete partial-area taxonomy is 
created for the ontology (the original partial-area taxonomy). Next, based on the given 
parameter b, “small” partial-areas are aggregated into their closest “large” ancestor 
partial-area(s) [96]. In this way, the small partial-areas are not removed but are instead 
hidden to obtain a more compact summary. The parameter b is used to distinguish 
between small and large partial-areas. The size of a partial-area is defined as the number 
of concepts it summarizes. The aggregated weight of a partial-area in the original partial-
area taxonomy is defined as the sum of its size and the sizes of all its descendant partial-
areas.  
The parameter b specifies the minimum aggregated weight of a partial-area in the  
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original partial-area taxonomy that will appear explicitly in the aggregate taxonomy. 
More precisely, all partial-areas with an aggregated weight greater than or equal to b will 
be included in the resulting aggregate taxonomy. Using a topological sort, an aggregate 
taxonomy is generated by aggregating any partial-areas with an aggregated weight less 
than b into their closest parent/ancestor partial-area(s) (which have an aggregated weight 
≥ b). The root partial-area will be included regardless of size, to ensure that there is 
always a root in the aggregate taxonomy. The nodes in the aggregate taxonomy, called 
aggregate partial-areas, summarize their descendant partial-areas from the original 
partial-area taxonomy. A partial-area may appear unchanged after performing the 
aggregation process.  
Figure 3.1 illustrates the derivation of an aggregate taxonomy with b=20 for a 
subhierarchy of eight partial-areas rooted at Colorectal Carcinoma (19). The partial-areas 
in the blue areas in Figure 3.1(a) are child partial-areas of Colorectal Carcinoma (19). 
The aggregated weight of Colorectal Carcinoma (19) is thus 56 (=19 + 24 + 4 + 3 + 1 + 3 
+ 1 + 1) and the aggregated weights of its seven child partial-areas are their sizes, as they 
have no descendant partial-areas. With b=20, the six child partial-areas with an 
aggregated weight less than 20 are aggregated into the partial-area node at the first level. 
The only child partial-area is Colorectal Adenocarcinoma (24) with an aggregated weight 
greater than 20. It stays unchanged and is represented by a white rectangle with “sharp 
corners” in Figure 3.1(b). A rectangle with rounded corners summarizes small descendant 
partial-areas. 
Figure 3.3 shows the weighted aggregate taxonomy with the parameter b as 200 
for the NCIt Neoplasm subhierarchy with 8,445 concepts, consisting of only 25 aggregate 
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partial-areas. Compared to the Neoplasm subhierarchy itself in Figure 1.1 on Page 2 and 
its partial-area taxonomy with 4,177 partial-areas shown in Figure 3.2, Figure 3.3 
captures the “big picture” of the subhierarchy. For example, there are 1199 concepts 
related to Reproductive System Neoplasm and 909 Connective and Soft Tissue Neoplasm 
concepts. 
Note that, given the original partial-area taxonomy and the aggregated weight of  
each of its partial-areas, the parameter b can be automatically adjusted such that the 
aggregate taxonomy will consist of no more than some fixed number of aggregate partial-
areas. In this way, the resulting aggregate taxonomy becomes smaller and more 
comprehensible. 
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Figure 3.1 (a) An excerpt of eight partial-areas in the NCIt Neoplasm partial-area 
taxonomy. (b) Weighted aggregate partial-area taxonomy for (a) with b=20. A “rounded” 
white rectangle represents an aggregate partial-area with its number of concepts in the 
original partial-area taxonomy in {}, its number of concepts in the aggregated taxonomy 
in () including all concepts from aggregated partial-areas, and the number of its 
aggregated partial-areas in []. A white rectangle with “corners” represents an aggregate 


















3.2 Ingredient Abstraction Network (IAbN) 
 
The effects of drugs depend mostly on their chemical ingredients and each drug in NDF-
RT is linked to its chemical ingredients via has_Ingredient roles (see Figure 2.2). 
Improving the modeling of NDF-RT’s chemical ingredient concepts would improve the 
modeling of NDF-RT’s drug concepts. The Chemical Ingredients (CI) hierarchy of NDF-
RT is relevant to Drug-Drug Interactions (DDIs), since in many cases drugs that are 
chemically similar tend to have similar interactions [97]. Hence, it is necessary to make 
sure the modeling of the Chemical Ingredients hierarchy is of high quality. 
In a long range research program, the SABOC team [54] has developed a 
framework that combines summarization, visualization and quality assurance (SVQA) 
into a sequence of well-ordered steps. The overall aim of the SVQA paradigm is to 
identify sets of concepts in a terminology that are expected to have a higher error rate 
than other concepts. The identification of theses sets is based on summaries derived from 
the terminology’s structure and semantics. Limited QA resources can be applied to the 
concepts in such a set, improving the rate of error detection and correction. 
However, it is impossible to derive partial-area taxonomies for large portions of 
NDF-RT; the structures of several of its concept hierarchies do not contain enough 
information to perform such a derivation. Seven of the NDF-RT hierarchies have no roles 
emanating from their concepts (i.e., their concepts only have hierarchical relationships). 
All of the roles in NDF-RT emanate from concepts in the Pharmaceutical Preparations 
(PP) hierarchy and point to concepts in the other hierarchies (see Figure 2.2). Hence, the 
only hierarchy of the NDF-RT that lends itself to deriving the partial-area taxonomy (see 
Section 2.2.1) is the PP hierarchy.  
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Thus, to apply the SVQA process to NDF-RT’s Chemical Ingredients (CI) 
hierarchy, a new summarization process is needed. The Ingredient Abstraction Network 
(IAbN) is the new Abstraction Network that summarizes NDF-RT’s chemical ingredients 
and their associated drug concepts.  
An Ingredient Abstraction Network (IAbN) is an Abstraction Network where the 
nodes summarize (1) the ingredients in the Chemical Ingredients hierarchy and (2) those 
drug concepts in the Pharmaceutical Preparations hierarchy that have no dosage 
information but that do have at least one has_Ingredient role to a drug ingredient in the 
Chemical Ingredients hierarchy. 
Drug ingredients are chemical ingredients that are used in prescription drugs. Five 
categories of concepts in the Chemical Ingredients (CI) hierarchy were defined. The right 
side of Figure 3.4(a) illustrates the following categories of drug concepts for an excerpt 
of 14 CI concepts.  
Definition 1: A drug ingredient concept is a concept in the Chemical Ingredients 
(CI) hierarchy that is the target of has_Ingredient role(s) from concepts in the 
Pharmaceutical Preparation hierarchy.  
Definition 2: A classification ingredient concept is a concept in CI that “organizes” 
other drug ingredient concepts below it. In other words, it has drug ingredient concepts as 
children. It may or may not be itself a target of a has_Ingredient role.  
Definition 3: A dual ingredient concept is both a drug ingredient concept and a 
classification ingredient concept in CI.  Such a concept is a target of a has_Ingredient 
role and has children that are drug ingredient concepts. 
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Definition 4: A strict classification ingredient concept is a classification 
ingredient concept that is not also a drug ingredient concept. That is, it is not a target of a 
has_Ingredient role.  
In other words, a classification ingredient concept is either a dual ingredient 
concept or a strict classification ingredient concept. 
Definition 5: An uncategorized ingredient concept is a concept in the CI hierarchy 
that is neither a drug ingredient concept nor a classification ingredient concept. Such 
concepts are not summarized in the IAbN. 
The design of an Abstraction Network for the CI hierarchy poses a challenge for 
several reasons: (1) A lack of roles emanating from CI concepts prevents the derivation 
of a partial-area taxonomy (see Section 2.2.1) that can be derived for many other 
description logic-based terminologies. (2) The need to distinguish between drug 
ingredient concepts and classification ingredient concepts is further complicated by the 
existence of dual ingredient concepts. (3) To obtain a “big picture” of the Chemical 
Ingredients hierarchy there is a need to summarize the drug concepts, which in NDF-RT 
are parts of the PP hierarchy, according to their ingredient concepts in CI, as was 
illustrated by Ochs et al. [11].  
The derivation algorithm for an IAbN begins with identifying all of the drug 
concepts in the PP hierarchy that have a has_Ingredient role but no has_DoseForm role. 
PP concepts with dosage information are ignored, since an ancestor concept, typically a 
parent (a PP generic drug ingredient), introduces the has_Ingredient role, which is 
inherited to such concepts. Hence, there is no need for direct summarization of PP 
concepts with dosage information, since such a summary is offered indirectly through the 
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summarization of the ancestor PP concepts without dosage information. All the PP 
concepts in Figure 3.4(a), except Pharmaceutical Preparations, have one has_Ingredient 
role to a concept in the CI hierarchy. Different drug concepts in the PP hierarchy can 
have a has_Ingredient role to the same CI concept, e.g., both Aspirin and Acetylsalicylate 
Sodium have the ingredient Aspirin. PP concepts may also have multiple has_Ingredient 
roles, e.g., Aspirin/Caffeine has distinct has_Ingredient roles to both Aspirin and Caffeine.  
In the next step, drug ingredient concepts (see Definition 1 above) are identified 
by collecting the target concepts of all the has_Ingredient roles. Classification ingredient 
concepts (see Definition 2 above) are identified by analyzing the parent concept(s) of 
each drug ingredient concept. Next, for each drug ingredient concept, the lowest 
ancestor(s) that are a strict classification ingredient concept(s) (see Definition 4 above) 
are identified, with the intention of finding groups of drug ingredient concepts. (Common 
ancestors will be used in the next step to define groups.)  
For example, for the Aspirin CI concept, the lowest ancestor that is a strict 
classification ingredient concept is Salicylates. Salicylates is the lowest common ancestor 
for Aspirin, Magnesium Salicylate, and Diflunisal. Warfarin Sodium’s parent concept 
Warfarin is a classification ingredient concept, but it is also a drug ingredient concept 
(i.e., it is a dual ingredient concept; see Definition 3 above). Thus, the lowest ancestor of 
Warfarin Sodium that is a strict classification ingredient concept is Warfarin’s parent, 4-
Hydroxycoumarins. Many CI hierarchy concepts have multiple parents, thus, a given 
drug ingredient concept may have more than one lowest ancestor that is a strict 
classification ingredient concept. 
In the next step of deriving the Abstraction Network, the drug ingredient concepts 
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are grouped together according to their common ancestor(s) that are strict classification 
ingredient concepts. For example, Aspirin, Magnesium Salicylate, and Diflunisal share 
Salicylates as a lowest common ancestor. Similarly, Warfarin, Warfarin Sodium, and 
Phenprocoumon share 4-Hydroxycoumarins as a lowest common ancestor. Figure 3.4(b) 
models the right side of Figure 3.4(a) and shows the “drug ingredient groups” induced by 
the lowest common ancestors. Color coding in Figure 3.4(b) helps to keep the groups 
apart: Every group has its own color.  
In the following step, each strict classification ingredient concept is recast as a 
root for its ingredient group. Roots of a group are shown with solid fill in Figure 3.4(b). 
Thus Salicylates becomes the root of the group with Aspirin, Magnesium Salicylate, and 
Diflunisal in it. The CI root concept, Chemical Ingredients, is also a root. Roots represent 
groups of CI concepts in the IAbN (Figure 3.4(c)). The text line “3 Ingredients” under 
Salicylates in Figure 3.4(c) indicates how much information is summarized by this box. 
Ingredient groups are not disjoint; drug ingredient concepts with multiple parents may be 
summarized by multiple ingredient groups. With this step, a summary (Figure 3.4(c)) of 
the “right side” (the Chemical Ingredients hierarchy) of Figure 3.4(a) has been created. In 
the next step, information from the left (PP) side of Figure 3.4(a) will be included into 
Figure 3.4(c). 
For each ingredient group, the PP drug concepts that have a has_Ingredient role 
to a drug ingredient concept in the ingredient group are identified. For example, the 
Aspirin and Acetylsalicylate Sodium drug concepts in PP both have Aspirin in CI as the 
target of their has_Ingredient roles. The Aspirin drug ingredient concept belongs to the 
Salicylates ingredient group, thus, the Aspirin and Acetylsalicylate Sodium drug concepts 
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from PP are also summarized by the Salicylates ingredient group. This is expressed by 
the text line “4 Drugs” under Salicylates in Figure 3.4(c). (The other two drug concepts 
are Magnesium salicylate and Diflunisal). Since ingredients may belong to multiple 
ingredient groups, a given PP drug concept may be represented by multiple ingredient 
groups. 
Within the IAbN, ingredient groups are organized into a hierarchy according to 
child-of links derived from the underlying IS-A hierarchy. An ingredient group A is a 
child-of another ingredient group B if A’s root has B’s root as an ancestor in the CI 
hierarchy and there are no other roots of the IAbN on any path from A’s root to B’s root 
in the CI hierarchy. An ingredient group may be a child-of multiple ingredient groups. In 
summary, Figure 3.4(c) shows the IAbN derived from NDF-RT excerpt in Figure 3.4(a). 
In the visualization of an IAbN, it is necessary to organize the ingredient groups 
in a way that helps the summary reflect the “big picture.” Thus, ingredient groups may be 
organized into color coded levels according to the length of the longest child-of path to 
the root ingredient group (Chemical Ingredients). This will be shown later in Figure 3.5. 
Figure 3.4(c) does not use this color level encoding.  
Note that Ethyl Biscoumacetate is an uncategorized ingredient concept (see 
Definition 5 above), as shown in Figure 3.4(a). This occurs when an ingredient is 
modeled in CI but no PP drug concept has a has_Ingredient role to this ingredient. For 
the current research, such concepts are not summarized by any ingredient group and are 





Figure 3.4 (a) An excerpt of concepts from NDF-RT’s Pharmaceutical Preparations (PP) and Chemical Ingredients (CI) hierarchies. 
On the left, drug concepts in the PP hierarchy with no dosage information have a shaded background. On the right, nine drug 
ingredient concepts have red borders and five classification ingredient concepts have a pink background. Two concepts, 
Aminosalicylic Acid and Warfarin, are both drug ingredient concepts and classification ingredient concepts, i.e., they are dual 
ingredient concepts. Ethyl Biscoumacetate is neither a drug ingredient concept nor a classification ingredient concept, i.e., it is an 
uncategorized ingredient concept. (b) CI grouped. Drug ingredient concepts are not shaded and their lowest common ancestor 
classification ingredient concepts are shaded. Each drug ingredient concept is color-framed according to its lowest common ancestor 
classification ingredient concept. (c) The IAbN for Figure 3.4(a). Ingredient groups are shown as boxes that are labeled with the name 
of the lowest common ancestor from Figure 3.4(b). In each box are the total number of ingredient concepts summarized by the group, 
and the total number of drug concepts (without dosage information!) with has_Ingredient roles pointing to the summarized concepts in 






An IAbN for the June 2015 release of NDF-RT’s Chemical Ingredients (CI) 
hierarchy, consisting of 10,145 concepts, was derived. This IAbN consists of 860 
ingredient groups, which summarize 2,664 drug ingredients and 6,872 Pharmaceutical 
Preparation hierarchy drug concepts. The abstraction ratio of the IAbN was defined to 
be the average number of drug ingredients per ingredient group. The abstraction ratio of 
the June 2015 IAbN is 3.07 (=2,664/860). There are 813 drug ingredient concepts 
summarized by more than one ingredient group (with a total of 535 such ingredient 
groups), and each such drug ingredient is summarized by an average of 1.52 (=813/535) 
ingredient groups. The average number of PP drug concepts summarized by each 
ingredient group is 7.99 (=6,872/860).  
Figure 3.5 shows an excerpt of 128 of the IAbN’s ingredient groups, as the IAbN 
is too large to fit on a single page. By reviewing the ingredient groups of the IAbN, one 
can see the major types of drug ingredients used in NDF-RT’s drugs. For example, the 
Polymers group (Level 2: green) summarizes 26 ingredients and 81 drugs, Piperidines 
(Level 3: blue) summarizes 47 ingredients and 76 drugs, Tetracyclines summarizes 17 
ingredients and 35 drugs, Ethanolamines summarizes 45 ingredients and 231 drugs, and 




Figure 3.5 An excerpt of 128 (15%) ingredient groups from the IAbN for the June 2015 
version of the CI hierarchy. The smaller ingredient groups have been hidden as follows. 
Each level shows as many groups as possible, in decreasing order by the number of 
ingredients in each group, while keeping the group names readable. Child-of links are 
hidden for readability. The numbers of ingredients and drugs summarized by each 
ingredient group are shown in parentheses and prepended with I: and D:, respectively. 
Salicylates and Aminosalicylic Acids, from Figure 3.4(c), are highlighted in yellow. 
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CHAPTER 4  
BIG KNOWLEDGE COMPREHENSION 
 
This chapter presents three applications of the two advanced Abstraction Networks 
introduced in Chapter 3 to demonstrate their effectiveness for the Big Knowledge 
comprehension. The first application is a summarization approach for the automatic 
identification and display of major topics covered by an ontology’s content. This 
approach is based on the weighted aggregate partial-area taxonomy. SNOMED CT’s 
Specimen hierarchy was the test-bed for evaluating the effectiveness of this approach. 
Another application of the  weighted aggregate partial-area taxonomy is a multi-layer, 
multi-granularity Big Knowledge visualization scheme. The visualization scheme is 
demonstrated on the National Cancer Institute thesaurus’s Neoplasm subhierarchy to 
support its comprehension. The innovative application of the Ingredient Abstraction 
Network is Drug-Drug Interaction discovery. 
 
 
4.1 Major Topic Identification 
 
This section presents a study on the summarization of the “big picture” of an ontology by 
automatically deriving concept groups that represent major topics in a specific domain. It 
is a parameterized methodology to identify major topics in an ontology based on the 
weighted aggregate partial-area taxonomy, followed by manual enhancement. Because of 
SNOMED CT’s importance in clinical applications and its large size, an experiment on 
its Specimen hierarchy is presented to test the effectiveness of such summarization 
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measured by “Big Knowledge” coverage of a given list of major topics related to the 
corresponding domain.  
4.1.1 Partial-area Taxonomies for Major Topic Identification 
 
A topic of an ontology, represented by a concept c, is considered a major topic if c has a 
large number of descendants. The above definition of major topic is based on the 
following two assumptions. First, it was assumed that concepts belonging to a given topic 
are all hierarchically related (i.e., they share a common ancestor concept c that represents 
and names the topic). That is, all the descendant concepts of a topic c belong to that topic, 
since they are specializations of c. Second, it was assumed that if there are relatively 
many concepts for a topic then it is “more important.” For example, there are 262 
concepts related to digestive system specimens, but only 12 related to bone marrow 
specimens. Thus the topic “digestive system specimens” was considered as more 
important in SNOMED CT. Note that it is not necessarily clinically more important, 
since this depends on the clinical context.  
The approach for evaluating the quality of the automatically identified major 
topics was based on a gold standard list provided by a domain expert. The domain expert, 
Dr. Gai Elhanan (GE), was asked to select a list of major topics for the specimen domain. 
(GE) is an MD with long experience in ontologies. A gold standard may also be derived 
from a published ontology of an authoritative organization. No other ontology for 
specimens was found, e.g., in the UMLS Metathesaurus. For the sake of normalization 
and to simplify the eventual matching task, each chosen topic was semi-automatically 
mapped to a SNOMED CT concept in the Specimen hierarchy, utilizing UMLS 
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synonyms. For example, the topic “Bone specimen” was mapped to the concept Specimen 
from bone. 
One straightforward heuristic for identifying major topics in an ontology is to 
review the ontology root’s children, which are typically general and cover high-level 
topics. For example, Specimen has 59 children (e.g., Biopsy sample and Blood specimen). 
However, among the 59 children, many would not be considered major topics (based on 
the second assumption above), since they have few descendants. For example, 13 of 
Specimen’s children do not themselves have children (e.g., Muscle specimen). Nine have 
few children and no grandchildren (e.g., Fibroblast specimen has one child). Of the 
remaining 37 children, only 13 were in the major topic list of the domain expert, while 
another eight on that list were not children of Specimen (e.g., Stool specimen is a 
grandchild of Specimen). Hence, a better methodology for identifying major topics is 
required. 
In previous studies, the SABOC team has derived a partial-area taxonomy [6] for 
each of the seven SNOMED CT hierarchies, including Specimen, that have outgoing 
lateral relationships. The partial-area taxonomies were not designed for the purpose of 
major topic identification, but for structure and content summarization. Indeed, the roots 
of partial-areas are not necessarily intuitive topics. A root of a partial-area is 
distinguished by the introduction of a new relationship type into the ontology, but it may 
or may not be a major topic. Moreover, a partial-area may be small, and thus, may not 
define a broad topic. A partial-area taxonomy typically has many small partial-areas [96]. 
As a result, the partial-area taxonomy for a large ontology, although smaller by an order 




Figure 4.1 An excerpt of the partial-area taxonomy for the Specimen hierarchy. Partial-
areas are sorted (left to right and top to bottom) according to their numbers of concepts. 
The yellow partial-areas are the descendant partial-areas of the pink partial-area 
Specimen from trunk. That is, there is a path of child-of relationships from any yellow 
partial-area to Specimen from trunk. 
 
 
“forest” summary of the topics is not seen for the many small “trees” (see Figure 4.1). 
Figure 4.1 shows an excerpt of the partial-area taxonomy (with child-of links omitted) for 
the entire Specimen hierarchy. 
Hence, a better solution for identifying major topics is to pick only the large 
partial-areas (with, e.g., dozens or more concepts). To illustrate these points, consider 
Figure 4.1, which shows an excerpt of Specimen’s partial-area taxonomy. Some concepts 
appear as (labels of) relatively large partial-areas. For example, Specimen from trunk 
(132), Specimen from head and neck structure (53), and Specimen from digestive system 
(50) from the area {Specimen source topography}, are partial-areas with 50 or more 
concepts. However, the seven large partial-areas account for only 536 Specimen concepts 
(33.1%). One may wonder about the topics of the other 66.9% of concepts.  
Moving to medium-sized partial-areas with 20–49 concepts, eight partial-areas 
cover 218 (13.5%) concepts, e.g., Blood specimen (28) and Soft tissue biopsy sample 
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(23). Together, the large and medium partial-areas cover only 754 specimen concepts 
(46.5%). There are other problems with the summarization provided by the large/medium 
partial-areas. For example, all descendant partial-areas (yellow) of Specimen from trunk 
(pink) in Figure 4.1 contain concepts that are refinements of this topic. They are in 
separate partial-areas because they have (an) extra relationship(s) and appear in another 
area. For example, Swab from abdomen (13) has an additional Specimen procedure 
relationship. Overall, there are 201 partial-area descendants of Specimen from trunk, 
covering 551 concepts. 
In summary, by only focusing on large and medium partial-areas, useful 
knowledge that is distributed among the many small partial-areas is ignored. Frequently, 
a large partial-area has many descendant small partial-areas. The concepts in these 
descendant partial-areas cover the same topic as the large parent/ancestor partial-area, but 
in more detail. Hence, they belong to the topic of the parent/ancestor partial-area.  
4.1.2 Weighted Aggregate Partial-area Taxonomies for Major Topic Identification 
 
During the aggregation process to derive the weighted aggregate partial-area taxonomy, 
small partial-areas are allowed to contribute to the identification of major topics. Since 
small partial-areas are folded into their larger ancestor partial-area(s), the lost knowledge 
in small partial-areas is accounted for. As an example, Figure 4.2 shows the aggregation 
process. The aggregated weight of the partial-area Endocrine sample (10) is 26, because 
it has nine descendant partial-areas summarizing 16 descendant concepts. Since the nine 
descendant partial-areas have no child partial-areas, their aggregated weights are the 
same as their original sizes, namely less than 11. Hence, in the weighted aggregate 
partial-area taxonomy with b=11 (Figure 4.2(b)), all the descendants partial-areas are 
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aggregated into and are represented by the partial-area Endocrine sample. 
In the topic identification experiment, the threshold b was iterated over the range 
1…30 and the weighted aggregate taxonomy was derived for each b. Each such weighted 
aggregate taxonomy was inspected to determine its effectiveness in capturing major 
topics. Precision, recall, and F measure [98] were calculated for each weighted aggregate  
taxonomy, with the expert’s topic list serving as a gold standard. Recall is the ratio of the 
number of correctly identified topics and the number of total topics. Precision is the ratio 
of the number of correctly identified topics and the number of partial-areas. 
 
Figure 4.2 (a) An excerpt of 10 partial-areas (b) Weighted aggregate partial-area with 
b=11 for (a), shown as a rounded white rectangle with its number of concepts in ( ) 
including all concepts from aggregated partial-areas and the number of aggregated 
partial-areas in [ ]. 
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As a preliminary experiment, it was determined how many of the gold standard 
topics appeared as partial-areas in the original partial-area taxonomy (not the weighted 
aggregate taxonomies). Out of the 21 topics chosen by the expert, 13 appear as partial-
areas. This yields a recall of 0.62 (13/21) and, with 503 partial-areas in the taxonomy, 
very low precision of 0.03 (13/503). Note that many partial-areas are very small. In 
contrast, the weighted aggregate taxonomy, which eliminates the small partial-areas, is 
more effective. To balance recall and precision, the weighted aggregate taxonomy with 
the b value that maximizes the F measure was considered as optimal. 
If the root concept r of a partial-area appears in the weighted aggregate taxonomy 
of threshold b, then r is considered a major topic identified by that weighted aggregate 
taxonomy; a corresponding checkmark “” is placed in Table 4.1. Otherwise, a dash “–” 
is written. For example, the topic Bone marrow specimen is captured by a partial-area 
Bone marrow specimen (8) with an aggregated weight 13 (Table 4.1). Therefore, it is 
identified by all weighted aggregate taxonomies with b <=13 (b=1, 5, 10). However, for 
b>13, Bone marrow specimen (8) is folded into a larger ancestor partial-area and 
disappears. No weighted aggregate taxonomy with b >13 identifies the topic Bone 
marrow specimen. As another example, Bone specimen was not identified by the 
weighted aggregate taxonomy with any b value as major topic (Row 5 of Table 4.1), 
since its mapped SNOMED CT concept Specimen from bone (Row 5, Column 2 of Table 
4.1) is not a root of a partial-area. 
The bottom of Table 4.1 shows the totals of the identified topics for the respective 
aggregate taxonomies. For example, for b=5, the total is 13. Table 4.2 shows each 
weighted aggregate taxonomy’s number of partial-areas (A), recall, precision, and F. 
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Recall is the ratio of identified topics and total topics (R=C/S, where S=21). Precision is 
the ratio of the identified topics and the number of partial-areas (P=C/A). For example, 
for b=25, the number of partial-areas is 29, the number of identified topics is 12, R=0.57, 
P=0.41 and F=0.48. Table 4.2 shows that b=25 yields the aggregate taxonomy where F is 
maximized. In this case, the weighted aggregate taxonomy captures 12 of the 21 topics. 
Figure 4.3 shows this weighted aggregate taxonomy with the 12 partial-areas identifying 
topics highlighted in yellow. The total number of concepts in these 12 aggregate partial-
areas is 988, accounting for 61.0% (988/1620) of the concepts in the Specimen hierarchy. 
 
 
Table 4.1 Identification Results for 21 Chosen Topics in Weighted Aggregate Taxonomies with Different Thresholds b 
Topic Concept Partial-area Weight b=1 5 10 15 20 25 30 
Blood specimen Blood specimen Blood specimen (28) 43        
Body substance sample Body substance sample Body substance sample (63) 498        
Fluid sample Fluid sample Fluid sample (50) 257        
Bone marrow specimen Bone marrow specimen Bone marrow specimen (8) 13    – – – – 
Bone specimen Specimen from bone Musculoskeletal sample (15) 44 – – – – – – – 
Specimen from nervous 
system 
Specimen from nervous 
system 
Specimen from nervous 
system (12) 
42        
Dermatological specimen Dermatological sample Dermatological sample (8) 30        
Device specimen Device specimen Device specimen (19) 40        
Digestive system specimen 
Specimen from digestive 
system 
Specimen from digestive 
system (50) 
126        
Endocrine system specimen Endocrine sample Endocrine sample (10) 26       – 
Genital system specimen, 
male 
Male genital sample Specimen from trunk (132) 489 – – – – – – – 
Genitourinary specimen Genitourinary sample Specimen from trunk (132) 489 – – – – – – – 
Hair specimen, scalp Hair specimen Dermatological sample (8) 30 – – – – – – – 
Musculoskeletal specimen Musculoskeletal sample Musculoskeletal sample (15) 56        
Skin specimen Specimen from skin Dermatological sample (8) 30 – – – – – – – 
Soft tissue specimen Soft tissue sample Soft tissue sample (21) 92        
Cardiovascular sample Cardiovascular sample Cardiovascular sample (12) 28       – 
Specimen from eye Specimen from eye 
Specimen from head and 
neck structure (53) 
196 – – – – – – – 
Specimen from joint Joint sample Musculoskeletal sample (15) 56 – – – – – – – 
Lesion sample Lesion sample Lesion sample (17) 118        
Stool specimen Stool specimen Body substance sample (63) 498 – – – – – – – 






Table 4.2 Performance of Weighted Aggregate Taxonomies for Various Thresholds 
 
b =  1 5 10 15 20 25 30 
# Identified topics  13 13 13 12 12 12 10 
# Partial-areas (A) 503 89 54 40 35 29 26 
Recall (R = C/S) 0.62 0.62 0.62 0.57 0.57 0.57 0.48 
Precision (P = C/A) 0.03 0.15 0.24 0.30 0.34 0.41 0.38 




Figure 4.3 Weighted aggregate taxonomy for the Specimen hierarchy with b=25. The 12 
partial-areas corresponding to the original given topics are highlighted in yellow. The 13 
topics added during the enhancement step are highlighted in pink. 
 
An ancillary experiment was carried out as a feedback step with the domain 
expert (GE). When inspecting the weighted aggregate taxonomy for threshold b, one can 
assess whether its other partial-areas beyond those in the gold standard list are worthy of 
the designation “major topic,” for example, those aggregate partial-areas in Figure 4.3 
categorizing over 25 concepts that are not in the given list. Some important topics may 
have been overlooked originally, due to various reasons, e.g., Specimen from head and 
neck structure, a compound topic name with two body parts, and Tissue specimen 
obtained by excision, corresponding to two relationships Specimen procedure and 
Specimen source topography. Figure 4.3 was shown to (GE). He manually determined 
that 13 more partial-areas, highlighted in pink, warranted inclusion in the list of major 
specimen topics, while the other three (in white) are deemed as non-major topics. 
Reevaluating the experiment (with 21+13=34 major topics), it was obtained that R=0.74 
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(=25/34), P=0.86 (=25/29) and F=0.79 for b=25. The number of concepts in these 25 
aggregate partial-areas is 1,524 (94.1% of the concepts in the Specimen hierarchy.) 
In summary, summarizing a large ontology is a challenge as there is a lack of an 
objective, universally accepted criterion for what constitutes a “good summarization” of 
an ontology. Various applications require different summaries of various granularities. 
Nevertheless, the management of ontologies requires “big picture” comprehension that 
can be enabled by compact summarization networks such as the weighted aggregate 
partial-area taxonomies introduced in this dissertation.  
This study utilized a knowledge-oriented approach, where the importance of a 
topic is based on the number of concepts related to that topic in an ontology. To measure 
the quality of the summarization, the number of identified major topics was compared 
with a gold standard list of topics selected by a domain expert, who selected topics from a 
clinical perspective. The results showed that the weighted aggregate partial-area 
taxonomy is viable as a method for capturing the major topics of a domain. 
 
 
4.2 Multi-layer Big Knowledge Visualization Scheme for Comprehending 
Neoplasm Ontology Content 
 
Visualizing Big Knowledge is challenging, due to the inherent complexity of knowledge. 
Consider, for example, an ontology as a structured knowledge repository. An ontology 
consists of a network of nodes (called concepts) interconnected by hierarchical 
relationships and semantic lateral relationships. Large ontologies contain several hundred 
thousand concepts and at least as many relationships.  
Figures are an effective way of presenting knowledge in a comprehensible format. 
Indeed, the knowledge in an ontology is often presented as a node-link diagram [99]. In 
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this type of visualization, concepts are displayed as nodes labeled with their names. 
Node-link diagrams for small portions of an ontology can be displayed on a single 
computer screen or on a single printed page. However, visualizing larger portions of an 
ontology requires larger and more complex figures, which pose significant problems 
related to the comprehension capacity of humans (which is limited, independent of the 
screen size).  
Heuristically, node-link diagrams become overwhelming if more than about 20 to 
30 nodes, and their associated links, are displayed [100, 101]. A figure with more nodes 
(and thus, more links between nodes) most likely will pose a challenge to the mental 
comprehension of most humans. Assuming that there is a capacity limit on 
comprehension, how can humans cope with comprehending large ontologies with 
hundreds of thousands of concepts? 
Large ontologies are often divided into disjoint subhierarchies, each dedicated to a 
specific topic. However, even the individual subhierarchies are typically far beyond a 
human’s comprehension ability. For example, the Disease, Disorder or Finding hierarchy 
of the National Cancer Institute (NCI) thesaurus (NCIt) [3] contains 27,045 concepts. The 
Neoplasm subhierarchy, dedicated to neoplastic diseases like Cancer, contains 8,445 
concepts.  
The overwhelming complexity of Figure 1.1 illustrated the challenges when 
trying to comprehend the contents of Big Knowledge repositories such as ontologies, in 
addition to the technical limitations associated with generating such a view on a computer 
screen (e.g., a lack of screen space and limited human visual acuity).  
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Without some level of mental comprehension of the contents of a large body of 
knowledge, humans will experience difficulty using the knowledge for innovative and 
sophisticated applications [95]. Furthermore, the curator(s) in charge of maintaining large 
knowledge repositories require such comprehension to achieve correct and exact 
modeling of the knowledge.  
How can a human achieve comprehension of large hierarchies of concepts? As 
can be seen in Figure 1.1, the amount of knowledge expressed in a node-link diagram can 
be overwhelming to the point of being unusable.  
The approach outlined in this section is a vision for coping with the “Big 
Knowledge challenge” using two techniques. First, Big Knowledge is automatically 
summarized into a compact visualization that captures the “big picture” of the knowledge 
by hiding less important details. This summary view allows a user to concentrate on the 
“major subjects” in a knowledge base. An interactive mechanism for recovering details 
that were lost in the summarization process allows a user to obtain more information on-
demand. Hence, in this approach, details are not lost, they are only hidden until they are 
exposed upon request. The second part of this approach is based on the heuristic that 
humans struggle to comprehend a node-link diagram with more than 30 labeled nodes. 
Thus, when visualizing Big Knowledge summaries, a limit on the number of named 
nodes will be strictly enforced. 
The contribution of this section consists of a multi-layer interactive system, based 
on the theory of Abstraction Networks, where the initial “big picture” summary presented 
to a user is of low granularity. From this view, a user “drills down” into more details as 
desired. Such a dynamic system enables a user to navigate through several layers of 
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summarization, where at each point in time the user views only one network with a fixed 
number of nodes (specifically, an example limit of 25 is enforced in this section).  
4.2.1 Hypothesis for Limited Human Comprehension Capacity 
 
In humans, working memory is a cognitive system with a limited capacity. It is 
responsible for temporarily holding information available for processing [102]. Working 
memory is important for reasoning and decision making. Although there are various 
hypotheses about the quantitative measure of working memory capacity, the general 
consensus is that there is a limit to that capacity.  
One of the most famous papers in cognitive psychology is “The Magical Number 
Seven, Plus or Minus Two: Some Limits on Our Capacity for Processing Information” by 
Miller [103]. According to Miller, the number of objects an average human can hold in 
working memory is 7 ± 2. A more recent paper by Cowan [104] identifies a smaller 
number (four items). 
The partial-area taxonomy created from the 8,445 neoplasm concepts in the 
September 2016 NCIt release consists of 4,177 partial-areas in 1,301 areas. Although the 
partial-area taxonomy is smaller than the underlying ontology, following the theory of 
limited working memory, it is still far too large for a human to comprehend its contents 
or the contents of the partial-area taxonomy. 
Based on the above heuristic, the hypothesis that an Abstraction Network (such as 
a partial-area taxonomy) with no more than 30 nodes, when displayed as a figure, will be 
comprehensible to a human was formulated. Therefore, a more compact summary than is 
provided by a partial-area taxonomy is required. As noted before, the weighted aggregate 
partial-area taxonomy offers a more compact summary of a size that can be controlled. It 
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will now be used to develop a multi-layer display where each layer is limited in its 
complexity. 
4.2.2 Multi-layer Visualization Scheme for Big Knowledge 
 
The technique defined in this section provides a compact summary of an ontology in the 
form of an aggregate taxonomy, created in a software system by using an automatically 
determined parameter b at each layer. Following the vision outlined above, the system 
should be able to expand a given aggregate partial-area to show its details (i.e., its 
constituent “small” partial-areas). The expansion process is the inverse procedure of 
aggregation. For example, if a user wants to see which partial-areas are summarized by 
the aggregate partial-area Colorectal Carcinoma {19}(32)[6] in Figure 3.1, then he/she 
could obtain the details shown in Figure 3.1(a) by “re-expanding” that aggregate partial-
area in the interactive system. This corresponds to a drill down operation. 
Expanding an aggregated partial-area into its constituent small partial-areas can 
result in a view that is overwhelming when the aggregate partial-area summarizes many 
small partial-areas. Thus, it may be required to apply the aggregate taxonomy process 
recursively, with a different automatically selected bound b, on the subhierarchy of small 
partial-areas that is to be displayed.  
For example, if the aggregate partial-area Malignant Digestive System Neoplasm 
{26} (467) [203] is expanded with 203 “small” partial-areas in the Neoplasm aggregate 
taxonomy shown in Figure 4.4, the resulting partial-area taxonomy will have 204 partial-
areas (far more than the recommended limit of 25).  
Thus, it is necessary to apply the aggregation process to the resulting partial-area 
taxonomy to obtain an aggregate taxonomy with no more than 25 aggregate partial-areas. 
 
59 
The automatically identified parameter b=8 makes the resulting aggregate taxonomy for 
Malignant Digestive System Neoplasm have 24 nodes, in the range of human 
comprehension ability. This bound is significantly lower than the parameter b=200, 
which limits the number of aggregate partial-areas in the Neoplasm aggregate taxonomy 
to 25. 
With repeated applications of this process, a multi-layer visualization scheme is 
obtained, where each summarizing view has at most 25 aggregate partial-areas. The first 
summary, of the least granularity, summarizes the entire ontology (or a selected 
subhierarchy of an ontology, e.g., Neoplasm). The second layer of summarization 
summarizes a chosen subject (e.g., Malignant Digestive System Neoplasm). Further 
summaries, as obtained by expanding additional aggregate partial-areas, will display 
more details for more specific subjects (e.g., Colorectal Carcinoma selected from within 
the Malignant Digestive System Neoplasm aggregate taxonomy). The final summary will 
be a partial-area taxonomy, with at most 25 partial-areas. From this summary, a user 
could “drill down” to individual concepts in individual partial-areas. This dynamic multi-
layer visualization system enables a user to view details in a desired part of the “big 
picture” through recursive application of the same aggregate-taxonomy-based 
summarization methodology. 
The multi-layer visualization scheme is demonstrated below using the Neoplasm 
subhierarchy in NCIt as a test bed. There are 27 role types defined for the Disease, 
Disorder or Finding hierarchy. To simplify the following figures, the 27 roles as coded as 
numbers in the figures. Table 4.3 shows the code numbers (index numbers) representing 
the 19 roles that appear in the following figures. 
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Table 4.3 The Index Numbers for the Roles in NCIt Appearing in this section 
 
Role Type Index Number 
Disease Excludes Abnormal Cell 1 
Disease Excludes Finding 3 
Disease Excludes Normal Cell Origin 5 
Disease Excludes Normal Tissue Origin 6 
Disease Excludes Primary Anatomic Site 7 
Disease Has Abnormal Cell 8 
Disease Has Associated Anatomic Site 9 
Disease Has Associated Disease 10 
Disease Has Finding 12 
Disease Has Normal Cell Origin 15 
Disease Has Normal Tissue Origin 16 
Disease Has Primary Anatomic Site 17 
Disease Is Grade 18 
Disease Is Stage 19 
Disease Mapped To Gene 21 
Disease May Have Associated Disease 23 
Disease May Have Cytogenetic Abnormality 24 
Disease May Have Finding 25 
Disease May Have Molecular Abnormality 26 
 
 
Layer 1: Neoplasm Aggregate Taxonomy 
Figure 4.4 shows the aggregate taxonomy for the Neoplasm subhierarchy with 
b=200 (the smallest b resulting in an aggregate taxonomy with [at most] 25 nodes). There 
are 25 aggregate partial-areas, shown in white. This would be the first layer of 
summarization for the Neoplasm subhierarchy. Note that the aggregate partial-areas 
shown in Figure 4.4 have root concepts that are general in nature and each summarizes a 
large number of concepts. This view provides the “big picture” of the contents of the 
Neoplasm subhierarchy. For example, the aggregate partial-area node Malignant 
Digestive System Neoplasm {26} (467) [203] summarizes 467 neoplasm concepts, about 




Neoplasm {440} (3582) [1845]




Neoplasm {43} (1199) [686]
Connective and Soft Tissue 
Neoplasm {2} (909) [599]
Nervous System Neoplasm 
{12} (832) [414]
Head and Neck Neoplasm 
{90} (425) [189]
Urinary System Neoplasm 
{22} (321) [199]
Hematopoietic and Lymphoid 
System Neoplasm {7} (183) [101]
Hematopoietic and Lymphoid 
Cell Neoplasm {4} (491) [312]
{8, 9, 15, 16, 17} (1 Partial-area)
Epithelial Neoplasm 
{43} (1953) [1006]
{1, 8, 12, 15, 16} (1 Partial-area)
Lymphocytic Neoplasm 
{5} (742) [457]
{5, 8, 9, 15, 16, 17} (1 Partial-area)
B-Cell Neoplasm 
{6} (374) [251]
{1, 5, 8, 9, 15, 16, 17} (2 Partial-areas)
Head and Neck Carcinoma 
{63} (537) [231]
{1, 8, 9, 12, 15, 16, 17} (1 Partial-area)
Non-Hodgkin Lymphoma
{6} (520) [330]
Intracranial Neoplasm  
{21} (311) [128]
{7, 8, 9} (2 Partial-areas)
Thoracic Neoplasm 
{14} (208) [139]
Mesenchymal Cell Neoplasm  
{8} (621) [437]
{8} (1 Partial-area)
Malignant Digestive System 
Neoplasm {26} (467) [203]
{3, 8, 9} (1 Partial-area)
Sarcoma {9} (545) [320]
{3, 5, 6, 8, 9, 16} (1 Partial-area)
Glandular Cell Neoplasm 
{56} (813) [337]
{1, 3, 8, 12, 15, 16} (3 Partial-areas)
Papillary Epithelial 
Neoplasm {18} (221) [101]
Squamous Cell Neoplasm 
{18} (354) [203]
{1, 3, 8, 9, 12, 15, 16, 17} (1 Partial-area)
Digestive System 
Carcinoma {56} (624) [259]
Endocrine Neoplasm 
{7} (489) [221]
{1, 8, 12, 15, 16, 17} (1 Partial-area)
Malignant Thoracic Neoplasm 
{15} (317) [193]
{3, 7, 8, 9} (1 Partial-area)
{5, 8, 9, 15, 16} (1 Partial-area)
 
Figure 4.4 Neoplasm Aggregate Taxonomy with 25 aggregate partial-areas (b=200). 
 
 
Layer 2: Malignant Digestive System Neoplasm Aggregate Taxonomy 
A user may be interested in the concepts summarized by Malignant Digestive 
System Neoplasm (surrounded by a red ellipse in Figure 4.4). In this case, the user can 
expand this aggregate partial-area. Since the partial-area taxonomy obtained from 
expanding Malignant Digestive System Neoplasm has more than 25 partial-areas (namely 
204), the aggregation process is recursively applied to obtain an aggregate taxonomy with 
at most 25 aggregate partial-areas (this time using b=8).  
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Figure 4.5 shows the aggregate taxonomy for the Malignant Digestive System 
Neoplasm subhierarchy with b=8, which is composed of 24 aggregate partial-area nodes. 
Comparing Figure 4.4 with Figure 4.5, the number of concepts summarized by each 
aggregate partial-area is much smaller in Figure 4.5. This is due to the aggregate partial-
areas in Figure 4.5 capturing more specific subjects. This view captures a relatively small 
part of the “big picture” in Figure 4.4. 
Malignant Digestive System 
Neoplasm {26} (129) [85]
{1, 3, 8, 9, 12, 15, 16, 17} (1 Partial-area)
Esophageal Squamous Cell 
Carcinoma {7} (23) [9]




{1, 3, 5, 7, 8, 9, 12, 15, 16, 17, 25, 26} 
(1 Partial-area)
Digestive System Carcinoma 
In Situ {11} (23) [8]
{1, 3, 8, 9, 12, 15, 16, 17, 18, 19} 
(1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 21, 25, 26} 
(2 Partial-areas)
{3, 8, 9} (1 Partial-area)
Digestive System Neuroendocrine 
Carcinoma {9} (39) [26]
{1, 3, 8, 9, 12, 15, 16, 17, 18} 
(1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 19, 21, 25, 26} 
(2 Partial-areas)
{3, 5, 8, 9, 12, 15, 16, 17} (1 Partial-area)
Digestive System Carcinoma 
{56} (237) [131]
Digestive System Lymphoma 
{19} (25) [6]
Digestive System Non-Hodgkin 
Lymphoma {11} (44) [27]
{1, 3, 5, 8, 9, 12, 15, 16, 17} 
(1 Partial-area)
Cholangiocarcinoma {6} (14) [8]
{1, 3, 8, 9, 12, 15, 16, 17, 25} 
(1 Partial-area)
Liver and Intrahepatic Bile Duct Malignant 
Non-Epithelial Neoplasm {2} (18) [16]
{1, 3, 5, 6, 7, 8, 9, 16, 17} 
(1 Partial-area)
Small Intestinal Carcinoma 
{3} (32) [18]




{1, 3, 8, 9, 12, 15, 16, 17, 23, 25} 
(1 Partial-area)
Sporadic Gastric 
Adenocarcinoma {11} (16) [5]
{1, 3, 8, 9, 12, 15, 16, 17, 25, 26 } 
(1 Partial-area)
Stage II Colorectal 
Cancer (13)
Stage III Colorectal 
Cancer (13)
Ampulla of Vater 
Adenocarcinoma {6} (8) [2]
{1, 3, 8, 9, 12, 15, 16, 17, 21, 25} 
(1 Partial-area)
Liver and Intrahepatic Bile 
Duct Carcinoma {13} (46) [15]
{1, 3, 5, 7, 8, 9, 12, 15, 16, 17} 
(1 Partial-area)
Extrahepatic Bile Duct 
Adenocarcinoma {9} (10) [1]








Gallbladder Adenocarcinoma  
{10} (11) [1]
{3, 7, 8, 9, 12, 15, 16, 17, 21, 23, 24, 25 } 
(1 Partial-area)
Hepatoblastoma {9} (18) [9]




{1, 3, 5, 7, 8, 9, 12 15, 16, 17, 24, 25, 26 } 
(1 Partial-area)
Pancreatic Ductal 
Adenocarcinoma {10} (11) [1]
 
Figure 4.5 Malignant Digestive System Neoplasm (from Figure 4.4) Aggregate 
Taxonomy with 24 aggregate partial-areas (b=8). 
 
 
Layer 3: Small Intestinal Carcinoma Partial-area Taxonomy  
Note that all nodes in Figure 4.5 are aggregate partial-areas (shown as rounded 
corner white rectangles) that summarize at least one descendant partial-area, except for 
Stage II Colorectal Cancer (13) and Stage III Colorectal Cancer (13) (shown as white 
rectangles with sharp corners). In this view, the expansion and aggregation process can 
be applied again to get a more detailed picture with at most 25 partial-areas for any 
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aggregate partial-area in the figure. For example, if Small Intestinal Carcinoma in Figure 
4.5 (again, marked by a red ellipse) is expanded, the resulting partial-area taxonomy has 
only 19 partial-areas. Thus, there is no need to apply aggregation after the expansion. 
Figure 4.6 shows the partial-area taxonomy for the Small Intestinal Carcinoma 
subhierarchy. 
{1, 3, 8, 9, 10, 12, 15, 16, 17, 23} (1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 23} (1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 18, 19, 23} (1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 23, 25} (8 Partial-areas)
{1, 3, 8, 9, 12, 15, 16, 17, 19, 23, 25} (4 Partial-areas) {1, 3, 8, 9, 12, 15, 16, 17, 18, 23, 25} (1 Partial-area)
{1, 3, 8, 9, 12, 15, 16, 17, 18, 23, 25, 26} (1 Partial-area)
Small Intestinal Carcinoma (3)

















{1, 3, 8, 9, 12, 15, 16, 17, 18, 23} (1 Partial-area)
Small Intestinal 
Neuroendocrine Carcinoma (1)
Stage 0 Small Intestinal 
Cancer (1)
Stage II Small 
Intestinal Cancer (3)
Stage III Small 
Intestinal Cancer (3)
Stage I Small Intestinal 
Cancer (1)
Stage IV Small 
Intestinal Cancer (1)
Small Intestinal Large Cell 
Neuroendocrine Carcinoma (1)
Small Intestinal Small Cell 
Neuroendocrine Carcinoma (1)
{1, 3, 8, 9, 12, 15, 16, 17, 23, 24, 25, 26} (1 Partial-area)
Small Intestinal Adenocarcinoma (6)
 




The multi-layer visualization scheme for ontologies has been integrated into the 
Ontology Abstraction Framework (OAF) software tool, described in detail by Ochs et al. 
[67]. The OAF provided all of the necessary modules for this visualization scheme, 
namely, the aggregate partial-area taxonomy module for the aggregation process, and the 
expanded sub-taxonomy module for the expansion process.  
In this study, the Neoplasm subhierarchy of NCIt was utilized to demonstrate the 
methodology. However, the OAF tool supports ontologies in various formats. Since the 
multi-layer visualization scheme is fully integrated into the OAF, the technique described 
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in this section will be applicable to many ontologies, thus enabling users to obtain a better 
understanding of the Big Knowledge in the displayed ontologies. 
The multi-layer visualization scheme is based on the heuristic that a human has a 
limited comprehension capacity that was assumed to be about 25 nodes in a node-link 
diagram. In future work, evaluation studies will be conducted to test this heuristic. This 
section proposed a general process for supporting the comprehension of Big Knowledge 
through summarization. In the future, usability studies will be  performed to evaluate the 
effectiveness of this technique. 
To conclude, comprehension of Big Knowledge is a significant challenge. In this 
study, a multi-layer visualization scheme was described for Big Knowledge repositories, 
which are ontologies in this research. The approach was based on Abstraction Networks, 
which, using a process of aggregation, can be tuned to automatically limit the amount of 
information presented to a user. This technique was illustrated using the Neoplasm 
subhierarchy of the NCIt ontology. 
 
 
4.3 Application of the IAbN to Drug-Drug Interaction Discovery 
 
A Drug-Drug Interaction (DDI) is a particularly important type of Adverse Drug 
Reaction (ADR) [105-108] that can cause excessive responses or altered toxicity [109]. 
The risk of adverse DDIs increases exponentially for each additional medication [110-
114]. One application of the IAbN is the discovery of candidate drug-drug interactions 
missing from existing DDI knowledge bases.  
The rationale is that drugs with similar chemical ingredients tend to have similar 
DDIs [97]. Given DDIs of the form (DrugConcept1, DrugConcept2, 
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ClinicalConsequence), each DrugConcept1 and DrugConcept2 element is coded as a 
concept in the NDF-RT’s Chemical Ingredients hierarchy [115].  In this study, the DDI 
knowledge base from First Databank (FDB) [116] was used as the test-bed to 
demonstrate the approach. By reviewing the known DDIs in FDB associated with the 
chemical ingredients in an IAbN ingredient group, one may discover candidate DDIs 
missing from First Databank’s DDI knowledge base [11]. 
Figure 4.7 illustrates the approach. There are 18 drug ingredients summarized by 
the IAbN’s Salicylates ingredient group, including its child ingredient group 
Aminosalicylic Acid (the two yellow highlights in Figure 3.5). Out of the 18 NDF-RT 
Salicylates ingredients, 13 ingredients appear in FDB’s DDI knowledge base. The DDI 
interactions between ten of these salicylates and seven anticoagulant drugs are “Avoid 
concurrent use when possible” (AVD) and “Increases the effect of latter drug” (INL), for 
a total of 70 DDIs between these two groups. However, three extra Salicylates 
(balsalazide, mesalamine, and salsalate) have no DDIs with any anticoagulant in the FDB  
 
Figure 4.7 (a) Illustration of 70 DDIs. There are 10x7=70 DDIs between the ten 
salicylates on the left and the seven anticoagulants on the right in FDB’s DDI knowledge 
base. AVD = “Avoid concurrent use when possible” and INL = “Increases the effect of 
latter drug.”  (b) Three new candidate DDIs not appearing in FDB’s DDI knowledge base, 




DDI knowledge base. This raised doubts regarding the existence of DDIs between the 
seven anticoagulants and these three salicylates. Indeed, upon investigating the DDIs 
between the three extra salicylates and these seven anticoagulants in another public 
source, Drugs.com (https://www.drugs.com/), DDIs between one salicylate Salsalate and 
three of the anticoagulants shown in Figures 4.7(b) were discovered. The reason FDB did 
not include these candidate DDIs in their knowledge base is that in these cases the drug 
formulation has a low potential for interactions. Nevertheless, FDB staff (Joan Kapusnik-
Uner) confirmed that this example demonstrates the fact that summaries of NDF-RT have 
the potential for supporting the discovery of new candidate DDIs. Of course, 
pharmacological investigation is required for each potential DDI. 
One has to realize that, as a leading Pharmacological knowledge company, FDB’s 
DDI knowledge is widely used by pharmacies, doctors and hospitals for decisions about 
preventing patients from taking drugs prescribed due to their conditions. These are 
critical clinical decisions that sometimes involve issues of life or death. Other DDI 
sources, like drugs.com, which are not used in this way in the healthcare industry, are 
thus more lenient in including questionable pairs of drugs as DDIs. 
Similar to the above study on one drug pair, another study was performed to 
examine several pairs of families of drugs, known to have DDIs, in search of drug pairs 
with potential DDIs that are not listed in the FDB knowledge base. For each such pair, 
one family is a chemical classification while the other is a pharmaceutical classification. 
Typically, the NDF-RT contains more drugs under the chemical classification than the 
FDB DDI knowledge base. Drugs.com was explored for DDIs for those additional drugs 
from the NDF-RT, looking for interactions with the drugs that are classified by the 
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corresponding pharmaceutical classification. 
Table 4.4 reports the details of this study for seven pairs of families. Column 2 
lists the DDI family pairs (A, B) as given in the FDB DDI knowledge base. For all seven 
pairs, A is a Chemical Ingredient family and B is a Pharmaceutical family. Column 3 
represents the number of ingredients in Family A (e.g., Sulfonamides) in FDB. Column 4 
shows the number of ingredients in Family B (e.g., Antidiabetics, Oral) in FDB. Column 
5 gives the number of drug DDI (A, B) pairs in FDB, which is the product of the number 
in Column 3 and the number in Column 4. Column 6 represents the number of 
ingredients in Family A in the NDF-RT. Column 7 shows the number of ingredients in 
Family A in both NDF-RT and FDB. Column 8 shows the total number of potential DDIs 
found in other sources than FDB’s knowledge base for the specific (A, B) drug pairs.  
For example, the first pair is (Sulfonamides; Antidiabetics, Oral). In FDB the 
DDIs between six sulfonamides (Family A) and eight antidiabetics (Family B) have the 
clinical effect “INL” (Increased effect of the latter drug). However, in the NDF-RT there 
are 52 drugs classified under Sulfonamides. When pairing the additional (i.e., not in 
FDB’s knowledge base) 48 A drugs with those eight B drugs, 93 pairs of drugs were 
found in the other sources as DDI pairs between Family A and Family B. An analysis of 
these 93 pairs revealed that for (A, B) pairs the interaction between the two drugs consists 
of a “protein binding displacement mechanism” that applies only for sulfonamide 
antibiotics, which describes the six sulfonamides listed in the FDB DDI knowledge base. 
This mechanism does not apply to the remaining sulfonamides found in the NDF-RT. 
One outcome from this study is that FDB will change, in its DDI knowledge base, the 
name of this Family A from “Sulfonamides” to “Sulfonamide Antibiotics,” which 
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describes it more accurately.  
Out of the 73 potential DDIs (Table 4.4, line 3) for the family pair (NSAID, ACE 
Inhibitor or ARBS) found in other sources, 16 potential DDIs for the Nonsteroidal Anti-
inflammatory Compound (NSAID) Diflunisal with 16 different ACE Inhibitors should be 
added to the FDB knowledge base. According to line 5 in the table, eight potential DDIs 
for the NSAID Diclofenac with various Beta Blockers were found. These should be 
considered for addition to FDB’s knowledge base. Similarly, for its salt form Diclofenac 
Potassium, nine DDIs were found to be missing from FDB’s knowledge base. However, 
the clinical studies reported in drugs.com for these pairs did not prove the DDIs to be at 
the stricter level required for inclusion by FDB. For the two NSAIDs Meclofenamate and 
Mefenamic Acid, which are currently not on the US market, eight and 11 DDIs, 
respectively, were found with various Beta Blockers. They should be added to FDB’s 
knowledge base for the case that these drugs will be made available for sale in the US. 
The DDI family pair in line 6 of Table 4.4 is known to cause many DDI alerts 
with a low severity level, i.e., it is a prime example of a combination that causes alert 
fatigue. Thus, line 6 interactions will be recommended for removal from FDB’s DDI 
knowledge base. A detailed pharmacological analysis of these various families of drugs 
will appear in a future publication. 
To summarize the results of this study, out of 394 potential DDI drug pairs found 
in other sources, 80 (20.3%) were approved for inclusion in FDB’s DDI knowledge base. 
Another 19 (4.8%) drug pairs will be added if their drugs are made available in the US. 
The following additional outcomes of this study do not relate to the potential DDI pairs 
of Column 8, but to the actual FDB DDI pairs of Column 5 in Table 4.4. One such 
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important outcome was that 66 DDI drug pairs for the family pair (Phenotiazines, 
Narcotics) were removed from the FDB DDI knowledge base, since they almost always 
cause false alerts.  
Even more interestingly, a deeper analysis of the FDB DDI drug pairs from three 
family pairs (rows 3, 4, and 5 of Table 4.4) showed that the issue was not the interaction 
of one drug with another drug, but the interaction between one drug and the disease that 
is present when the other drug is used. These interactions will be removed from the FDB 
DDI knowledge base, since the adverse drug reaction (ADR) is between a drug and a 
disease, rather than an interaction between two drugs. The relevant ADR knowledge will 
be placed in the proper FDB ADR knowledge base. The total number of DDI pairs 
removed is 1632+490+324=2446.  Hence, beyond the additional DDI pairs, the study led 





Table 4.4 Potential DDI Findings for Seven Pairs of Drug Families 
 2 3 4 5 6 7 8 
 
DDI Family Pair 
(A, B) 
# of Ingredients 
in Family A in 
FDB 
# of Ingredients 
in Family B in 
FDB 
# of Actual 
FDB DDIs 
# of Ingredients 
in Family A in 
NDF-RT 
# of Ingredients 
in Family A  in 
Both FDB and 
NDF-RT 
# of Potential 









22 6 132 52 15 21 
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(NSAIDs, 
ACE Inhibitors or ARBs) 
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CHAPTER 5  
FAMILY-BASED QUALITY ASSURANCE 
OF BIOMEDICAL ONTOLOGIES 
 
 
As described in Chapter 2 and Chapter 3, the SABOC team has developed different 
Abstraction Network-based quality assurance (QA) techniques for individual biomedical 
ontologies. To improve the efficiency of the Abstraction Network-based QA 
methodology, Ochs et al. [8] have classified BioPortal [117] ontologies into families 
according to ontologies’ structural features and have introduced a family-based QA 
approach such that one QA methodology could be applicable to a whole family of 
structurally similar ontologies. Statistically, in order to correctly draw the conclusion that 
a QA technique is likely to work for at least half of the ontologies in a family, the QA 
methodology has to be demonstrated successfully for six out of six sample ontologies in 
the family.  
It has been demonstrated that two main characterizations of concepts ‒ complex 
concepts and uncommonly modeled concepts ‒ are more likely to have errors for 
individual ontologies (Section 2.3). To demonstrate the effectiveness of these two 
characterizations for six ontologies in the same family, this chapter presents several 
Abstraction Network-based quality assurance studies on some ontologies in the same 
family. These ontologies are the NCIt’s Neoplasm subhierarchy of the Disease, Disorder 
or Finding hierarchy, the Gene hierarchy and the Biological Process hierarchy, 
SNOMED CT’s Infectious Disease subhierarchy of the Clinical finding hierarchy, the 




5.1 Quality Assurance of Complex Concepts 
 
In the long-range research of the SABOC team [54], a repeated theme in QA of 
ontologies has been that “complex” concepts tend to have a significantly higher error rate 
than “simple” concepts. There are various interpretations of “complex concept” for 
different methodologies and different ontologies. A likely explanation is that the human 
activity of modeling complex concepts is more challenging and thus there is more room 
for errors in the modeling of a complex concept. This section mainly involves two types 
of complex concepts, overlapping concepts and concepts with more lateral relationship 
types. The latter concepts, laterally complex concepts, intuitively can be deemed to be 
more complex than a concept with fewer lateral relationship types. Two studies on this 
type of concepts in the NCIt’s Biological Process hierarchy and the ChEBI ontology are 
presented in the following sections. 
Overlapping concepts are hierarchically complex, because they derive semantics 
from two or more source concepts that are roots of partial-areas in the partial-area 
taxonomy.  For example, the concept Papillary Serous Cystadenoma in Figure 2.6(a) 
inherits semantics from three partial-area roots Serous Neoplasm, Cystadenoma, and 
Papillary Cystic Neoplasm. Its two parents Serous Cystadenoma and Papillary 
Cystadenoma are themselves overlapping concepts. Hence, from the view point of 
hierarchy complexity, Papillary Serous Cystadenoma is more complex than its two 
parents, which in turn are more complex than the area roots.  
The SABOC team has demonstrated that overlapping concepts are more likely to 
have errors than non-overlapping concepts for three ontologies [16, 91-93]: the Specimen 
hierarchy of SNOMED CT, the Bleeding subhierarchy in the Clinical finding hierarchy of 
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SNOMED CT [7], and the Uber Anatomy Ontology (Uberon) [94]. In order to 
confidently make a statement that concentrating on overlapping concepts constitutes a 
successful methodology for a whole family of ontologies, the effectiveness of the 
methodology needs to be shown for six out of six sample ontologies. To achieve six out 
of six, studies on overlapping concepts in three more ontologies that belong to the same 
family as the above mentioned three ontologies will be presented in the following 
sections. These six ontologies belong to the family of ontologies in BioPortal with (a) 
object properties used only in restrictions and (b) with multiple parents allowed. 
5.1.1 Quality Assurance of Complex Neoplasm Concepts in NCIt 
 
The QA study on overlapping neoplasm concepts in NCIt presented in this section was 
conducted with the goal to add a fourth ontology to the set of three ontologies (the 
Specimen hierarchy and the Bleeding subhierarchy of SNOMED CT and Uberon) for 
which the QA methodology of overlapping concepts was previously shown as effective.  
5.1.1.1 Methods. As mentioned in Section 2.1.3, the concepts in the Neoplasm 
subhierarchy of the NCIt’s Disease, Disorder or Finding hierarchy are modeled with 
more details, compared to the other concepts in the Disease, Disorder or Finding 
hierarchy. Furthermore, according to Ochs et al. [8], the Neoplasm subhierarchy has the 
same structural features as the above three ontologies for which the “overlapping concept” 
QA methodology was demonstrated as effective. Hence, this QA study concentrated on 
the Neoplasm subhierarchy. Although the number of concepts (8,166) in the Neoplasm 
subhierarchy is much smaller than that of the complete Disease, Disorder or Finding 
hierarchy (25,360), it was still impossible to review all concepts in the Neoplasm 
subhierarchy, considering the reality of limited QA resources. 
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The disjoint partial-area taxonomy for the Neoplasm subhierarchy clearly 
distinguishes between overlapping concepts and non-overlapping concepts. In this study 
overlapping concepts were considered as complex concepts and non-overlapping 
concepts were considered as simpler concepts which serve as control concepts. The 
following hypothesis was investigated. 
Hypothesis 5.1: Overlapping concepts are more likely to have errors than non-
overlapping concepts in the disjoint partial-area taxonomy for the Neoplasm subhierarchy 
of the Disease, Disorder or Finding hierarchy of NCIt. 
Hypothesis 5.1 is of practical importance. If Hypothesis 5.1 is confirmed with 
statistical significance, then the disjoint partial-area taxonomy can be viewed as a fully 
automatic screening test that identifies sets of concepts with a likely higher error yield 
than other neoplasm concepts, defined by the ratio of the number of discovered errors to 
the number of reviewed concepts. Thus, it is justified to invest QA resources, such as the 
time of domain experts, into a careful review of overlapping concepts. 
A randomized controlled trial was conducted on a sample of neoplasm concepts to 
evaluate Hypothesis 5.1. The Neoplasm disjoint partial-area taxonomy contains exactly 
225 overlapping concepts, which were used as the study concepts. A sample of 350 non-
overlapping concepts from the same areas that the study concepts came from was 
randomly picked as a control group. Since concepts in small partial-areas are prone to 
have more errors, as mentioned in Section 2.3, the control population excluded such 
concepts. The study concepts and control group concepts were combined into a list. The 
order of the concepts in the list was randomized and the resulting list was presented to 
two domain experts for review.  
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The two domain experts, Dr. Gai Elhanan and Dr. Yan Chen, were trained in 
medicine and have extensive terminology QA experience. The QA study consisted of 
three steps. First, the two experts reviewed all 575 concepts independently. Each of the 
reviewers generated a report of errors with reasons, error severities (moderate or severe) 
and suggested corrections. Non-critical errors were not reported. In the second step, a 
combined list of errors reported by the two experts in the first step was created and 
presented to the same two reviewers. They had to express agreement or disagreement 
with each error in the list. The information of who had marked a concept as erroneous in 
the combined list was not included to avoid biased results.  
In the third step, all concepts that were considered erroneous by only one reviewer 
in the second step were eliminated. Concepts on the list were then divided according to 
whether they came from the study group (overlapping concepts) or from the control 
group (non-overlapping concepts) and the numbers of errors were counted. The two 
tailed p-value of Fisher’s exact test [118] was calculated to evaluate the statistical 
significance of the different error rates for overlapping concepts and for non-overlapping 
concepts. 
5.1.1.2 Results. The partial-area taxonomy for the Neoplasm subhierarchy of the 
February 2015 release of the NCIt was first derived. The 8,166 neoplasm concepts are 
summarized by 920 areas and 4,824 partial-areas in this partial-area taxonomy. The 
partial-area taxonomy for the complete Disease, Disorder or Finding hierarchy of 25,360 
concepts contains 986 areas and 5,080 partial-areas. 
Comparing the numbers of areas and partial-areas for the Neoplasm subhierarchy 
versus the whole Disease, Disorder or Finding hierarchy, 95% (4,824/5,080) of the 
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Disease, Disorder or Finding partial-area taxonomy summarize all the neoplasm 
concepts, which account for only 32% (8,166/25,360) of the complete Disease, Disorder 
or Finding hierarchy. The remaining 68% of the hierarchy are covered by only 5% of the 
partial-areas. In order to perform a direct quantitative comparison, the abstraction ratio 
of a partial-area taxonomy is defined as the average number of concepts summarized per 
partial-area. The abstraction ratio for the Neoplasm subhierarchy is 1.69 (=8,166/4,824) 
and the standard derivation is 6.49, while the abstraction ratio is 4.99 (=25,360/5,080) 
and the standard derivation is 201.55 for the whole Disease, Disorder or Finding 
hierarchy. A lower number is indicative of more structural and semantic diversity, which 
is the result of detailed modeling efforts. The structural diversity is due to the large 
average number (23) of roles per neoplasm concept, since every combination of roles 
defines a different area. Thus, the structural diversity is reflected in the large number of 
areas. The semantic diversity is borne out by the many partial-areas. 
The partial-area taxonomy for the complete Disease, Disorder or Finding 
hierarchy has 396 overlapping concepts. Among those, 225 overlapping concepts are in 
the Neoplasm partial-area taxonomy, and they appear in 45 areas. Most overlapping 
concepts are summarized by two partial-areas each. Only six overlapping concepts appear 
in three partial-areas simultaneously.  
There are six areas with more than 10 overlapping neoplasm concepts in the 
partial-area taxonomy of the Neoplasm subhierarchy. The largest area contains 137 
partial-areas, 463 concepts, and 27 overlapping concepts. These overlapping concepts are 
distributed over 18 partial-areas. The second-largest area contains 100 partial-areas, 321 
concepts and 25 overlapping concepts. These overlapping concepts are distributed over 
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24 partial-areas. These two areas contain the two largest sets of overlapping concepts 
among all areas in the Neoplasm subhierarchy.  
Figure 5.1 shows the disjoint partial-area taxonomy for the area with the six role 
types Disease Excludes Abnormal Cell, Disease Excludes Finding, Disease Has 
Abnormal Cell, Disease Has Finding, Disease Has Normal Cell Origin, and Disease Has 
Normal Tissue Origin that summarizes 98 concepts in 26 partial-areas. Of these 98, 20 
concepts are overlapping concepts. The overlapping concepts appear in nine partial-areas. 
An excerpt of this disjoint partial-area taxonomy was also shown in Figure 2.6(c). In 
Figure 5.1, Level 2 had to be distributed over two rows, as there are 15 disjoint partial-
areas at this level that do not fit into one row.  
After the three-step QA study, the two domain expert reviewers agreed that 71 
concepts (12.3% = 71/575) had errors with a moderate or severe error type. Among the 
71 erroneous concepts, 36 concepts (16% = 36/225) were overlapping concepts in 16 
areas, with 48 errors (1.33 errors per erroneous overlapping concept) and 35 (10% = 
35/350) were non-overlapping concepts with 39 errors (1.11 errors per erroneous non- 
overlapping concept). 
 
Figure 5.1 The disjoint partial-area taxonomy of the area with the six role types Disease 
Excludes Abnormal Cell, Disease Excludes Finding, Disease Has Abnormal Cell, 
Disease Has Finding, Disease Has Normal Cell Origin, and Disease Has Normal Tissue 
Origin. To reduce the density of the figure, the child-of links for the disjoint partial-areas 
at the second row of Level 2 are not shown. 
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Table 5.1 shows the area distribution of overlapping concepts and erroneous 
overlapping concepts. Table 5.2 is the contingency table for the p-value calculation 
between erroneous overlapping concepts and erroneous non-overlapping concepts. The 
two-tailed p-value of Fisher’s exact test [118] was calculated to evaluate the statistical 
significance of the study. The p-value is 0.0377 (p<0.05), which means the study result 
has statistical significance. In other words, the overlapping concepts are likely to exhibit 
significantly more errors than non-overlapping concepts. Thus, Hypothesis 5.1 was 
supported by the results. 
Table 5.1 The Distribution of Overlapping Concepts and Erroneous Overlapping 
Concepts 
 
# of Overlapping 
Concepts in an Area 
# of Areas 
# of Areas with 
Errors 
# of Erroneous 
Concepts 
1 15 5 5 
2 5 1 2 
3 6 1 2 
4 3 1 1 
5 4 1 5 
6 3 1 5 
7 2 1 2 
10 1 1 1 
12 3 3 12 
20 1 0 0 
25 1 0 0 
27 1 1 1 
Total: 45 16 36 
 
 
Table 5.2 The 2x2 Contingency Table for Erroneous Overlapping Neoplasm Concepts 
and Non-overlapping Neoplasm Concepts in NCIt 
 
 # Erroneous Concepts # Concepts w/o Errors 
Overlapping concepts 36 189 




Of the 225 overlapping concepts, 195 came from disjoint partial-areas containing 
only one concept. The remaining 30 overlapping concepts came from disjoint partial-
areas with at most four concepts. Altogether, only 18 overlapping concepts were not 
overlapping roots. Out of the 36 erroneous overlapping concepts, two concepts (11.1% = 
2/18) were not overlapping roots and the other 34 concepts (16.4% = 34/207) were 
overlapping roots. In addition, only three concepts (10% =3/30) were from a disjoint 
partial-area with three concepts. The remaining 33 concepts (16.9% = 33/195) were from 
singleton disjoint partial-areas (disjoint partial-areas with only one concept).  
There were two main error types of the overlapping concepts, 14 concepts with 
missing roles and 23 concepts with incorrect roles. The concept Pancreatic Vipoma has a 
missing role error and an incorrect role error at the same time. Table 5.3 illustrates five 
examples of errors found in overlapping concepts with suggested corrections and reasons. 
Besides 21 non-overlapping concepts with missing role errors and 12 non-overlapping 
concepts with incorrect role errors, the two domain experts also found incorrect parent, 
missing parent and incorrect neoplastic status for three non-overlapping concepts, which 
is illustrated in Table 5.4. “Neoplastic status” is a data property for neoplasm concepts in 
NCIt [119], with possible values “Benign,” “Malignant,” “Precancerous,” “Uncertain 
Malignant Potential,” and “Undetermined.” It defines a neoplastic growth as non-
cancerous, cancerous, or of uncertain cancerous potential. The concept Basophilic 
Adenocarcinoma has both a missing parent error and a missing role error.  
Figure 5.2 shows an interesting error case, in which the corrections of three 
erroneous overlapping concepts transform them into non-overlapping concepts in another 
area, by adding a new role Disease Has Primary Anatomic Site suggested by the two 
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domain experts. Figure 5.2(a) shows an excerpt of the disjoint partial-area taxonomy 
consisting of three disjoint partial-areas for the area with the three role types Disease 
Excludes Primary Anatomic Site, Disease Has Abnormal Cell, Disease Has Associated 
Anatomic Site and the area with an additional role type Disease Has Primary Anatomic 
Site (italic and underline). Notably, there is a child-of link between the two partial-areas 
Recurrent Anterior Pituitary Gland Neoplasm (1) and Pituitary Gland Neoplasm (3), 
because the concept Recurrent Anterior Pituitary Gland Neoplasm is a child concept of 
Anterior Pituitary Gland Neoplasm in the partial-area Pituitary Gland Neoplasm (3).  












Remove the role Disease Has 
Abnormal Cell with the target 
Malignant Cell  







Remove the role Disease 
Excludes Finding with the 
target No Evidence of 
Radiologic Finding or change 
the role to Disease Has 
Finding with the same target 
According to the 
definition “The 










Add the role Disease Has 
Normal Cell Origin with a 
more refined target Granulosa 
Cell 
According to the 
definition “It is 







Add the role Disease May 
Have Associated Disease with 
the target Multiple Endocrine 
Neoplasia Type 1 
This concept has the 
role Disease Mapped 
To Gene with the 
target MEN1 Gene 




Add the role Disease Is Stage 
with the target AJCC v7 Stage  
According to the 







Table 5.4 Three Other Error Types Identified in Non-overlapping Concepts of the QA 
Study 
 





Add an IS-A link 
directed to Anterior 
Pituitary Gland 
Neoplasm 
According to the definition 
“A malignant epithelial 






Replace the parent 
Benign Sweat Gland 
Neoplasm with 
Hidradenoma 








Change the value 
“Undetermined” to 
“Malignant” 
According to the definition 
“An invasive mixed 
adenoneuroendocrine 





Figure 5.2 Simplification of the complexity of the disjoint partial-area taxonomy due to 
correction of overlapping concepts: (a) Excerpt from disjoint partial-area taxonomy 
before correction of three erroneous overlapping concepts in the partial-area Pituitary 
Gland Neoplasm (3) with the error “missing the role Disease Has Primary Anatomic 
Site”; (b) after correction by adding the missing role (italic and underline) to the three 
erroneous overlapping concepts. The two partial-areas in Figure 5.2(a) Pituitary Gland 
Neoplasm (3) and Recurrent Anterior Pituitary Gland Neoplasm (1) are merged together 
to become a new partial-area Pituitary Gland Neoplasm (4), because Recurrent Anterior 
Pituitary Gland Neoplasm (1) is child-of Pituitary Gland Neoplasm (3). All three partial-
areas are not colored, since they do not contain overlapping concepts. 
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The two concepts Pituitary Gland Neoplasm and its child Posterior Pituitary 
Gland Neoplasm were two overlapping concepts in the audited sample (Figure 5.2(a)). 
The domain experts reported that both concepts missed the role Disease Has Primary 
Anatomic Site with the target Pituitary Gland. Hence, after correction by adding the 
missing role in NCIt, these two concepts (in fact three concepts, including the other child 
Anterior Pituitary Gland Neoplasm due to inheritance) in the newly derived 
corresponding disjoint partial-area taxonomy appear in the bottom area with four role 
types in Figure 5.2(b). The name of the added role in NCIt is again italicized. 
Furthermore, the two partial-areas in Figure 5.2(a) Pituitary Gland Neoplasm (3) and 
Recurrent Anterior Pituitary Gland Neoplasm (1) are merged into a new partial-area 
Pituitary Gland Neoplasm (4) in Figure 5.2(b).  The three concepts of the partial-area 
Pituitary Gland Neoplasm (3) in Figure 5.2(a) are not overlapping concepts anymore in 
the new area in Figure 5.2(b). Specifically, Pituitary Gland Neoplasm became an area 
root in the new area. That is, after the correction these three concepts are not “complex” 
anymore, because they are not overlapping concepts, since they are in a separate area 
with one root.  
Figure 5.2 demonstrates that the corrections of erroneous overlapping concepts 
may transform overlapping concepts into non-overlapping concepts. Thus, the 
complexity of the disjoint partial-area taxonomy is reduced. For example, in Figure 5.2(b) 
this is expressed by the elimination of one disjoint partial-area (Pituitary Gland 
Neoplasm) in the disjoint partial-area taxonomy, leading to a simpler summary. Hence, 
correcting erroneous overlapping concepts may reduce the complexity of the ontology. 
The simplification in Figure 5.2 is expressed by eliminating the “striped” node of Figure 
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5.2(a) when generating Figure 5.2(b). This reduces the total number of boxes and makes 
it unnecessary to color any of the partial-area nodes. This phenomenon shown in Figure 
5.2 is a novel, important, and useful one during quality assurance of “overlapping 
concepts.” 
To conclude, in this study, the partial-area taxonomy and the disjoint partial-area 
taxonomy for the Neoplasm subhierarchy of the Disease, Disorder or Finding 
subhierarchy of NCIt were derived. A three-step manual QA study was performed on a 
sample of 575 neoplasm concepts consisting of overlapping concepts and non-
overlapping concepts selected from the Neoplasm disjoint partial-area taxonomy. The 
results of the QA study show that overlapping concepts have a statistically significantly 
higher error rate than non-overlapping concepts (16% vs. 10%), making the Neoplasm 
subhierarchy in NCIt became the fourth ontology in its BioPortal family, for which the 
methodology of reviewing overlapping concepts was successfully demonstrated.  
5.1.2 Quality Assurance of NCIt Gene Hierarchy by Role-subset Partial-area Sub-
taxonomy 
 
Overlapping concepts existing in partial-area taxonomies of ontologies are more likely to 
have errors than control concepts. This effective QA technique has been successfully 
demonstrated on the four ontologies of the same BioPortal ontology family, i.e., the 
Specimen hierarchy and the Bleeding subhierarchy of SNOMED CT, Uberon, and the 
Neoplasm subhierarchy of NCIt. The reason is as follows. All the concepts of a partial-
area share the same semantics. A concept that simultaneously belongs to multiple partial-
areas has a compound semantics combining the “simple” semantics of each of those 




However, the number of such complex concepts of compound semantics in the 
NCIt Gene hierarchy introduced in Section 2.1.3 is small (96). Hence, in spite of the fact 
that such concepts have been shown to have a statistically significantly higher error rate 
than control concepts, reviewing all such gene concepts will have a very limited impact 
on the quality of the Gene hierarchy. A new innovative QA methodology is needed to 
discover additional complex concepts that display similar properties as the concepts with 
compound semantics, even though these additional concepts have simple semantics in the 
Gene hierarchy as seen through the prism of a partial-area taxonomy. This section 
demonstrated that the role-subset partial-area sub-taxonomy for the Gene hierarchy 
contains more complex concepts than the original partial-area taxonomy and such 
additional complex concepts were statistically significantly more likely to have errors 
than “simple” concepts in the role-subset partial-area sub-taxonomy. 
5.1.2.1 Methods. In the NCIt Gene hierarchy, overlapping concepts are manifested 
as genes that are simultaneously related to multiple processes. Therefore, these concepts 
have the compound semantics of relating to different processes. For example, the PARP2 
Gene is only involved in the process of DNA Repair, while the RAD9A Gene plays roles 
in three processes, Cell Cycle, Hydrolysis, and DNA Repair. The compound semantics 
makes overlapping concepts more difficult to model. Hence, in this study, the disjoint  
partial-area taxonomy for the Gene hierarchy was derived and the following hypothesis 
was investigated.   
Hypothesis 5.2: Overlapping concepts are more likely to have errors than non-
overlapping concepts in the disjoint partial-area taxonomy derived from the Gene 
hierarchy of NCIt. 
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Validity of Hypothesis 5.2 implies the following QA methodology: the disjoint 
partial-area taxonomy can be utilized to identify overlapping concepts. These concepts 
are likely to have a high error yield, measured by the ratio of the number of discovered 
errors to the number of reviewed concepts, compared to non-overlapping concepts. This 
auditing methodology is a complement to the methodology described by Cohen et al. [83]. 
To test Hypothesis 5.2, a QA study was conducted on a random sample consisting 
of 50 overlapping concepts in the disjoint partial-area taxonomy of the Gene hierarchy as 
the study sample and 50 non-overlapping concepts from the same partial-areas as the 
study sample, as the control sample. The study sample and control sample were 
combined into one list in randomized order. The randomized list was presented to the 
domain expert Dr. Hua Min for review. The domain expert reviewed each concept using 
the NCI term browser and focused on commission errors (of wrong features) and 
omission errors of hierarchical relationships and roles (missing features). She generated a 
report in which she marked which concepts have what kinds of errors and she suggested 
corrections for these errors. Her report was reviewed by the NCIt team. Based on the 
errors confirmed by the NCIt team, the two-tailed p-value of Fisher’s exact test [118] was 
calculated to evaluate the statistical significance of the difference between the error rate 
of overlapping concepts and that of non-overlapping concepts. 
However, as mentioned before, the number of overlapping concepts is low (1%). 
The practical impact of auditing all 96 overlapping concepts would be small, even if the 
error rate turns out to be high. The reason that the number of overlapping concepts turned 
out to be low is that there are relatively many role types (16). The impact of each 
additional role type R is that it has the potential of dividing an area into two smaller areas, 
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separating those concepts with R from those concepts without R. The probability of 
having several roots and overlapping concepts in a small area is reduced, compared to a 
large area. 
It should be noted that all 96 overlapping concepts are in the same area, 
containing only the role “Gene Plays Role In Process.” That is, all the overlapping 
concepts in the Gene hierarchy are deriving their extra complexity from belonging to two 
or three partial-areas referring to two or three different kinds of processes. Thus, a “role-
reduced Gene hierarchy” was derived by eliminating all roles except for “Gene Plays 
Role In Process.” Then a new disjoint partial-area taxonomy for the reduced Gene 
hierarchy was constructed. The Ontology Abstraction Framework (OAF) software system 
[67] could easily derive such a role-subset partial-area sub-taxonomy. This new disjoint 
partial-area taxonomy with only two areas, denoted T1 (“Taxonomy 1”), was found to 
contain 376 overlapping concepts in the area {Gene Plays Role In Process}. No 
overlapping concepts exist in the other area. Figure 5.3 shows the flowchart of obtaining 
overlapping concepts for the original Gene hierarchy (Figure 5.3(a)) and for the role-
reduced Gene hierarchy (Figure 5.3(b)). 
This increase of overlapping concepts (from 96 to 376) is expected and desired. 
As a simplified example of the observed effect, consider the case of another role-reduced 
 
Figure 5.3 Flowchart for finding overlapping concepts (a) for the original Gene 




Gene hierarchy with exactly two roles Gene Plays Role In Process (“Process” for short) 
and Gene Associated With Disease (“Disease” for short). Using the OAF software with 
this assumption, the resulting disjoint partial-area taxonomy, denoted T2 (“Taxonomy 2”), 
has four areas, and all the overlapping concepts are again concentrated in the area 
{Process}. However, the number of overlapping concepts in this area is now only 298. 
Why did the addition of the second role decrease the number of overlapping concepts in 
the area of concepts with only the “Process” role (Figure 5.4)?   
The total number of concepts in the {Process} area in T1 is 8,775, but the number 
of concepts in this area in T2 is only 7,571. The reason is that 8775–7571=1204 of the 
concepts in the {Process} area in T1 have both roles in T2. Hence, adding an extra role is 
increasing the number of areas and some concepts of the previous {Process} area appear 
now in a new area {Process, Disease} with both roles. Areas are always, by definition, 
disjoint. Hence, some of the roots and thus the corresponding partial-areas, (e.g., NAT2 
Gene (6) of the {Process} area in T1) are now in the area {Process, Disease} in T2. As a 
result, some overlapping concepts in T1 belong to the {Process} area in T1, but appear in 
the {Process, Disease} area in T2 where they are not overlapping concepts, since the two 
partial-areas that contained them in T1 are in the {Process} area in T2. This somewhat 
complex reasoning chain is elucidated by Figure 5.4. 
The following example, shown in Figure 5.4, demonstrates that adding a role to a 
hierarchy decreases the number of overlapping concepts belonging to both partial-areas 
Ligand Binding Protein Gene and Phosphotransferase Gene in the {Process} area as a 
result of splitting the area into two smaller areas. The number of overlapping concepts 




Figure 5.4 (a) Two overlapping partial-areas in T1. (b) An excerpt of T2 shows the 
effect of the addition of one role. 
 
 
Binding Protein Gene (1940) and Phosphotransferase Gene (610) are two partial-areas in 
T1 and they have 126 common concepts (overlapping concepts), e.g., AR Gene and its 
corresponding wild-type allele AR wt Allele represented by “AR Gene (2)” in Figure 
5.4(a). The addition of the role Disease transforms 40 (=126–86) overlapping concepts in 
T1 into non-overlapping concepts in T2, since these 40 concepts now have both roles 
Process and Disease, and thus they are in the new area {Process, Disease} in T2 in 
Figure 5.4(b). For example, the two former overlapping concepts AR Gene and AR wt 
Allele in T1 are now in their own partial-area AR Gene (2) in the area {Process, Disease} 
in T2, thus they are not overlapping in T2. 
The concepts that become overlapping in a partial-area taxonomy – by reducing 
the number of roles that are considered – are called extra overlapping concepts. The 
interesting questions with regard to the 376–96=280 extra overlapping concepts are, (1) 
are they as complex as the 96 original overlapping concepts? (2) do they have a 
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comparable higher error rate? It is important to note that when auditing those concepts all 
their roles in the original Gene hierarchy are taken into account. The “role-reduced 
hierarchies” above were only used to derive T1 and T2, not to permanently change the 
Gene hierarchy. 
The complexity of concepts in the Gene hierarchy is caused by their belonging to 
multiple partial-areas reflecting their participation in multiple different biological 
processes and not by their roles. This kind of complexity was already evident in T1. The 
addition of extra roles definitely does not decrease the complexity of concepts. To the 
contrary, in a recent paper investigating the Neoplasm subhierarchy of NCIt [14], 
concepts with more roles have been shown to have higher error rates due to their higher 
complexity measured in that case by the number of role types. Hence, the extra 
overlapping concepts are expected to have at least similar error rates as the original 
overlapping concepts. 
In order to find the answer to the above two questions, the role-subset partial-area 
sub-taxonomy T3 [120] was derived using the subset of roles {Gene Has Abnormality, 
Gene Involved In Pathogenesis Of Disease, Gene Is Biomarker Type, Gene Plays Role In 
Process} in the Gene hierarchy.  The taxonomy T3 with its four roles has 12 areas and 
874 partial-areas. A QA study on a second random sample was conducted to test 
Hypothesis 5.3. 
Hypothesis 5.3: Extra overlapping concepts in a role-subset partial-area sub-
taxonomy derived from the Gene hierarchy of NCIt are more likely to have errors than 
non-overlapping concepts, when reviewed in the Gene hierarchy itself. 
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The reason why this subset of roles was chosen is that in T3, for this subset of 
roles, there are 340 extra overlapping concepts that are all in the area {Process}. This 
number of extra overlapping concepts is the closest to the 376 overlapping concepts in T1 
for all role-subsets with four role types, which is an option with a balance between the 
number of overlapping concepts and the number of role types. The study sample for this 
second study was composed of 50 concepts randomly selected from the 340–96=244 
extra overlapping concepts in T3, excluding the 96 overlapping concepts from the 
original Gene partial-area taxonomy.  
The control sample consists of 50 non-overlapping concepts randomly selected 
from the same partial-areas in T3 as the study concepts. After the study sample and the 
control sample were randomly mixed, this random list was reviewed by the same domain 
expert Dr. Hua Min. The domain expert’s error report was reviewed by the NCIt team 
who confirmed some of the errors. Based on the errors upheld by the NCIt team for the 
second study, the two-tailed p-value of Fisher’s exact test [118] was calculated to 
evaluate the statistical significance for the difference between the error rate of extra 
overlapping concepts and the error rate of non-overlapping concepts in the partial-area 
taxonomy for the Gene hierarchy. 
5.1.2.2 Results. The partial-area taxonomy of the NCIt Gene hierarchy, derived for 
the September 2016 release, is composed of 5,318 partial-areas in 140 areas, with 96 
overlapping concepts. All these overlapping concepts are in the area {Process}, which 
summarizes 3,232 concepts (33.88% = 3,232/9,540) by 417 partial-areas (7.84% 




other 94 overlapping concepts are simultaneously in two partial-areas. Figure 5.5 shows 
an excerpt of the disjoint partial-area taxonomy for the area {Gene Plays Role In 
Process}, which includes 75 overlapping concepts (78% = 75/96).  
After auditing the 100 concepts of the first sample using the NCIt term browser, 
the domain expert found 76 concepts having errors, distributed over 32 (64%) non-
overlapping concepts and 44 (88%) overlapping concepts. There were two kinds of errors, 
redundant Process roles (i.e., redundant role targets) and missing roles. One concept may 
have both kinds of errors. 
After reviewing the errors reported by the domain expert, the NCIt team 
confirmed 65 erroneous concepts, including 23 non-overlapping concepts (46%) and 42 
overlapping concepts (84%). The two-tailed p-value for the errors confirmed by the NCIt 
team, using Fisher’s exact test [118], is p=0.0001, meaning the error rate of overlapping 
concepts is statistically significantly higher than that of non-overlapping concepts. Thus, 
Hypothesis 5.2 was supported by the confirmed errors. Table 5.5 shows four examples of 
errors that were confirmed by the NCIt team. 
 
Figure 5.5 An excerpt of the disjoint partial-area taxonomy for the {Gene Plays Role In 
Process} area, which only shows the nine largest partial-areas and all disjoint partial-
areas derived from these nine partial-areas. Child-of links are omitted for readability, 
since they are implied by the color coding. 
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The NCIt team confirmed all 53 concepts with redundant Process role errors, 
including 37 overlapping concepts and 16 non-overlapping concepts, as well as 14 
concepts with missing roles. Table 5.6 summarizes the distribution of confirmed 
erroneous concepts with missing role errors by role type. All missing Gene Has Physical 
Location role errors were not accepted, because these errors were reported for wild-type 
allele concepts and the NCIt team does not require the addition of such a role for this case. 













Redundant target: The target of 
Process role Phosphorylation 








RYK Gene Y 
Missing the Process role with the 
target Signal Transduction 
according to its definition 




Missing the role Gene In 
Chromosomal Location with the 
target 1p36.11 




Missing the role Gene Found In 
Organism with the target Human 
Add the role 
 
 
Table 5.6 The Distribution of Confirmed Erroneous Concepts with Missing Role Errors 
by Role Type 
 
Role Type 
# of Confirmed 
Erroneous 
Concepts   
# of Confirmed 
Overlapping 
Concepts  
# of  Confirmed 
Non-overlapping 
Concepts 
Gene Plays Role In 
Process 
8 6 2 
Gene In Chromosomal 
Location 
3 1 2 
Gene Found In 
Organism 




For the concepts with missing Gene Found In Organism errors, the NCIt team 
accepted only three error reports, because the NCIt editor thought that such a role should 
be instantiated at a more general concept not at a specific gene, since this role is suitable 
for all non-human genes. That is, these errors reported by the domain expert are indeed 
errors, but should be corrected at other concepts. 
For the missing Gene In Chromosomal Location errors, the NCIt team only 
accepted errors with chromosomal band positions that already exist in NCIt (for example, 
2q35), since they do not wish to create new specific chromosomal band positions, unless 
a user requests them. There are two reasons for this. First, the NCIt team is not notified 
when these values change, as it happens when experimental evidence refines the 
locations. Secondly, they are considering modeling such information differently in the 
future. Therefore, even though the suggested value is correct, if it does not currently exist 
as a concept in NCIt, they will not add this role. 
For the missing Gene Plays Role In Process errors, as a rule, they only model 
gene concepts with this role but do not model wild-type allele concepts with it. More 
specifically, they add the role only to such gene concepts for which the associated Gene 
Ontology annotation evidence codes are either experimental or based on authors’ 
statements.  
Based on the analysis of errors not accepted by the NCIt team, it is observed that 
the problems reported by the domain expert are indeed errors, but due to various internal 
NCIt rules that were not known to the external auditor they were not corrected in NCIt. 
For the second sample of 100 concepts, 78 concepts (78%) were found to have 
errors consisting of 45 extra overlapping concepts (90% of 50) and 33 non-overlapping 
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concepts (66% of 50) by the domain expert. The kinds of errors for this sample are 
similar to those of the first sample, namely, redundant targets of Process roles and 
missing roles. The NCIt team confirmed 26 erroneous concepts, including 22 extra 
overlapping concepts (44%) and four non-overlapping concepts (8%). The p-value for the 
second QA study, based on the NCIt team’s confirmed errors, is less than 0.0001, 
meaning the error rate of extra overlapping concepts is significantly higher than that of 
non-overlapping concepts. These results confirmed Hypothesis 5.3. 
In conclusion, a QA study of complex concepts discovered with the help of the 
partial-area taxonomy of the Gene hierarchy in NCIt was conducted. The results show 
that complex concepts are more likely to have errors than simple concepts (84% vs. 46%). 
To extend the practical impact of “complex” concepts on the QA process of the Gene 
hierarchy, a new QA methodology was introduced by deriving the partial-area sub-
taxonomy using a subset of roles defined for the Gene hierarchy. In other words, the 
partial-area taxonomy for the role-reduced Gene hierarchy was derived. This new 
methodology identified an additional set of complex concepts that also exhibited a 
statistically significantly higher error rate. The error rate for the additional complex gene 
concepts (44%) was about five times as large as the error rate for control concepts (8%). 
Thus, this study is the fifth study that confirmed the usefulness of QA based on partial-
area taxonomies, with a focus on complex concepts, and constitutes an important building 






5.1.3 Quality Assurance of Complex Infectious Disease Concepts in SNOMED CT 
 
This section presents an overlapping concept-based QA study on the sixth ontology, the 
Infectious Disease subhierarchy of SNOMED CT, which is in the same BioPortal 
ontology family as the five ontologies, the Specimen hierarchy and the Bleeding 
subhierarchy of SNOMED CT, the Uberon ontology, and the two ontologies in the 
previous two sections, to which the overlapping complex concepts-based QA 
methodology has been successfully applied.  
During the year 2015, editors of SNOMED International conducted a project of 
remodeling the Infectious Disease subhierarchy of SNOMED CT. Details of this work 
were published by Ochs et al. [121]. Due to scheduling difficulties, the project was not 
completed. In the process they remodeled the stated concepts, and by using a classifier 
[122]  the inferred view of the subhierarchy was generated.  
The QA study on the Infectious Disease subhierarchy took advantage of the 
remodeling project initiated by SNOMED International. The study concentrated on all the 
inferred changes made to the Infectious Disease subhierarchy between the January 2015 
release and the July 2015 release. During this period, 4,308 concepts were changed. Any 
time a concept was changed during such a remodeling process it is apparent that this 
concept was previously erroneous. A similar idea was extensively used by Ceusters et al. 
[123]  and by Zhang et al. [124].  This approach is substantially different from the studies 
in the previous sections, in which several domain experts reviewed a sample of 
overlapping concepts and a sample of non-overlapping concepts for errors. The following 
hypothesis was investigated in this study. 
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Hypothesis 5.4: Overlapping concepts are more likely to have errors than non-
overlapping concepts for the SNOMED CT Infectious Disease subhierarchy. 
In evaluating Hypothesis 5.4, only “severe” and “moderate” errors were 
considered, just as was done for the NCIt Neoplasm subhierarchy. Since there was no 
domain expert involved in determining what is considered a severe or moderate error, the 
judgment of what makes an error “severe” or “moderate” had to be arrived at indirectly. 
Previous feedback of ontology curators has indicated that commission errors are 
considered more severe than omission errors, because commission errors indicate that 
some part of the modeling of a concept is outright wrong. Omissions are sometimes done 
on purpose by ontology curators, because there is no use case for the omitted information. 
Such errors are generally considered non-critical.  
 For this study, a sample was generated containing all the overlapping Infectious 
Disease concepts and a random control sample consisting of an equal number of non-
overlapping concepts from the Infectious Disease subhierarchy. To assure a fair 
comparison, the control concepts were randomly taken from the same areas as the 
overlapping concepts. Since concepts in small partial-areas are prone to have more errors, 
the control population excluded such concepts as a confounding factor. The two-tailed p-
value of Fisher’s exact test [118] was calculated to evaluate the statistical significance of 
the different error rates for overlapping Infectious Disease concepts and for non-
overlapping Infectious Disease concepts. 
The SNOMED CT Infectious Disease subhierarchy contained 6099 concepts in 
the January 2015 release. Its partial-area taxonomy contains 80 areas and 1305 partial-
areas with 196 overlapping concepts distributed over eight areas. The area with the most 
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overlapping concepts has three role types Associated morphology, Finding site, and 
Pathological process with 665 concepts among which there are 83 overlapping concepts.  
The overlapping concepts were found by the Ontology Abstraction Framework 
(OAF) software tool [67]. The concepts that underwent a change between two releases 
were found by the SNOMED CT Visual Semantic Delta tool [125]. The concepts with 
commission errors were obtained from the sample of 196 overlapping concepts and from 
the control group of 196 randomly chosen non-overlapping concepts.  
Table 5.7 is the contingency table for the p-value calculation distinguishing 
between erroneous overlapping and erroneous non-overlapping concepts. Erroneous 
concepts that have commission errors, such as wrong parent, wrong role type, or wrong 
role target were counted. A sample of commission errors of different kinds appears in 
Table 5.8. The two-tailed p-value of Fisher’s exact test [118] was calculated to evaluate 
the statistical significance of the study. The p-value is 0.0067 (p<0.05), which means the 
study result has statistical significance. Thus, Hypothesis 5.4 was supported by the results.  
To summarize, the hypothesis that overlapping concepts are more likely to have 
errors than non-overlapping concepts was supported for this sixth ontology, the Infectious 
Disease subhierarchy of SNOMED CT, in addition to the other five ontologies in the 
same family, the Specimen hierarchy and the Bleeding subhierarchy of SNOMED CT, 
Uberon, the Neoplasm subhierarchy and the Gene hierarchy of NCIt. Thus, the “six out of  
Table 5.7 The 2x2 Contingency Table for Erroneous Overlapping versus Non-





# Concepts w/o 
Errors 
% Errors 
Overlapping concepts 76 120 38.8 
Non-overlapping concepts 50 146 25.5 
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Table 5.8 Different Kinds of Commission Errors for Overlapping versus Non-
overlapping Concepts 
 
 Overlapping concepts Non-overlapping concepts 
Wrong Parent Tuberculous enteritis Tuberculous ascites 
Wrong Parent Oculoglandular tularemia Mumps nephritis 
Wrong role type Tuberculous peritonitis Anal candidiasis 
Wrong role type Bullous staphylococcal impetigo Bacterial peritonitis 
Wrong target 
Beta lactam resistant bacterial 
infection 
Infection by Diplodinium 
Wrong target 
Superficial foreign body of anus 
without major open wound but with 
infection 
Infection by Theileria parva 
 
 
six” requirement for this family is fulfilled.  
Among the six ontologies, there are two from NCIt and three from SNOMED CT. 
However, there are differences between them. The NCIt Gene subhierarchy is different 
from the Neoplasm subhierarchy, since all the genes are modeled as leaves or as parents 
of leaves in cases where they have alleles. In contrast, diseases can appear anywhere in 
the Neoplasm subhierarchy. Regarding SNOMED CT, Specimen is a small subhierarchy, 
while Clinical finding is the largest subhierarchy of SNOMED CT. It is two magnitudes 
larger than Specimen. Because it is so large, two subhierarchies of it were reviewed, the 
small Bleeding subhierarchy and the medium-sized Infectious Disease subhierarchy, to 
assess the validity of the overlapping concepts-based QA technique for ontologies of 
different sizes.  
The implication of confirming the efficacy of the above uniform QA methodology 
for six ontologies is that for at least half of the other ontologies in the substantial 
BioPortal family studied in this paper the error rate for overlapping concepts will be 
significantly higher than the error rate for non-overlapping concepts [8]. Hence, by 
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concentrating QA efforts on overlapping concepts in the ontologies of that family, a 
higher QA yield is expected in terms of the number of concepts identified as erroneous 
for a given number of reviewed concepts, exercising the best possible use of scarce 
human resources. Thus, when embarking on quality assurance for members of this family 
under resource constraints, overlapping concepts should be audited first. At the very least, 
all overlapping concepts should be audited for every member of this family of ontologies.  
Besides higher yield, another advantage of the family-based QA approach [8] is 
that it is supported by the OAF software tool [67] that finds the overlapping concepts for 
each ontology of the family, rather than having to  develop algorithms separately for each 
member of the family. Hence, this methodology is semi-automatic, because the 
overlapping concepts are found automatically by the OAF software and the manual 
review is only performed for those concepts. Finding a method that prioritizes among the 
overlapping concepts would be beneficial for ontologies with many such concepts.  
Hence, the results in this study suggest that the methodology of reviewing 
overlapping concepts is an effective QA methodology for ontologies of one family in 
BioPortal, as this methodology has been demonstrated successfully for six out of six 
ontologies in the chosen BioPortal family. This means that the overlapping concept 
methodology can be applied to the whole BioPortal family of 76 similar ontologies and is 
likely to be successful for at least half of the members of this family.  
5.1.4 Quality Assurance of Complex Concepts in NCIt Biological Process 
Hierarchy 
 
This section reports a QA study [14] on another kind of complex concepts in the NCIt 
Biological Process (BP) hierarchy from the perspective of a relatively straightforward 
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characterization of lateral complexity of concepts, namely, their overall numbers of role 
types.  
5.1.4.1 Methods. This section intends to explore whether more laterally complex 
concepts, where “complexity” is defined in terms of the number of exhibited role types, 
are more prone to errors than less complex concepts. Roles play a central part in logically 
modeling concepts, and thus it is natural to focus on them as a measure of complexity. As 
an example, consider the concept G1 to S Transition Process in NCIt’s Biological 
Process hierarchy, with the five role types Location, Initiator Chemical or Drug, Initiator 
BP, Resulting BP, and Part of Process (the full names were given in Table 2.2). It is one 
of the four concepts in the bottom area of the area taxonomy in Figure 5.6. This concept 
elaborates five different aspects of a biological process and can be considered more 
complex than Neuronal Transmission with only three of those aspects. Neuronal 
Transmission, in turn, is more complex than its parent Intercellular Communication 
Process, which has only the one role type Initiator Chemical or Drug.   
In this study, the area taxonomy of the NCIt Biological Process hierarchy was 
divided into two halves, based on a level that forms the boundary between more laterally 
complex and less complex concepts. Specifically, let r be the maximum number of 
different role types exhibited by any actual concept in a given hierarchy. (The value r is 
obviously less than or equal to the number of predefined kinds of role types for the 
hierarchy.) For this study, r serves as a lateral complexity measure of the concepts. 
Following the principle of Divide-and-Conquer [126], the straightforward application of 
this principle, according to this complexity measure, is to divide the range into two equal-
sized parts. That is, let h = ⌊
𝑟
2





Figure 5.6 Complete area taxonomy of the Biological Process hierarchy. Most child-ofs have been omitted to avoid overload. Note 
how the importance of the role Location is reflected in the area taxonomy. The area {Location} has 207 concepts, and Location 







The difference between this study and the study in Section 5.2.2 is that this study targeted 
only concepts with roles and excluded the concepts in the top area (Level 0), while the 
study in Section 5.2.2 was about the concepts in the top area.  
Concepts residing on Levels 1, 2, …, h (the lower-half levels) of the taxonomy 
were taken to be simpler concepts. The concepts on Levels h + 1, h + 2, …, r (the upper-
half levels) were taken to be more complex. In the case of the Biological Process 
hierarchy, r = 5 (though there are seven predefined role types), and the partition of the 
area taxonomy of Figure 5.6 was between Levels 1 and 2 versus Levels 3, 4, and 5. For 
the Disease, Disorder or Finding hierarchy with 20 levels in its area taxonomy, the levels 
would be divided into Levels 1–9 and Levels 10–19. It was postulated that concepts in 
the upper-half levels would have on average a higher number of modeling errors than 
concepts in the lower-half levels. 
In this study, various concepts in the BP hierarchy were subjected to a thorough 
QA analysis by the subject-domain expert Dr. Hua Min. Since the number of concepts in 
the upper-half levels of an area taxonomy is typically much smaller than that in the 
lower-half levels (e.g., in the taxonomy of Figure 5.6, only four concepts are on Level 5), 
all concepts in the upper-half levels were analyzed. As a second group, a random sample 
comprising the same number of concepts from the lower-half levels underwent a QA 
analysis. The random sample was chosen in such a way that there was proportional 
representation according to the number of concepts on each of the lower-half levels. 
The domain expert was looking for all types of errors, including errors of 
omission (e.g., an omitted role from the predefined set for the hierarchy) and commission 
(e.g., an incorrect target concept for a defined role). After the initial phase of QA, a 
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review phase was carried out by a curator of NCIt, who was asked to re-analyze and 
verify the discovered errors. 
The following hypothesis is central to this study: 








⌋ + 1, …, r). 
The statistical significance for the error rates between the lower-half levels and 
the upper-half levels was evaluated using a two-tailed Fisher’s exact test [118]. The 




kinds of roles denote a characterization of concepts where more errors are expected. 
Concentrating a QA analysis on such a set of concepts is expected to yield more 




⌋  kinds of roles. The Ontology Abstraction Framework (OAF) tool [67] can 
automatically extract concepts at the levels where higher error rates are expected and its 
Neighborhood Auditing Tool (NAT) [127] can support the review of the auditor. 
5.1.4.2 Results. The QA analysis was carried out on the NCIt’s Biological Process 
hierarchy, consisting of 1,145 concepts (15.02d release). For this hierarchy, r = 5, i.e., no 
concept exhibits more than five role types, though there are seven possible predefined 
role types. Level 0 (concepts with no roles) contains 513 concepts, so the pool of 
concepts for the study (i.e., those with roles) is 632 concepts (55.2% of the overall 
hierarchy). Out of these 632 concepts, 393 concepts (62.2%) are defined in terms of the 




using the NCI Term Browser [128]. The domain expert reviewed for each concept all 
hierarchical relationships as well as all roles. Verification of the results was done by a 
curator of the NCIt. 
On the upper-half Levels 3, 4, and 5 of Biological Process, there are 57, 59, and 4 
concepts, respectively, totaling 120 concepts (10.5% of the hierarchy). Correspondingly, 
120 concepts were randomly selected from the lower-half Levels 1 and 2. These 120 
concepts were divided between the Levels 1 and 2, approximately in the same ratio as 
their numbers of concepts. 
Table 5.9 shows the primary results of the initial phase of the QA analysis, with 
the numbers of erroneous concepts given for each of the levels of the area taxonomy. For 
example, on Level 1, seven erroneous concepts were discovered among the 80 concepts 
that were analyzed, for an error rate of 8.75%. On Level 3, nine of the 57 concepts were 
deemed erroneous, for a 15.79% error rate. It should be noted that the error rates are in 
the single digits for the lower-half levels and in the double digits for the upper-half levels. 
In total, there were 43 errors for the 40 erroneous concepts, among which 22 errors (for 
20 concepts) were missing-role errors. Another prominent error type involved conflicting 
semantics between IS-A hierarchical relationships and Part of Process roles. In particular, 
the reviewer deemed that these two relationships should not target the same concept, 
directly or transitively, from a single source. For example, it was found that the concept 
Anaphase has the role Part of Process with the target Cell Cycle Process, while at the 
same time Cell Cycle Process is the grandparent of Anaphase (i.e., Anaphase is 
transitively connected to Cell Cycle Process via IS-A relationships). This was considered 
a conflict, and Anaphase was marked as erroneous. Twenty occurrences of such modeling 
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were found with respect to 20 different concepts. 
Additionally, the concept Negative Regulation of G0 to G1 Transition was 
reported as having a missing Resulting BP role error and an incorrect Part of Process role 
error. The remaining error discovered in the first phase of QA analysis was for the 
concept Tumor Immunity with an incorrect target of the role Resulting BP, which required 
a change of its target from Cancer Progression to Tumor Progression.  
Table 5.9 Distribution of Erroneous Concepts in the Biological Process Hierarchy 
 
Level  









1 352 80 7 8.75% 
2 160 40 3 7.50% 
3 57 57 9 15.79% 
4 59 59 19 32.20% 
5 4 4 2 50.00% 
Total: 632 240 40 16.67% 
 
 
The 2x2 contingency table (Table 5.10) was calculated for comparing the 
probability of erroneous concepts in the lower-half levels and upper-half levels. The 
results are statistically significant, since the p-value for the two-tailed Fisher’s exact test 
equals 0.0008 (p < 0.05). Therefore, the results confirm Hypothesis 5.5 that concepts in 
the upper-half levels are more likely to have errors than concepts in the lower-half levels. 
Table 5.10 The 2x2 Contingency Table for the Lower-half Levels and the Upper-half 
Levels 
 
 # Erroneous Concepts # Concepts w/o Errors Error Rate 
Lower-half 
 ( 2 role types) 
10 110 8.33% 
Upper-half 
 ( 3 role types) 




There were errors among four out of the seven kinds of roles in the Biological 
Process hierarchy. Table 5.11 shows the distribution of erroneous concepts for each of 
these four role types. The major issues were concepts with missing Location and Part of 
Process roles. For example, the concept Erythrocyte Differentiation is missing Location 
with a target value of Bone Marrow. In total, 16 concepts (40%) with errors were found 
for the Location role, and 20 concepts (50%) for the Part of Process role. 














Add the role with the target 
Megakaryocyte 
Resulting BP 3 T-Cell Activation 
Add the role with the target  




Remove the role with the 
target Cell Cycle Process 
 
 
The secondary review phase of this study led to the confirmation of 33 errors for 
32 concepts (80% = 32/40). These included nine errors for nine concepts concerning 
missing Location roles, four errors for four concepts concerning missing Resulting 
Anatomy roles, and 20 errors for 20 concepts with incorrect Part of Process roles that 
should be removed. One of the confirmed erroneous concepts Megakaryopoiesis is 
missing both Location and Resulting Anatomy.  
Table 5.12 shows the distribution of confirmed erroneous concepts according to 
the lower-half levels and upper-half levels. For example, the secondary review phase by 
the NCIt curator confirmed 27 concepts out of 30 concepts (90% = 27/30) in the upper-
half levels reported in the initial phase of QA as erroneous. The two-tailed p-value by 
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Fisher’s exact test is less than 0.0001, meaning there was also statistical significance in 
the difference between the numbers of confirmed erroneous concepts in the lower-half 
levels and the upper-half levels. 
Table 5.12 Erroneous Concepts in the Lower-half and Upper-half Levels Confirmed by 
the NCIt Curator 
 
 # Erroneous Concepts # Concepts w/o Errors Error Rate 
Lower-half  
( 2 role types) 
5 115 4.17% 
Upper-half  
( 3 role types) 
27 93 22.50% 
 
 
Some of the results of the secondary review phase are summarized in Tables 5.13 
and 5.14. Table 5.13 lists examples of errors that were confirmed on review by the 
curator of NCIt. For example, Megakaryopoiesis is indeed missing the role Location with 
the target Bone Marrow as well as the role Resulting Anatomy with the target 
Megakaryocyte. An internal modeling rule used by the NCIt team expressly forbids the 
target of a Part of Process role from simultaneously being an ancestor of the source 
concept. As noted, this conflicting semantics was observed during the first phase of the 
QA analysis. Thus, all such errors were confirmed during the secondary review phase. 
Three examples of this error are given in Table 5.13. Table 5.14 shows examples of 
errors for each kind of role that were rejected by the curator along with the reasons for 
the rejection. For example, the suggestion that the concept Expiration be given the role 
Location with the target Lung was rejected, because of the fact that expiration can involve 
other locations besides the lung. Table 5.15 shows the breakdown of the errors according 
to the various types of errors. 
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Target of Role 
Corrective 
Action 
Location Megakaryopoiesis Bone Marrow Add the role  




Epithelial Cell Add the role  
Resulting Anatomy Megakaryopoiesis Megakaryocyte Add the role  
Part of Process Antigen Presentation 
Immune Response 
Process 
Remove the role  
Part of Process Anaphase Cell Cycle Process Remove the role 
Part of Process 
Positive Regulation 
of Mitosis 
Cell Cycle Process Remove the role 
 
 
Table 5.14 Example Concepts with Rejected Errors in the Biological Process Hierarchy 
 
Role 
Reported Example of 
Concept Missing Role 




Location Expiration Lung 
Other locations can 
involve Expiration 
Resulting BP T-Cell Activation T-Cell Proliferation Incorrect 
 
 
Table 5.15 Erroneous Concept Distribution by Error Types for Concepts in Each Level 




(# Role Types) 
# Concepts 
Missing Role 
# Concepts with 
Incorrect Role 
# Concepts with 
Incorrect Role Target 
Total 
1 6 0 1 7 
2 3 0 0 3 
3 9 0 0 9 
4 1 18 0 19 
5 0 2 0 2 
1-2 9 0 1 10 





The disagreements between the domain expert and the curator in the two phases 
of the study can partially be explained by their different perspectives. In the initial phase 
of QA analysis, the work was carried out by (HM), who is outside the ontology’s 
curatorial organizational structure. As such, her analysis was not influenced by any 
prescribed modeling approaches that may have been utilized in the ontology’s original 
design and ongoing maintenance. Her job was to use her own judgment to point out any 
potential errors or inconsistencies and, from that analysis, to suggest changes (e.g., 
additions, corrections) to improve the ontology.  
The secondary phase reviewer (the curator of NCIt) was obliged to work with an 
eye toward established protocols of the organization. For example, as noted, an internal 
NCIt rule says that a concept A cannot simultaneously be IS-A and Part of Process with 
respect to another concept B. Moreover, user-driven decisions are important to the 
curatorial staff. For example, in NCIt, the completeness of neoplasm concepts in the 
Disease, Disorder or Finding hierarchy is more important than that of non-neoplasm 
concepts due to the overall focus of the ontology. The lack of sufficient resources is also 
a factor. For example, additional, correct ontological elements are not necessarily 
included in NCIt unless there are compelling use-cases, to avoid the maintenance 
overhead involved as a result of such additions. 
In summary, this study was performed to determine whether a measure of lateral 
complexity could be used as a guiding factor in QA. In particular, it was investigated 
whether more complex concepts are more prone to errors than simpler concepts. The 
foundational ontological unit of “role type” was used as the basis for the distinction 
between a complex and a simple concept. The outcomes of the two-phase QA study on 
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the NCIt’s Biological Process hierarchy indeed showed a statistically significant 
difference between the error rate of the more laterally complex concepts vis-à-vis the 
error rate of simpler concepts. As such, this distinction can be used to guide ongoing 
efforts in ontology QA. 
5.1.5 Quality Assurance of Complex Concepts in ChEBI 
 
ChEBI was introduced in Section 2.1.4. Because it comprises a large collection of 
concepts and their interconnections and it undergoes frequent changes, it is not 
reasonable to expect that ChEBI would be completely free of modeling errors and 
inconsistencies. In fact, its curatorial team maintains a GitHub issue tracking system [53] 
to allow the user community to report problems as well as request various modifications 
to the ontology. Any modeling problems persisting in ChEBI could have an adverse 
impact on the applications dependent on it. As such, quality assurance (QA) of ChEBI’s 
content is a critical maintenance task. Due to ChEBI’s magnitude, repeated 
comprehensive QA reviews are not practical. 
This section describes a semi-automated approach that concentrates QA efforts on 
complex concepts in ChEBI expected to harbor modeling problems with a higher 
likelihood. Similar as in the study in Section 5.1.4 on the NCIt Biological Process 
hierarchy, the number of lateral relationship types that a concept exhibits was considered 
as a measure of concept complexity. The more aspects to a concept’s definition—from an 
interconnectedness perspective—the more involved and complex such a concept is and 
the more modeling errors can be expected. A structural artifact that is very helpful in 
classifying concepts along these complexity lines is the area taxonomy. 
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5.1.5.1 Methods. The complete area taxonomy for ChEBI’s inferred version has a 
total of 135 areas, spanning nine levels. (The asserted version of ChEBI is released by the 
EMBL-EBI and includes all explicitly defined knowledge, while the inferred version was 
obtained by running a reasoner on the asserted version.) Figure 5.7 shows an excerpt of 
the area taxonomy consisting of 62 areas, each of which contains at least 10 ChEBI 
concepts. To save space, relationship names have been letter-coded, with the legend 
appearing in the figure. For example, the area {B, C} is {has parent hydride, has part}. 
At the left side of the figure, the total number of areas and the total number of concepts at 
each level are for the complete area taxonomy, not the excerpt shown. Child-of links have 
all been omitted from the figure. Note that the inclusion of the most prominent root (with 
most descendants) serves as an illustration of the semantics elaborated in an area. For 
example, for the area {has parent hydride, has part} with 918 concepts at the left-most 
position on Level 2 in blue, the root organic amino compound (385) gives an idea about 
the nature of the chemical concepts in the collection, which happens to include 92 
cyanides. The areas in Figure 5.7 represent a total of 60,786 ChEBI concepts (98.2%). 
The goal of this study was to determine whether or not ChEBI concepts with more 
relationship types have a higher expectation of being in error vis-à-vis concepts with 
fewer relationship types. With relationships representing the most critical components of 
concepts’ logical definitions, it is reasonable to rely on them to measure a form of 
complexity. As an example, consider the ChEBI concept L-alanine defined with the 
following eight relationship types: has functional parent, has parent hydride, has part, 











is one of the 11 concepts in the highest numbered level (Level 8) area of the area 
taxonomy of Figure 5.7. This concept elaborates eight different aspects of a chemical 
entity and can be considered more complex than, say, polypeptide-derived cofactor 
exhibiting three aspects. Polypeptide-derived cofactor, in turn, is more complex than its 
parent organic group, which has only the two relationship types, has part and is 
substituent group from. 
To make the determination about concept-error likelihood, a QA-analysis study of 
a random sample of the concepts in ChEBI was performed. In the study, 300 ChEBI 
concepts (about 0.5% of the entire ontology) were sampled based on the level 
arrangement of the area taxonomy in Figure 5.7. In particular, concept selection from the 
various levels was based on the number of concepts in each level. From Figure 5.7, it can 
be seen that the number of concepts in each of the Levels 1, 2, 3, and 4 (more than 10,000 
concepts) is significantly greater (by orders of magnitude) than that of the other levels. 
For Levels 1, 2, 3 and 4, the numbers of concepts were randomly selected approximately 
proportional to the respective numbers of concepts on each level. Due to the small 
number of concepts at Level 8 (highest numbered level, most complex concepts) and its 
importance for this study, all its 11 concepts were included for QA analysis. Similarly, 
for Levels 6 and 7 with relatively small sizes, 11 concepts each were randomly selected 
to match Level 8’s contribution. For Level 5 (2,853 concepts), the number of concepts 
selected was 20, reflecting a percentage that is between the higher percentage of Level 6 
and the lower percentages for the Levels 1–4. The concepts completely lacking 
relationships (i.e., those on Level 0 in area  of Figure 5.7) were ignored in the study 
 
114 
since they tend to be more general and abstract concepts, such as chemical entity, 
molecular entity, and mineral. 
The actual QA analysis of the 300 ChEBI concepts was performed by two 
chemistry subject-domain experts using a multi-step process. In the first step, every 
sample concept was analyzed by the two experts independently, with no communication 
permitted between them. Their respective results were tabulated in two error reports. 
Each error finding was accompanied by the rationale for the judgment plus a suggested 
means of remediation.  
In the second step, a combined error report, listing both experts’ respective error 
findings for all sample concepts, was shared with the two experts. Each was separately 
asked to mark their agreement or disagreement with the findings of the other person. 
Furthermore, they were asked to review their own findings in light of the other expert’s 
decisions. In this phase, each expert was permitted to change their mind regarding their 
own original judgment of a discovered error. A concept previously deemed to be 
exhibiting a modeling error could instead be deemed correct, and vice versa. In the final 
step of the analysis, a concept was marked erroneous if the two subject-domain experts 
agreed on that conclusion. Such findings collectively formed the consensus QA report, 
upon which the results are based. 
The subject-domain experts were requested to look for errors of commission and 
errors of omission. Errors of commission included problems such as incorrect 
hierarchical relationships, incorrect lateral relationships, and incorrect relationship targets. 
Errors of omission included missing hierarchical relationships and missing lateral 
relationships. At the conclusion of the QA study, the errors of commission, the more 
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severe kind, were first submitted to ChEBI’s curators for review, and later the errors of 
omission were submitted. 
In regard to the QA analysis, the validity of the following hypothesis expressed in 
terms of area taxonomy levels was investigated: 
Hypothesis 5.6: For a given ontology, concepts on the lower numbered levels of 
its area taxonomy have a lower average number of errors than concepts on the higher 
numbered levels. 
Note that Hypothesis 5.6 does not specify the boundary between the lower 
numbered levels and the higher numbered levels. For confirmation of Hypothesis 5.6, it is 
sufficient that there exists a level m such that the average error rate for Levels 1, 2, …, m 
is lower than the average rate for Levels m + 1, m + 2, …, n, where n is the highest 
numbered level in the area taxonomy. The selection of the level m will be done in a way 
to maximize the difference between the two averages. The implication of verifying 
Hypothesis 5.6 is that the set of concepts with more relationship types offers a 
characterization of concepts for which more errors are expected to be found. A 
methodology focusing QA efforts on such a set is expected to yield more corrections than 
auditing a random set of the same number of concepts with fewer relationship types. The 
two-tailed Fisher’s exact test [118] was used to analyze the results and judge the 
statistical significance of the difference between the error rates for the lower numbered 
levels and the higher numbered levels of the area taxonomy. 
5.1.5.2 Results. The sample of 300 ChEBI concepts was taken from the February 
2016 release based on the levels of its area taxonomy. The first-step QA analysis of the 




Hasan Yumak (HY). Out of the 300 concepts analyzed, 155 of them (51.7%) made it into 
the consensus report, i.e., were deemed by both experts in the second-phase analysis to be 
erroneous. In the following, a ChEBI concept will often be referred to by its name 
together with its unique ChEBI ID, written in a format such as “CHEBI: 63667” (which 
happens to be the concept with the name dipyridodiazepine). 
Table 5.16 shows the distribution of all ChEBI concepts with respect to the levels 
in the area taxonomy, the number of those that underwent QA analysis, and the number 
of erroneous concepts. For example, in the area taxonomy, there are 10,105 concepts at 
Level 4 (Figure 5.7), of which 44 (0.44%) were randomly selected for QA analysis. The 
domain experts found 22 concepts (50.0%) of the analyzed concepts on Level 4 to be 
erroneous. Note that as the level number increases, the percentage of erroneous concepts 
at each level (last column) does not decrease, i.e., the error rate shows a monotonic trend. 
There are two cases in Table 5.16 where the error rate increases significantly, 
between Level 2 and Level 3 and between Level 4 and Level 5. Hence, in this case there 
are two options of how to divide the concepts by their levels into simple and complex 
concepts. Table 5.17, the 2x2 contingency table, presents the comparison of the 
cumulative error rates of Levels 1–4 and Levels 5–8. For example, 44.5% of the sample 
concepts on Levels 1–4 have errors in the consensus report. These results are statistically 
significant, because the p-value (two-tailed Fisher’s exact test) is less than 0.0001 (p < 
0.05). Table 5.18 gives the comparison between the cumulative error rates of Levels 1–2 
and Levels 3–8. The corresponding p-value is 0.0003. The result for this division is also 
statistically significant even though the p-value is slightly higher. Hence, the results of 
the study confirm the hypothesis that concepts with more relationship types are more 
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Table 5.16 Distribution of Erroneous Concepts According to Levels in the Area 
Taxonomy 
 





% of Erroneous 
Concepts 
1 11,055 49 19 38.8% 
2 16,763 74 29 39.2% 
3 18,158 80 40 50.0% 
4 10,105 44 22 50.0% 
5 2,853 20 14 70.0% 
6 1,287 11 9 81.8% 
7 117 11 11 100.0% 
8 11 11 11 100.0% 
Total: 60,349 300 155 51.7% 
 
 
Table 5.17 The 2x2 Contingency Table for the Lower Numbered Levels (Levels 1–4) 
and the Higher Numbered Levels (Levels 5–8) with m= 4 
 
 # Erroneous Concepts # Concepts w/o Errors Error Rate 
Level 1 – Level 4 110 137 44.5% 
Level 5 – Level 8 45 8 84.9% 
 
 
Table 5.18 The 2x2 Contingency Table for the Lower Numbered Levels (Levels 1–2) 
and the Higher Numbered Levels (Levels 3–8) with m= 2 
 
 # Erroneous Concepts # Concepts w/o Errors Error Rate 
Level 1 – Level 2 48 75 39.0% 
Level 3 – Level 8 107 70 60.5% 
 
 
likely to exhibit errors than concepts with fewer relationship types, for both of the above 
optional dividing points. 
Table 5.19 shows the different kinds of errors encountered from the ontological 
perspective. For example, there were 48 concepts (16.0%) having incorrect relationship 
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targets, an error of commission, and 105 concepts (35.0%) with missing hierarchical 
relationships, an error of omission. 
Table 5.19 Error Distribution from the Ontological Perspective 
 
Error Type # Erroneous Concepts % (/300) 
Incorrect relationship target 48 16.0% 
Incorrect hierarchical relationship 42 14.0% 
Missing hierarchical relationship 105 35.0% 
Missing lateral relationship 7 2.3% 
 
 
An interesting question was whether the more complex concepts are also 
exhibiting a higher rate of errors of commission than the simpler concepts. Among the 88 
erroneous concepts with errors of commission, 60 (24.3% = 60/247) were from Levels 1–
4 and 28 concepts (52.8% = 28/53) were from Levels 5–8. Furthermore, the difference in 
the rates of errors of commission between Levels 1–4 and Levels 5–8 has statistical 
significance, because the p-value (for the two-tailed Fisher’s exact test) is less than 
0.0001. Another observation is that out of the 48 concepts with the error of Incorrect 
charge difference between conjugate acids and bases (Row 2 in Table 5.20), 26 concepts 
are from Levels 1–4 and 22 concepts are from Levels 5–8. So for this special kind of 
error, the error rate in Levels 1–4 is 10.5% (= 26/247) and the error rate in Levels 5–8 is 
41.5% (= 22/53). This difference also has statistical significance with p < 0.0001. Hence, 
analyzing the more complex concepts for errors is a more efficient way. 
 Table 5.20 presents the typical kinds of chemistry-based modeling errors in the 
consensus report along with their numbers and sample percentages. For example, 11 
concepts (3.7% of the sample) were found to exhibit incorrect amide classifications. Note 
that the kinds of errors in the table are not necessarily disjoint, meaning some concepts 
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may have several kinds of errors. As an example, piperidine (CHEBI: 18049) has both an 
incorrect conjugates charge error and an incorrect chemical classification error.  
Table 5.20 Typical Chemistry-based Errors 
 
Error Type # Erroneous Concepts % ( / 300) 
Missing chemical classification 105 35.0% 
Incorrect charge difference between 
conjugate acids and bases 
48 16.0% 
Incorrect chemical classification 21 7.0% 
Incorrect amide classification 11 3.7% 
Incorrect number of cyclic units 10 3.3% 
Unmatched chemical name and structure 2 0.7% 
 
 
Errors of commission are considered more severe than errors of omission, since 
they reflect incorrect modeling with respect to at least one aspect of a defined concept. 
On the other hand, there are more degrees of freedom regarding decisions about errors of 
omission, as it may have been a conscious editorial decision not to include some 
conceptual modeling details. An ontology’s editorial policy may in fact dictate that some 
modeling elements be omitted, or it may simply be a matter of personal taste of an editor. 
To further validate the findings, 62 concepts exhibiting errors of commission were 
first submitted to the curators for consideration. These were from among all the kinds of 
errors reported in Table 5.20 except for the first kind, “missing chemical classification,” 
which is an error of omission. To date, ChEBI’s curators have reviewed 49 concepts and 
confirmed 21 of them as being in error (42.9%). Some of the review details by ChEBI’s 
curators are summarized in Tables 5.21 and 5.22. Table 5.21 lists examples of errors that 
were confirmed upon review and have subsequently been corrected in a new release of 
ChEBI. Table 5.22 shows examples of errors rejected by ChEBI’s curators, along with 
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their reasons for this judgment. The errors of omission were submitted later via ChEBI’s 
GitHub and are still awaiting review. 
In summary, this study was carried out by two chemistry experts using the area 
taxonomy Abstraction Network to determine whether ChEBI concepts having more 
relationships—and in this sense higher complexity—warrant special attention in QA 
efforts. From the QA analysis of a random sample of ChEBI concepts consisting of both 
complex and simple concepts, it was confirmed with statistical significance that more 
complex concepts are more likely to harbor modeling errors than simpler concepts.  
 
 
Table 5.21 Example Concepts with Confirmed Errors by ChEBI Curators 
Concept with 
Confirmed Error 
Confirmed Error Error Explanation Corrective Action 
uric acid 
(ChEBI: 27226) 
Incorrect target of the relationship is 
conjugate acid of: urate anion 
Charge difference between 
conjugates should be 1 
Add a new relationship is conjugate 
acid of with the target urate(1−) 
trans-vaccenic acid 
(ChEBI: 28727) 
Incorrect target of the relationship is 
conjugate acid of: trans-vaccenate 
Charge difference between 
conjugates should be 1 




Incorrect classifications: dicarboxylic 
acid, carboxylic acid, hydroxides 
Chemical does not contain 
carbocyclic acid structure 
and hydroxyl group 
Replace with the correct 
classification organic thiophosphate 
Glucolepidiin 
(CHEBI: 5408) 
Incorrect classifications: glycosinolate, 
anion, polyatomic anion, ion 
No ion structure is shown in 
the structure 
Replace with the correct 
classification alkylglucosinolic acid 
 













Concept has 4 rings 
Bicyclic, tricyclic, tetracyclic, etc., do not refer to the 
number of rings in a structure, but to the number of 
fused rings (i.e., rings that share one atom (spirocycles) 
or, more commonly, two atoms) 
thermospermine 
(CHEBI:59564) 
Incorrect target of the 
relationship is conjugate base 
of: thermosperminium(4+) 
Charge of its 
conjugate base 
should be 1+ not 4+ 
Although the IUPAC definition of conjugate acid/base 
refers to a difference in charge of 1 unit only, for 






Concept does not 
contain ketone 
groups 
Polyketide is structurally a very diverse group of 
compounds. For this reason, ChEBI denotes 
‘polyketide’ as “is a” organooxygen compound, rather 
than “is a” carbonyl compound. The ChEBI definition 







5.1.6 Auditing the Chemical Ingredient Hierarchy Based on the IAbN 
The Abstraction-Network-based QA framework can be summarized as follows. First, an 
Abstraction Network is developed to summarize the specific terminology [4]. An 
algorithm is developed and implemented to computationally derive this Abstraction 
Network from the terminology. Based on the Abstraction Network, characterizations of 
sets of concepts of the terminology that are expected to display a higher percentage of 
errors are identified, compared to a control sample [8, 60]. Those sets of concepts can be 
computationally retrieved [67, 129], because the characterizations of such sets of 
concepts are based on structural features. 
One of the recurring themes in such characterizations has been that there are 
concepts that are more complex than “arbitrary” concepts of the terminology. Examples 
of characterizations of complex concepts include overlapping concepts [91, 92, 130] and 
multiple inheritance regions [6, 57]. Complex concepts are typically more error-prone. 
While those characterizations were based on deriving a partial-area taxonomy [5, 6, 59] 
their complexity stems from concepts having multiple generalizations through multiple 
parents, reflecting an entity that is simultaneously “this and that.” Not surprisingly, the 
modeling of such concepts is more challenging and a higher ratio of errors can be 
expected for them. 
The characterization of concepts that were tested in this study on the NDF-RT CI 
hierarchy is “drug ingredients belonging to only one ingredient group with multiple 
parent ingredient groups” in the IAbN. Such concepts fit the above theme of complex 
concepts being “this and that” and are expected to have higher error rates.  
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Hypothesis 5.7: Among drug ingredients belonging to only one ingredient group, 
those in an ingredient group with multiple parent ingredient groups are more likely to 
have errors than those in an ingredient group with only one parent ingredient group. 
The drug ingredients from those ingredient groups that have multiple parent 
ingredient groups inherit multiple classifications. The more classifications the drug 
ingredients belong to, the more complex those ingredients are, which increases the 
possibility that the classifications may have errors.  
Hypothesis 5.8:  Among drug ingredients belonging to only one ingredient group, 
those in an ingredient group with more than two parent ingredient groups are more likely 
to have errors than those with exactly two parent ingredient groups. 
To test the above hypotheses, a sample of drug ingredient concepts within only 
one ingredient group was reviewed by two chemistry domain experts Dr. Ling Chen (LC) 
and Dr. Hasan Yumak (HY). Table 5.23 shows the distribution of NDF-RT’s drug 
ingredients appearing in exactly one ingredient group according to their group’s number 
of parent ingredient groups. There were a total of 263 drug ingredients as study concepts 
picked from the ingredient groups that have multiple parent ingredient groups. The study 
concepts included 118 randomly selected drug ingredients with two parent ingredient 
groups plus all drug ingredients with three (118), four (25) or five (2) parent ingredient 
groups. Thus, in total there were 263 study concepts. The control concepts consisted of 
170 drug ingredients randomly chosen from the ingredient groups that have only one 
parent ingredient group. Hence, the total number of reviewed drug ingredients in the 
study was 433.  
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Table 5.23 The Distribution of the Drug Ingredients in Exactly One Ingredient Group 
Based on their Number of Parent Ingredient Groups 
 
# of Parent Ingredient 
Groups 
# of Drug Ingredients 
Percentage  
(Column 2/1851) 
0 1 0.05% 
1 1136 61.37% 
2 569 30.74% 
3 118 6.37% 
4 25 1.35% 
5 2 0.11% 
Total: 1851 100.00% 
 
 
The two domain experts were blind to the hypotheses and the sampling 
methodology. The concepts were presented in alphabetical order. There were three steps 
of the review process. First, each of the reviewers studied the sample individually and 
submitted an error report that consisted of identified errors with corresponding 
corrections.  
The domain experts were instructed to review the hierarchical relationships of 
each concept for correctness and to mark those they considered incorrect. The individual 
error reports from the domain experts were combined into a single anonymized list of 
unique errors. In the second step, the list of combined errors was sent back to the domain 
experts who had to obtain a consensus. Each reviewer marked ‘agree’ or ‘disagree’ for 
each error in the list.  
In the third step, an additional evaluation of the consensus result was performed 
by Joan Kapusnik-Uner (JKU), a pharmacologist who is leading First DataBank’s drug 
vocabulary standards initiatives. Only the errors agreed upon by both LC and HY were 
sent to JKU for the third round review. JKU recorded those concepts for which she 
agreed that there was an error in a hierarchical relationship. Thus, in this study a concept 
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was considered erroneous only if all three domain experts (LC, HY, and JKU) agreed on 
the error.  
In the two initial auditing reports generated at the first step, the two reviewers 
agreed on 100 erroneous drug ingredients; 19 drug ingredients were judged as erroneous 
by one or the other reviewer. A new data set including all the errors reported by any of 
the two auditors, without the name of the originator of the error, was compiled and sent 
back to the two auditors for generating a consensus report. The two auditors gave their 
responses (agree or do not agree) to all the errors listed in the new dataset (in fact, they 
agreed on all errors at the second step), which were compiled into a consensus report 
including all 119 erroneous drug ingredients that both reviewers agreed to. Then the 
consensus report was reviewed by JKU. Only when an error of a concept listed in the 
consensus report of LC and HY was confirmed by JKU, then this concept was labeled 
“erroneous,” i.e., a consensus of three reviewers was achieved for these concepts in this 
three step study. In fact, JKU confirmed all consensus errors reported by LC and HY.  
Table 5.24 shows the error distribution of the 433 audited drug ingredients. The 
percentage of erroneous concepts increases with the number of parent ingredient groups 
(except for the small number with five parents). 
Table 5.25 shows the contingency table for the control and study concepts to 
calculate the p-value for Hypothesis 5.7. The two-tailed p-value is less than 0.0001 by 
Fisher's exact test [118], which means that the drug ingredients from the ingredient 
groups that have multiple parent ingredient groups are statistically significantly more 




Table 5.24 The Statistical Analysis of the Auditing Results of the 433 Drug Ingredients 
 
# of Parent 
Ingredient Groups 
# of Audited 
Concepts 




1 170 22 12.9% 
2 118 29 24.6% 
3 118 55 46.6% 
4 25 13 52.0% 
5 2 0 0.0% 
Total: 433 119 27.5% 
 
 
Table 5.25 The 2x2 Contingency Table for the Control and Study Concepts 
 
# of Parent Ingredient 
Groups 
# of Erroneous 
Concepts 
# of Concepts w/o 
Errors 
1 22 148 
>1 97 166 
 
 
In order to test Hypothesis 5.8, the error counts of drug ingredients from the 
ingredient groups that have more than two parent ingredient groups were compared with 
those that have exactly two parent ingredient groups. Table 5.26 shows the contingency 
table for the concepts with two and more than two parent ingredient groups to calculate 
the p-value. The two-tailed p-value equals 0.0002 by Fisher's exact test, which means that 
Hypothesis 5.8 was confirmed. 
Table 5.26 The 2x2 Contingency Table for the Concepts with Two and More Than Two 
Parent Ingredient Groups 
 
# of Parent Ingredient 
Groups 
# of Erroneous 
Concepts 
# of Concepts w/o 
Errors 
2 29 89 
>2 68 77 
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Overall, there were 119 concepts (119/433 =27.5%) with errors. Some errors 
appeared at the parent level, while other errors were introduced at higher levels (up to 
several levels above the erroneous concept). The types of errors are summarized in Table 
5.27. The sets of erroneous concepts for the different error types in Table 5.27 are not 
disjoint, since one concept may have multiple errors. Row 1 in Table 5.27 shows that 
eight concepts in this study are assigned wrong parents, e.g., Loracarbef was erroneously 
defined as child of Cephalosporins, while the direct parent of Loracarbef should be 
Carbacephem. 
Row 2 and Row 3 show two most common errors in the study that cover most of 
the erroneous concepts. In Row 2 an organic (or inorganic) concept is assigned to both 
Organic Chemicals and Inorganic Chemicals, due to the inheritance from its ancestor 
classification, which can be either organic or inorganic. For example, Sulfur Compounds 
appear as inorganic or organic compounds that contain sulfur as an integral part of the 
molecule according to the definition. For example, Rabeprazole actually is an organic 
chemical while it is classified under both Organic Chemicals and Inorganic Chemicals, 
because the parent of its grandparent is Sulfur Compounds. Row 3 indicates that the 
specified chemical ring structures of a concept which is a Heterocyclic Compound[s] are 
contradicting each other. For example, a concept is assigned several classifications out of 
the set R = {“Heterocyclic Compounds, 1-Ring,” “Heterocyclic Compounds, 2-Ring,” 
“Heterocyclic Compounds, 3-Ring” and “Heterocyclic Compounds with 4 or More 
Rings”}. That is due to inheritance from its ancestor classifications, i.e., a concept may 
have several ancestor classifications (at a very general level) and each of its ancestor 
classifications may be under one of the four choices in R. For example, Alosetron is a 4-
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ring structure with three fused rings. Its parent is Carbolines with a 3-ring structure, the 
parents of which are, Pyridines with a 1-ring structure and Indoles with a 2-ring structure. 
Hence due to transitivity, Alosetron is a Heterocyclic Compound(s), 1-Ring, and also a 
Heterocyclic Compound(s), 2-Ring, and even a Heterocyclic Compound(s), 3-Ring. 
Row 4 represents the other types of erroneous classifications, happening above 
the parent level, which cover 26 concepts (21.8%). For example, Hydrogen Peroxide 
does not belong to Electrolytes, because it is a molecule without ions, and it is not an 
electrolyte. 
Table 5.27 Examples of Error Types with Counts 
 
Error Type 





1 Incorrect direct 
classification  












3 Heterocyclic Compounds, 
X-Ring(s)  


















5.2 Quality Assurance of Concepts with Uncommon Modeling 
 
The following sections report two quality assurance studies focusing on concepts with 
uncommon modeling. Both studies utilized the “prism” constituted by Abstraction 
Networks for the detection of concepts with uncommon modeling, which were found to 
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contain relatively higher ratios of errors. An Abstraction Network offers an alternative 
compact visualization of an ontology’s structure and content, which helps in detecting 
various anomalies not visible in the structure of the ontology itself. The first study is on 
concepts in small partial-areas within a partial-area taxonomy. The other study is on 
concepts in the area without any relationship within an area taxonomy.  
5.2.1 Auditing NCIt Neoplasm Concepts in Groups of High Error Concentration 
 
There are two major activities that lead to corrections of ontologies. (1) Curators of 
ontologies receive occasional requests of users to correct modeling errors they find, but 
such requests are ad hoc and do not constitute a rigorous QA process. (2) Ontology 
maintenance teams execute internal QA processes to test and verify the correctness of 
every new release of an ontology. See, for example, the internal QA process of NCIt in 
place at the National Cancer Institute (NCI) as described by De Coronado et al. [42].  
Automated QA processes can only expose errors detectable by algorithms, such as 
redundant role assignments. Such QA algorithms can detect structural errors but not 
semantic errors, which are more difficult to uncover.  
Hence, there is a need for a rigorous QA process as an integral part of the life 
cycle of an ontology that detects semantic errors as well [5]. As in finance, software 
verification, etc., such QA processes should not be the responsibility of the editorial team 
of an ontology, but be outsourced to an external department or even an external 
organization that has no emotional attachment to the modeling decisions of the ontology 
and thus can be objective in an ontology review.  
Considering the fact that ontology errors are created as a result of unintentional 
human mistakes, rather than occurring as natural phenomena, one might think that they 
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will be distributed uniformly over the concepts of an ontology. However, this study 
refutes the assumption that errors are uniformly distributed in the investigated medical 
ontology. While this phenomenon is not so obvious when viewing an ontology with 
existing visualization tools that do not perform summarization, it becomes clear when 
viewing the same ontology through the prism of an Abstraction Network, which provides 
guidance for where to look for errors. Therefore, an economical approach to the QA of 
ontologies is to identify structural characterizations of sets of concepts for which a 
relatively high rate of errors is expected, compared to a random control sample. 
Reviewing such sets of concepts by domain experts is expected to provide a high QA 
yield, measured by the ratio of concepts confirmed as erroneous for a given number of 
reviewed concepts. This study explored the QA methodology concentrating on concepts 
in small partial-areas of the partial-area taxonomy for the Neoplasm hierarchy in NCIt. 
5.2.1.1 Materials and Approach. A partial-area in a partial-area taxonomy represents 
a particular set of concepts in the ontology. These concepts are similar in their structure 
and semantics. That is, they all share the same roles and the same root. When 
encountering the partial-area Neoplasm with 403 concepts, the modeling of its concepts is 
considered “common” – there are many concepts with the same neoplasm semantics and 
structural modeling – with the role Disease Has Abnormal Cell. However, when 
encountering a small partial-area of, say, of two concepts only, their combination of 
structure and semantics is unique to them among the thousands of concepts in the 
hierarchy; then this would be a case of “uncommon modeling,” since no other concepts 
have the same combination of structure and semantics. 
It is, of course, possible that an ontology correctly contains only two concepts that 
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are represented with a specific structure and semantics. However, another option is that 
the reason for this uncommon modeling is that there is an error in how these two concepts 
are represented in the ontology. If so, once this error is corrected, say by adding a role or 
changing a parent link, then these concepts are likely to reappear in another partial-area 
to reflect the changes in their structures or semantics. It may well be the case that the new 
“home partial-area” is not small. This was an example scenario where the modeling was 
“uncommon” due to an error, and correcting the error(s) eliminated a small partial-area. 
In previous studies [5, 90, 120], small partial-areas were indeed found to be characterized 
by higher error rates.  
As mentioned in Section 2.1.3, the Neoplasm subhierarchy of NCIt with 8,166 
concepts is of special importance because of the priority given to modeling cancer-related 
concepts due to the mission of NCIt to support cancer research and care. Thus, the NCIt 
team is paying increased attention to the modeling of neoplasm concepts compared to 
many other concepts in NCIt. 
Therefore, it is of interest to explore the problem whether a location where there 
is a higher concentration of erroneous concepts in the relatively large Neoplasm 
subhierarchy can be identified. Can the following hypothesis be confirmed with statistical 
significance?   
Hypothesis 5.9: Small partial-areas in the Neoplasm sub-taxonomy of the 
Disease, Disorder or Finding hierarchy of NCIt harbor sets of concepts with higher rates 
of errors than large partial-areas. 
Having the partial-area taxonomy available, 150 concepts from small partial-areas, 
defined here as having sizes between 1 and 10, were randomly selected as the study 
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sample. For the control sample, 40 concepts were randomly selected from large partial-
areas of at least 20 concepts. The range 11-19 is considered to define medium-sized 
partial-areas. The study sample and the control sample were combined and the order of 
concepts was randomized. 
The QA analysis on the 190 neoplasm concepts was carried out by three domain 
experts Dr. Yan Chen, Dr. Hua Min and Dr. Julia Xu who are domain experts in medicine 
with extensive experience in ontology QA. The review of the selected concepts involved 
two steps following the modified Delphi procedure [131]. Namely, first, each of three 
domain experts, being blind to the sampling technique that was used, independently 
reviewed all the concepts in the sample and reported all erroneous concepts. The three 
error reports were combined into a questionnaire, where each error identified by any of 
the experts was listed, without attributing it to the expert reviewer(s) who discovered it. 
For every reported error a suggested correction was included.  
In the second step of the process, each of the reviewers marked whether she 
agreed with each error in the combined report or not. A concept is considered a 
“consensus erroneous concept” only if all three reviewers agreed that this concept has an 
error. Finally, the numbers and percentages of “consensus erroneous concepts” in small 
partial-areas and in large partial-areas were compared with each other. 
5.2.1.2 Example of Group-based Auditing. The partial-area taxonomy of an 
ontology divides concepts into groups. The basic idea of the “group-based” auditing 
method is that if “many” concepts in a group are found to exhibit errors, then a 
conscientious auditor should review all the concepts of that group [91]. This is suported 
by work of He et al. [132], which showed that it is advisable to review the other concepts 
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of a group if some errors were found in the group. This is the abstract idea of group-based 
auditing.  
Now follows a concrete example for illustrating group-based auditing, utilizing 
the partial-area taxonomy where the partial-areas function as groups. Figure 5.8 
demonstrates a group-based auditing scenario. White boxes within colored boxes are 
partial-area nodes within area nodes. The indented format in each partial-area in Figure 
5.8(a) represents the IS-A hierarchical structure inside of a partial-area node (e.g., Benign 
Posterior Tongue Neoplasm IS-A Benign Tongue Neoplasm, which IS-A Benign Oral 
Cavity Neoplasm). This detailed information is normally not shown in a partial-area 
taxonomy diagram, but is necessary for the demonstration of group-based auditing. The 
concept in bold (e.g., Benign Oral Cavity Neoplasm) in each partial-area node is the root, 
and the arrows denote the hierarchical child-of links between partial-area nodes. For 
example, the root concept Oral Cavity Benign Granular Cell Tumor IS-A Benign Oral 
Cavity Neoplasm, so there is a child-of link from the partial-area node Oral Cavity 
Benign Granular Cell Tumor (2) to the partial-area node Benign Oral Cavity Neoplasm 
 
Figure 5.8 Example of the structure of the Neoplasm partial-area taxonomy (a) before 
and (b) after auditing. 
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 (8). The number in parentheses () is the number of concepts summarized by a node. 
Out of the eight concepts in the partial-area node Benign Oral Cavity Neoplasm (8) 
in the top area node (Figure 5.8(a)), only the four underlined concepts were in the random 
sample sent to the auditors (rows 1, 2, 4 and 7 under Benign Oral Cavity Neoplasm (8)). 
The auditors recommended adding the following three roles to these four concepts to 
improve the correctness of the modeling: Disease Has Finding with the target Benign 
Cellular Infiltrate, Disease Has Normal Cell Origin with the target Connective and Soft 
Tissue Cell and Disease Has Normal Tissue Origin with the target Connective and Soft 
Tissue. As noted above, this was a consensus decision.  
Due to the suggested corrections, these four concepts should not remain in their 
current location. Rather they should appear in the lower area node {Disease Excludes 
Abnormal Cell, Disease Has Abnormal Cell, Disease Has Associated Anatomic Site, 
Disease Has Finding, Disease Has Normal Cell Origin, Disease Has Normal Tissue 
Origin, Disease Has Primary Anatomic Site}. When the partial-area taxonomy is re-
derived, as shown in Figure 5.8(b), it is indeed the case that each of the four concepts 
now appears in the lower area node. Furthermore, each of the four concepts is a root in 
the area node, thus it gets its own partial-area. 
After observing the above errors of concepts in the reviewed sample, the question 
whether the other four concepts in the same partial-area node might have the same errors 
as the four concepts in Figure 5.8(a) was raised. In other words, group-based auditing of 
the remaining four concepts in the area node at the top of Figure 5.9(a) was applied. 
These concepts were not in the random sample that was originally given to the auditors.   
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The consensus auditing result of the three domain experts confirmed that the four 
concepts Benign Oral Cavity Neoplasm, Benign Gingival Neoplasm, Benign Tongue 
Neoplasm and Benign Anterior Tongue Neoplasm were also missing the same three roles 
as the four concepts that were in the original sample. Thus, group-based auditing in this 
case doubles the number of errors found, with little extra effort.  
 
Figure 5.9 Example of error correction propagation and the resultant partial-area 




5.2.1.3 Error Correction Propagation and Partial-area Taxonomy Simplification.  
Once correction of errors is achieved for a whole group, potentially through group-based 
auditing, one should consider the propagation of the correction of errors to descendant 
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groups. Errors of a parent group are typically inherited by descendant groups. Thus, one 
can easily examine the inheritance of the corrections suggested for such errors. 
The method of error correction propagation will now be demonstrated, where the 
corrections of the above errors, discovered for concepts within a partial-area A, will be 
propagated to three descendant partial-areas of the partial-area A. This happens as 
follows. 
During group-based auditing, the root concept Benign Oral Cavity Neoplasm, 
describing the semantics of the whole partial-area, was determined to miss the above 
three roles. Because of that, the 22 concepts in Figure 5.9(a) should all have the same 
roles, due to inheritance of the corrected set of relationships.  
The concepts in the partial-area nodes of the area nodes in the second and third 
level from the top in Figure 5.9(a) originally had some, but not all, of the three missing 
roles discovered in Figure 5.8. However, those missing roles are now added due to 
inheritance from the corrected Benign Oral Cavity Neoplasm root concept. After adding 
these three roles, the 22 concepts in the eight partial-area nodes in Figure 5.9(a) will be 
summarized by only one partial-area node Benign Oral Cavity Neoplasm (22) in Figure 
5.9(b), which is not small anymore. 
Figure 5.9 demonstrates an interesting visual impact of the error correction 
propagation process described above, namely partial-area taxonomy simplification. The 
eight partial-area nodes in four different area nodes appearing in Figure 5.9(a) are unified 
into one single partial-area node of 22 concepts in Figure 5.9(b). That is, modeling errors 
are manifested when more small partial-areas “than needed” appear. The process 
described by Figure 5.9 shows the flip side of this observation, namely that the correction 
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of modeling errors may lead to a beneficial simplification of the partial-area taxonomy 
(the summary) of the ontology, by unifying several small partial-area nodes into one 
larger partial-area node. Furthermore, due to inheritance, the simplification occurred 
across several area nodes.  
5.2.1.4 Results. The Neoplasm subhierarchy, containing 8,166 concepts (32.25% of 
the whole Disease, Disorder or Finding hierarchy) in the February 2015 release of NCIt, 
is summarized by 4,824 partial-area nodes in the Neoplasm partial-area taxonomy. The 
three experts found 76 concepts out of 190 (40.0% = 76/190) having errors. Table 5.28 
shows the number of audited concepts (that appeared in the random sample), the number 
of erroneous concepts and the error rate for each partial-area node size. For example, the 
random sample contained 10 concepts from partial-area nodes with size=1, and among 
these the experts found five concepts (50.0%) exhibiting errors.  
Table 5.28 Distribution of Erroneous Concepts According to Partial-area Node Size in 




# of Concepts 
Audited 




1 10 5 50.0% 
2 17 3 17.6% 
3 10 5 50.0% 
4 15 7 46.7% 
5 13 3 23.1% 
6 12 6 50.0% 
7 21 8 38.1% 
8 17 9 52.9% 
9 19 10 52.6% 
10 16 11 68.8% 
11-19 - - - 
 20 40 9 22.5% 




According to the results in Table 5.28, the average error rate for the concepts from 
small partial-area nodes with up to 10 concepts is 44.7% (= 67/150), while the error rate 
for the concepts from large partial-area nodes, summarizing at least 20 concepts, is 22.5%. 
Table 5.29 summarizes the comparison of these two error rates. The error rate difference 
is statistically significant (p < 0.05 according to Fisher’s exact test). Therefore, the results 
confirm Hypothesis 5.9, namely that concepts represented by small partial-area nodes are 
more likely to have errors than concepts in large partial-area nodes.  








small partial-area nodes 
(size < 11) 
67 83 44.7% 
large partial-area nodes  
(size  20) 
9 31 22.5% 
 
 
With one exception, all errors reported by the three domain experts are errors of 
omission. Table 5.30 summarizes the distribution of erroneous concepts according to 
different error types. The most common type of error is the omission of roles, which 
occurs for 60 concepts from small partial-area nodes (40.0% = 60/150) and five concepts 
from large partial-area nodes (12.5% = 5/40). The second most common type of error is 
“missing parent” with 13 (8.67% = 13/150) concepts having this error among small 
partial-area nodes and three (7.5% = 3/40) among large partial-area nodes.  
Table 5.31 lists some examples of concepts having modeling errors in their IS-A 
relationships. For example, the concept Benign Epithelial Neoplasm from a partial-area 
node summarizing only one concept is missing an IS-A relationship to Benign Neoplasm. 
Another concept Benign Iris Neoplasm from a small partial-area node was found missing  
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a child Iris Nevus. The experts also found one concept, Combined Carcinoid and 
Adenocarcinoma, from a large partial-area node having an incorrect IS-A relationship. 
As mentioned in Section 2.1.3, the Disease, Disorder or Finding hierarchy has 29 
role types. For the 150 concepts from small partial-area nodes, the three domain experts 
found 60 concepts missing 12 role types. Table 5.32 shows the distribution of these 60 
erroneous concepts by role types and gives an example of one erroneous concept for each 
role type. For example, there are 10 concepts from small partial-area nodes missing the 
role Disease Excludes Abnormal Cell. Acantholytic Squamous Cell Skin Carcinoma is 
one of the 10 erroneous concepts, and it is missing this role with the target Malignant  
Table 5.30 Comparison of Error Distribution by Types between Concepts from Small 
and Large Partial-area Nodes 
 
Error Type 
# Erroneous Concepts from 
Small Partial-area nodes 
# Erroneous Concepts from 
Large Partial-area nodes 
Total 
Missing role 60 5 65 
Missing parent 13 3 16 
Missing child 1 1 2 
Incorrect parent 0 1 1 
 
 








small Missing parent 
Benign Epithelial 
Neoplasm 
Missing parent Benign 
Neoplasm 
small Missing child Benign Iris Neoplasm Missing child Iris Nevus 
large Missing parent 
Reproductive 
Endocrine Neoplasm 
Missing parent Endocrine 
Neoplasm 
large Missing child 
Intraventricular Brain 
Neoplasm 
Missing child Glioblastoma 
and Pilocytic Astrocytoma 
large Incorrect parent 
Combined Carcinoid 
and Adenocarcinoma 





Basaloid Cell. Another issue discovered was that 32 concepts are missing the Disease 
Has Finding role.  
The error correction propagation method (Section 5.2.1.3) was applicable to a 
number of concepts in the sample, leading to the unification of several partial-area nodes 
from several area nodes into one larger partial-area node. This can be observed, for  
Table 5.32 The Number of Concepts from Small Partial-area Nodes Missing Roles for 






Missing Role Type 
Target of 
Missing Role 














8 Amelanotic Melanoma 
Favorable 
Clinical Outcome 
Disease Has Primary 
Anatomic Site 
7 











Disease Has Normal 
Cell Origin 
5 Granulosa Cell Tumor Granulosa Cell 
Disease Excludes 





Disease Has Associated 
Anatomic Site 
3 Hemolymphangioma Lymphatic Vessel 
Disease Excludes 












Disease Has Abnormal 
Cell 
1 Clear Cell Adenoma 
Neoplastic Clear 
Cell 









example, by looking at the roots Benign Muscle Neoplasm (11), Benign Brain Neoplasm 
(15) and Benign Female Reproductive System Neoplasm (11). 
The consensus erroneous concepts (76) were submitted to the NCIt editorial team. 
The NCIt team confirmed 17 erroneous concepts (22.4%), of which only one concept is 
from a large partial-area (with size 53) and the other 16 concepts are from small partial-
areas. The NCIt team did not review any other concepts from the 190 concept sample and 
thus their review cannot be considered an alternative QA study. Table 5.33 lists five 
example concepts with errors that were confirmed and corrected by the NCIt team. Table 
5.34 shows another four concepts that were reported as having errors by the domain 
experts that were not corrected by the NCIt team. The third column in Table 5.34 reports 
the NCIt team’s reasons for not correcting the concepts, while the fourth column presents 
the external domain experts’ consensus counter arguments, explaining why nevertheless 
these errors should be considered legitimate. Table 5.35 shows the distribution of 
concepts into small, medium and large partial-areas.  
To summarize this study, errors in the NCIt Neoplasm subhierarchy are not 
uniformly distributed. Uncommon modeling of concepts, which is reflected in small 
partial-areas in the partial-area taxonomy, resulted in a significantly larger percentage of 
erroneous concepts than in a control group of concepts from large partial-areas. The error 
rate for small partial-areas (44.7%) was twice as large as the error rate for large partial-
areas (22.5%). Furthermore, group-based auditing, using groups constituted in the partial-
area taxonomy, was demonstrated to support easy discovery of additional erroneous 
concepts in the same partial-areas of the partial-area taxonomy. By error correction 
propagation, additional errors at lower levels in the partial-area taxonomy were also  
 
 
Table 5.33 Example Concepts with Errors Confirmed by NCIt Curators 
 
Concept Confirmed Error Correction 
Benign Buccal Mucosa Neoplasm 
Missing roles: Disease Has Finding with targets Benign 
Cellular Infiltrate and Indolent Clinical Course 
Add these two roles 
Granulosa Cell Tumor 
Missing role: Disease Has Normal Cell Origin with the 
target Granulosa Cell 
Add the role 
High Grade Vaginal Intraepithelial 
Neoplasia 
Missing role: Disease Has Primary Anatomic Site with 
the target Vagina 
Add the role 
Human Papillomavirus-Related Malignant 
Neoplasm in AIDS Patient 
Missing role: Disease Has Associated Disease with the 
target Acquired Immunodeficiency Syndrome 
Add the role 
Reproductive Endocrine Neoplasm Missing parent: Endocrine Neoplasm 
















Table 5.34 Example Concepts with Errors Not Corrected by NCIt Curators 
 






Disease Has Finding with 
the target High Grade 
Lesion 
This concept already has the role 
Disease Is Grade with the target 
High Grade. 
The role Disease Is Grade pointing to High 
Grade only hints at the existence of the role 
Disease Has Finding pointing to High Grade 
Lesion. In an ontology, information should be 
explicit so it is usable for computers. Besides, 




Disease Has Associated 
Anatomic Site with the 
target Skeletal Muscle 
Tissue 
This concept already has the role 
Disease Has Normal Tissue 
Origin with the target Skeletal 
Muscle Tissue. 
Similarly as above, the suggested role is not 




Disease Has Primary 
Anatomic Site with the 
target Meninges 
This concept already has the role 
Disease Has Normal Tissue 
Origin with the target Meninges. 
Same as previous. However, some concepts in 
NCIt, (e.g., Benign Meningioma), have both 
roles Disease Has Primary Anatomic Site and 
Disease Has Normal Tissue Origin pointing to 
Meninges. 
Clear Cell 
Squamous Cell Skin 
Carcinoma 
Missing parent: Primary 
Malignant Neoplasm 
Primary Malignant Neoplasm is 
under "Neoplasm by Special 
Category." The NCIt team had 
decided not to populate such 
terms with specific 
histopathologies and not to 
model/define such terms. 
The NCIt curator agrees with the correction and 








Table 5.35 The Neoplasm Concept Distribution According to Partial-area Size 
 
Partial-area size # of Partial-areas Total # of Concepts % of Concepts 
1-10 4762 6581 80.59% 
11-19 44 642 7.86% 
≥20 18 1014 12.42% 
Total: 4824 8166  
 
 
found and corrected with minimal additional effort. On a more general level, this study 
concluded that Abstraction Networks were again successful in aiding the process of 
discovering “suspicious” concepts.  
5.2.2 Quality Assurance of Concept Roles in NCIt Biological Process Hierarchy 
 
Roles, an important component of NCIt modeling, are used to define concepts and are 
inherited down the hierarchies. The complete and accurate representation of biomedical 
knowledge for a concept through roles is important for the NCIt applications such as 
reasoning. Hence, it is necessary to conduct a QA study concentrated on missing role 
errors. One of the inherent concept groupings in an area taxonomy, called the top area, 
comprises all concepts without any roles at all. This is a natural place to search for 
concept with missing role errors. Besides, factors such as disproportional size or 
disproportional growth over time of the top area could be indicators in determining 
whether QA efforts are warranted. Moreover, the hierarchical depth of the top area can be 
another factor to be considered. 
As mentioned in Section 2.1.3, 513 concepts (44.8% of the complete Biological 
Process hierarchy) are in the top area (see Figure 5.6 on Page 101). For comparison, in 
the year 2004 [5], only 47 concepts out of 589 concepts (8%) were in the top area. That is, 
while the Biological Process hierarchy grew about two-fold, the top area grew about 
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eleven-fold. When there is such disproportional growth of the top area, it can be 
interpreted as an anomaly alerting QA experts to the possibility of widespread missing-
role errors.  
For each NCIt hierarchy, there is a list of role types that can be used to define its 
concepts. The Biological Process (BP) hierarchy has seven possible associated roles 
whose full names and abbreviated names were given in Table 2.2.  Figure 5.6 shows the 
complete area taxonomy of the BP hierarchy. This section presents a QA study on the 
concepts in the top area of the area taxonomy for the BP hierarchy. 
5.2.2.1 Methods. Quality assurance (QA) efforts on large and complex biomedical 
ontologies need to be highly focused and aided by techniques that automatically identify 
sets of concepts that are suspicious or anomalous and warrant special attention. Such 
concepts are expected to be in error, with a high likelihood. One characterization of 
concepts shown to have a higher error rate identified by Abstraction Networks is 
uncommonly modeled concepts, which were described in Section 2.3.  
In this study, a concept residing in the top area Ø was considered to be an 
uncommonly modeled concept, one of the major themes for concept sets expected to 
harbor errors at a high rate [4]. More specifically, when the top area Ø for a given 
hierarchy is disproportionately large, this can be taken to be anomalous. This means that 
a high percentage of concepts in the hierarchy suffer from a lack of roles and inherent 
under-definition. The BP hierarchy is an example where this phenomenon exists. To be 
sure, there are concepts that rightfully do not have any roles. But those are typically 
concepts capturing general subjects or categories, for which no roles are relevant due to 
their general nature, e.g., Pathologic Process and Reproductive Process. Typically, such 
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concepts reside close to the hierarchy’s root as its children or grandchildren. However, in 
general, the number of such concepts is expected to be relatively small.  
This study proposed that an anomalous top area warrants special attention in QA 
efforts in regard to the error of omission “missing role.”  The following Hypothesis 5.10 
was formulated. 
Hypothesis 5.10: If a large percentage of a hierarchy’s concepts are in the top 
area of its area taxonomy, then the percentage of concepts in the top area that are lacking 
roles is statistically significantly higher than the percentage of such concepts in other 
areas. 
A QA study was conducted to assess Hypothesis 5.10. In the study, the QA 
analysis of the BP hierarchy’s top-area concepts and control concepts was carried out 
manually by the domain expert Dr. Yan Chen, who has medical training and extensive 
experience in ontology QA. A manual review by a domain expert is required since human 
understanding is needed for such judgements. However, the detection of sets of concepts 
with high likelihood of errors was performed algorithmically. The missing-role errors 
found in the analysis were submitted for secondary review and confirmation by a curator 
of the NCIt. 
In some hierarchies of large ontologies, even the top area is very large, and a QA 
review of all its concepts is not practical. For example, in the February 2015 release of 
NCIt, the Disease, Disorder, or Finding hierarchy contains 25,360 concepts, and its top 
area has 14,347 concepts. Similarly, the top area in the Clinical finding hierarchy of 
SNOMED CT contains 7,000 concepts. In such a case, the challenge is to narrow down 
the QA effort to a more promising subset of the top area. This is where another version of 
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“complex modeling of concepts” was employed.  
One way to measure the complexity of a concept is by the number of roles 
defined for it as in the two Sections 5.1.4 and 5.1.5. A concept with six roles is likely to 
be more complex than a concept with, say, one or two roles. Intuitively, it is more 
difficult to correctly model a complex concept than it is for a simpler concept, and thus 
there is a higher likelihood of introducing a modeling error for the former. However, this 
measure of complexity is not relevant to the top area, where concepts have no roles at all. 
Another way of characterizing the notion of “complex concept” in that context was 
needed. 
The hierarchical distance of concepts from the root of the top area is one rational 
way to measure the complexity of concepts in the top area. For example, DNA Major 
Groove Binding has a path of seven IS-A links to the root concept, Biological Process, of 
the whole hierarchy (see Figure 5.10). The concepts along the path accumulate more 
complexity in their nature and definitions as they are getting farther away from the root. 
 
Figure 5.10 Path of seven IS-A links to the root. 
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In this light, the assumption is that the likelihood of a missing-role error increases with 
the additional refinement and complexity associated with the increasing distance from the 
root. In other words, one can expect a higher percentage of concepts with missing roles at 
the top area’s levels with higher level numbers, where “level” is defined as the number of 
IS-A links in the path from the root to a given concept.  
For example, in Figure 5.10, the level of DNA Major Groove Binding is seven. By 
definition, the root, Biological Process, resides on Level 0. (When a concept has multiple 
parents—and hence there are multiple paths to the root—its longest path defines its level. 
Topological sort [133] can be used to calculate the longest-path distance for all concepts 
in the top area in linear time.) Assuming a continuum of increased complexity along a 
path of concepts from the root, the levels of the hierarchy are divided into two halves, the 
upper and lower halves, with the expectation of more missing roles in the upper-half (by 
path length) of the hierarchy where concepts are more complex.  
The above assumption has practical implications for QA in the case where the top 
area is too large to be reviewed in its entirety. In such a case, it is recommended that QA 
processing be concentrated on the levels with higher level numbers, since their concepts 
are generally more complex and are expected to have more missing roles. These levels 
appear lower in the diagram. In this regard, the following Hypothesis 5.11 was tested in 













+ 1, …, n, assuming there are n levels in total in the top area. These are 






 – 1. These 
levels appear closer to the root in the diagram. For example, in Figure 5.10, where there 
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are eight levels, the lower-half levels are 0, 1, 2, and 3, and the upper-half levels are 4, 5, 
6, and 7. 
Hypothesis 5.11: Concepts in the upper-half levels of the top area have a higher 
likelihood of missing-role errors than concepts in the lower-half levels. 
Since the BP hierarchy has an unusually large top area of 513 concepts (44.8% of 
the overall hierarchy), in the study, all concepts of its top area were reviewed for the 
specific error of “missing role.” The number of erroneous concepts found in each level 
and their percentages were analyzed. As a control group, a random sample of 100 
concepts was selected from all areas excluding the top area. However, since previous 
research with the NCIt BP hierarchy, mentioned in Section 2.3, by Min et al. [5] reported 
a higher likelihood of errors in small partial-areas, concepts from such groups were 
excluded so as not to bias this study. 
Note that the QA analysis of concepts in the top area has potential implications 
beyond that area. Specifically, if a concept C from the top area is found to be missing a 
role R pointing to a target concept D, then all of C’s descendant concepts that do not have 
the role R, both inside and outside the top area, should also have the role R. Such a role R, 
if added, will point either to the same target D or to a descendant of D. If some such 
descendants do not have R, then they must be missing it. Hence, there is a potential 
propagation of the QA efforts for the top area into other areas of the hierarchy. Such 
propagation will save the QA analyst effort, since the additional concepts to be reviewed 
can be identified automatically by looking for missing roles.  
5.2.2.2 Results. The overall results are summarized in Table 5.36, which shows the 
level distribution of concepts in the top area and the number of concepts found to be  
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Table 5.36 Missing-role Error Distribution by Level in the Top Area 
 
Level # Concepts # Concepts Missing Roles % of Concepts Missing Roles 
0 1 0 0% 
1 7 0 0% 
2 69 15 21.7% 
3 138 53 38.4% 
4 125 58 46.4% 
5 88 61 69.3% 
6 44 32 72.7% 
7 14 8 57.1% 
8 23 5 21.7% 
9 4 0 0% 
Total: 513 232 45.2% 
 
 
missing roles at the different levels. For example, at Level 5, consisting of 88 concepts, 
61 concepts (69.3%) were missing roles. Out of the 513 concepts in the top area, 45.2% 
were missing roles. Furthermore, as the level number increases, the percentage of 
concepts missing roles at each level also increases. The exceptions to this are Levels 7, 8, 
and 9, probably due to the fact the numbers of concepts at these three levels are relatively 
small. It is not surprising that there are no concepts missing roles at Level 0 and Level 1, 
because these concepts are very general and roles are often introduced at more specific 
levels. For example, two general concepts at Level 1 are Regulatory Process and 
Pathologic Process. 
Table 5.37 lists the number of concepts reported as having missing roles, for each 
different kind of role, and how many of them were confirmed. For example, 103 concepts 
were deemed to be missing the role Location, but only 84 of these were confirmed in the 
secondary review. As can be seen in the table, the largest numbers of missing roles in the  
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Table 5.37 Number of Concepts in the Top Area Reported Missing Roles for Each Role 
Kind 
 
Role # Concepts w/Missing Role 
# Concepts Confirmed 
by Curator 
Location 103 84 
Initiator Chemical or Drug 1 0 
Initiator BP 2 0 
Resulting Anatomy 1 1 
Resulting BP 3 1 
Resulting Chemical or Drug 20 10 
Part of Process 113 4 
Total: 232 99 
 
 
initial QA analysis appeared with respect to Location and Part of Process. But the 
curator’s highest levels of agreements were for Location (82%) and Resulting Chemical 
or Drug (50%).  
Table 5.38 shows five examples of concepts missing various kinds of roles 
confirmed by the curator of NCIt. For example, Adrenal Hormone Activity Induction is 
indeed missing the role Location that should be directed to the concept Adrenal Gland. 
On the other hand, Table 5.39 shows some examples of findings that were rejected by the 
curator, along with accompanying reasons. For example, initial QA analysis deemed the 
concept Glucocorticoid Secretion Process to be missing the Resulting Chemical or Drug 
role directed to Glucocorticoid. However, while it is true that in order for a product (e.g., 
a hormone) to be secreted, it first has to be produced, the set of processes (and enzymes) 
involved in production may not overlap with those involved in secretion. (Thyroid 
hormone is a good example of a product where production and secretion are two 
completely separate processes.) 
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Table 5.38 Examples of Concepts Confirmed to Have Missing Roles in the Top Area for 
Different Roles 
 
Role Example Confirmed Concept 
Missing Role 
Target of Missing 
Role 
Location Adrenal Hormone Activity 
Induction 
Adrenal Gland 
Resulting Anatomy Coagulation Process Fibrin 
Resulting BP Evolution Genetic Drift 
Resulting Chemical or Drug Histamine Production Histamine 
Part of Process Postpartum Recovery Postpartum Process 
 
 
Table 5.39 Rejected Examples of Concepts Missing Roles in the Top Area for Different 
Roles 
 
Role Reported Example of 
Concept Missing Role 
Proposed Target 
of Missing Role 
Reason for 
Rejection 
Location RNA Processing Nucleus Not always true 
Resulting BP Antigen Binding 
Immune Response 
Process 








do not produce 
chemicals 








The examples of Table 5.39 demonstrate the subtleties of the modeling issues 
involved and that it is possible that different experts differ in their opinions. The last 
example in Table 5.39 demonstrates two legitimate modeling options. Defecation IS-A 
Gastrointestinal Process and can also be viewed as Part of Process linked to 
Gastrointestinal Process. The curator, however, followed rules established in the overall 
modeling of the BP hierarchy. 
Out of the 100 control concepts gleaned from non-top areas, 13 concepts were 
found by the domain expert to be missing roles. Table 5.40 shows the contingency table 
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Table 5.40 The 2x2 Contingency Table for the Concepts with Errors in the Top Area and 
Non-top Areas 
 
 # Erroneous Concepts # Concepts w/o Errors 
Non-top areas 13 87 
Top area 232 281 
 
 
for the control (concepts in non-top areas) and study concepts (those in the top area). The 
Fisher’s exact test two-tailed [118] p-value is less than 0.0001, which means the result 
has statistical significance. In other words, the concepts in the top area are significantly 
more likely to have missing roles than concepts in non-top areas. Thus, Hypothesis 5.10 
is confirmed. Out of the 13 erroneous control concepts, the secondary review of the NCIt 
curator confirmed 10 concepts (76.9% = 10/13). Table 5.41 is the corresponding 
contingency table for erroneous concepts in the top and non-top areas confirmed by the 
NCIt curator. The two-tailed p-value by Fisher’s exact test is 0.0311, which also 
confirmed Hypothesis 5.10 only considering the confirmed erroneous concepts. 
Table 5.41 The 2x2 Contingency Table for Erroneous Concepts in the Top Area and 
Non-top Areas Confirmed by the NCIt Curator 
 
 # Erroneous Concepts # Concepts w/o Errors 
Non-top areas 10 90 
Top area 99 414 
 
 
Table 5.42 summarizes the comparison between concepts missing roles at the 
lower-half levels (Levels 0–4) and those missing roles at the upper-half levels (Levels 5–
9). There are 340 concepts in the lower-half levels, which is nearly twice of the 173 
concepts in the upper-half levels. However, the percentage of concepts missing roles in 
the upper-half levels (61.3%) is higher than that in the lower-half levels (37.1%). The 
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two-tailed p-value is less than 0.0001 by Fisher’s exact test. Thus, the results confirm 
Hypothesis 5.11 that concepts in the upper-half levels (Levels 5–9) of the top area have a 
significantly higher likelihood of missing roles than those in the lower-half levels. 
Table 5.42 The 2x2 Contingency Table for Concept Errors between the Lower-half 
Levels and Upper-half Levels 
 
Level Range # Erroneous Concepts # Concepts w/o Errors 
0–4 (lower-half) 126 214 
5–9 (upper-half) 106 67 
 
 
Out of the 513 concepts in the top area, 354 concepts (69%) are leaves, i.e., do not 
have any descendants. Among the 159 non-leaf concepts, 68 concepts were found to be 
missing roles. Due to role inheritance, after correction, the descendants of those 68 
concepts should now also have the same kinds of roles, with targets that are the same or 
more specific. Therefore, for those descendants outside the top area, it is necessary to 
check whether they have the roles that were missing in their ancestors in the top area. The 
results for the descendants of these 68 concepts are shown in Table 5.43. For five of them 
(Row 1), all their descendants are in non-top areas. For another 40 (Row 3), all their 
descendants reside with them in the top area. For the remaining 23 concepts (Row 2), 
some of their descendants are in the top area with them and others reside in areas below. 
The number of affected descendants reported (last column of Table 5.43) is the number 
of descendant concepts missing the same roles as their ancestors plus the number of 
descendants having the roles, but with targets different from their ancestors’ (and not 
more specific than those). Figure 5.11 shows the new area taxonomy of the Biological 
Process hierarchy to illustrate the changes that occurred as a result of the QA analysis, 
including corrections in the non-top areas due to the propagation of the additional roles. 
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Table 5.43 Affected Descendants of the 68 Non-leaf Concepts Missing Roles in the Top 
Area 
 
 # Concepts 
Total # Descendants 
Outside Top Area 
# Affected 
Descendants 
All Descendants are in 
Non-Top Areas 
5 15 5 
Some Descendants are 
in the Top Area 
23 102 50 
All Descendants are in 
the Top Area 
40 N/A N/A 




Figure 5.11 Revised area taxonomy for the Biological Process hierarchy incorporating 




In conclusion, this study introduced a QA methodology targeted at missing-role 
errors. The foundation of the approach was an Abstraction Network called “area 
taxonomy.” An anomalous feature of the area taxonomy, when present, was used as an 
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indicator in guiding the QA analysts in their search for missing-role errors. The 
methodology was demonstrated with an application to the NCIt’s Biological Process 
hierarchy. A statistically significant number of missing-role errors was discovered by an 
external reviewer and confirmed by a curator of the NCIt. Overall, the methodology can 




CHAPTER 6  
CONCLUSIONS AND FUTURE WORK 
 
In conclusion, this dissertation conducted several studies based on Abstraction Networks 
with the goal of trying to solve the Big Knowledge to Use (BK2U) problem, which is the 
implied problem of the Big Data to Knowledge (BD2K) challenge. The studies in this 
dissertation can be summarized under the following two main subjects: 
1. Advanced Abstraction Networks for Big Knowledge summarization and 
visualization: the weighted aggregate partial-area taxonomy and the Ingredient 
Abstraction Network (IAbN). 
2. Applications of the Big Knowledge summarization and visualization techniques: 
the identification of major topics in ontologies, the multi-layer multi-granularity 
visualization scheme for ontology comprehension, the discovery of Drug-Drug 
Interactions and the family-based quality assurance of large biomedical ontologies. 
The weighted aggregate partial-area taxonomy was developed based on the 
partial-area taxonomy, which provides a more compact summary of ontologies to get a 
better big picture of the content in ontologies compared with the partial-area taxonomy. 
The weighted aggregate partial-area taxonomy was applied to identify and visualize 
major topics in SNOMED CT’s Specimen hierarchy with the guidance of a list of gold 
standard topics provided by a domain expert. A new multi-layer multi-granularity 
visualization approach based on the weighted aggregate partial-area taxonomy was 
developed for the comprehension of Big Knowledge in ontologies. 
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The weighted aggregate partial-area taxonomy will be applied to enhance an 
existing ontology, for example, the Ophthalmology-related components in SNOMED CT. 
According to Ophthalmologists, the current components in SNOMED CT are not suitable 
for coding in an EHR, thus, they are not used in clinical practice as desired. In order to 
improve this situation, first, a weighted aggregate partial-area taxonomy will be created 
for each of the subhierarchies related to Ophthalmology, which will provide major 
subjects in the subhierarchy, serving as a “big picture.” The weighted aggregate partial-
area taxonomy will be expanded to derive a second level weighted aggregate partial-area 
taxonomy, showing more details than the first level. These first two levels will be 
modified to make each of the subhierarchies more suitable to express clinical terms used 
in practice. After that, each node in the second level partial-area taxonomy will be further 
expanded into a subhierarchy. This process will result in a more practical subhierarchy 
that will be used to code ophthalmological concepts in an EHR. 
Due to NDF-RT’s structure, the previously developed Abstraction Networks are 
not suitable to summarize most of NDF-RT’s hierarchies. Hence, in this dissertation, the 
Ingredient Abstraction Network (IAbN) was designed to summarize the NDF-RT’s 
Chemical Ingredients hierarchy. In fact, the idea of the IAbN could be applied to the 
other six hierarchies in NDF-RT, except for the Pharmaceutical Preparations hierarchy. 
In this dissertation, the IAbN was applied to discover missing Drug-Drug interactions 
(DDIs) from First Databank’s DDI knowledge base.  
In March 2018, NDF-RT was replaced by the Medication Reference Terminology 
(MED-RT), which refers to clinical drug concepts, chemical ingredient concepts, and 
assorted other concepts in external terminologies such as RxNorm, MeSH, and 
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SNOMED CT, and maintains the relationships between concepts. In future, a virtual 
Chemical Ingredients hierarchy will be built according to the relationships between 
clinical drug concepts and chemical ingredient concepts. A new Abstraction Network 
called Virtual Ingredient Abstraction Network (VIAbN) will be derived to summarize and 
visualize the virtual Chemical Ingredients hierarchy. The VIAbN could be applied to 
discover missing Adverse Drug Reactions in First Databank’s knowledge base. 
Chapter 5 presented eight Abstraction Network-based quality assurance (QA) 
studies on different hierarchies in an ontology or on different ontologies. The two 
characterizations of concepts with higher error rates, complex concepts and uncommonly 
modeled concepts, were successfully utilized to guide the QA studies. Such studies are 
needed in order to demonstrate the validity of the family-based quality assurance 
approach. A quality assurance technique is required to be successfully demonstrated for 
six out of six BioPortal ontologies in the same family to claim that it is applicable to the 
whole family.  
The three studies in Chapter 5 on overlapping concepts within partial-area 
taxonomies for the NCIt’s Neoplasm subhierarchy and Gene hierarchy and the SNOMED 
CT’s Infectious disease hierarchy, combined with the previous three studies by the 
SABOC team on another three ontologies in the same family, made the overlapping 
concept QA technique applicable to the whole family with 76 ontologies in BioPortal. 
Furthermore, new QA techniques were introduced in this dissertation, i.e., utilizing the 
partial-area sub-taxonomy to look for additional overlapping concepts to increase the 
impact of the overlapping concept QA technology, utilizing group auditing and error 
propagation methods to save QA efforts. In future, the additional overlapping concept 
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technique will be investigated in other large hierarchies/ontologies with a limited number 
of overlapping concepts in their partial-area taxonomies. 
The two studies on the NCIt’s Biological Process hierarchy and the ChEBI 
ontology focused on concepts with many lateral relationship types in area taxonomies, 
which is another type of complex concepts, that is, laterally complex concepts. This QA 
technique was demonstrated successfully on the above two ontologies. In order to show 
that this technique is applicable to a whole family, in future, four additional studies on 
another four ontologies in this family will be conducted.  
Furthermore, in this dissertation, the new Abstraction Network IAbN was applied 
to support the quality assurance of the Chemical Ingredients hierarchy in NDF-RT. The 
two new hypotheses for this topic focused on a new characterization of complex concepts, 
namely chemical ingredients in ingredient groups with multiple parent ingredient groups. 
In addition, the chemical ingredients with more parent ingredient groups were 
demonstrated as more complex, thus, more likely to have errors. 
For uncommonly model concepts, the study on the NCIt’s Neoplasm subhierarchy 
investigated concepts in small partial-areas within its partial-area taxonomy. This is the 
third study showing that the small partial-area QA technique is successful. The previous 
two studies by the SABOC team demonstrated this technique successfully on the NCIt’s 
Biological Process hierarchy and the SNOMED CT’s Procedure hierarchy. In future, 
three more QA studies on the ChEBI ontology, the SNOMED CT’s Specimen hierarchy, 
and the NCIt’s Gene hierarchy belonging to the same family, will be performed to meet 
the requirement of “six out of six” under the family-based QA framework.  
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There were 44.8% of concepts in the NCIt’s Biological Process hierarchy having 
no lateral relationships, which was indicating that these concepts may miss lateral 
relationships. In the study on all these concepts, 45.2% were found missing lateral 
relationships. This study also confirmed the hypothesis that concepts in the area without 
any relationship are more likely to miss relationships than concepts in other areas within 
the area taxonomy. The complexity measure for the former type of concepts was explored 
as well, which will guide ontology curators to focus on auditing more complex concepts 
without relationships to achieve a better error yield, when it is impossible to perform 
quality assurance on all concepts without any relationship in the hierarchy/ontology. In 
future, this phenomenon will be investigated on other ontologies with a large number of 
concepts without lateral relationships, such as the NCIt’s Neoplasm subhierarchy and the 
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